Yaya tsawon lokacin da waɗannan alamun ke faruwa?
Kuma wannan shine yadda ake magance ciwon kirji, musamman a wannan shekarun.
Kuma yana rashin lafiya.
Kuma za su gwada yawan cholesterol da kuma hawan jini.
Kuma kuna da zazzabi yanzu?
Har yanzu kuna da ciwon kirji?
Ban da haka, kana da wahalar numfashi?
Kuma ka gaya mini wasu alamun da suke tare da shi.
Kuma yaya yawan zafin jikinka ya tashi?
Ina da mummunan tari.
Kuma ina da ɗan sanyi da tari.
Kuma a yau, ina da ciwon kirji mai tsanani.
Kuma wannan ba lokacin da kuke yawan zuwa Haifa ba?
Kuma hakan yana sa ni jin ciwo.
Kuma ina tsammanin ina da zazzabi kadan.
Kuma ina so ku gaya mani inda ciwon kirji yake.
Wasu kuma suna da zazzabi.
Kuma kana da tarihin ciwon sukari.
Kuma kun san, na ji kamar ƙirjina ya karye.
Kuma mutane suna juya gare ni koyaushe suna tari.
Kuma kana da ciwon kirji.
Kuma ya ce kuna da matsin lamba a kirji.
Shin wani a cikin iyalinku yana da ciwon zuciya, cututtukan zuciya, ciwon jini, hawan cholesterol, ko hawan jini?
Shin kun lura da wasu alamomi ko matsaloli ban da ciwon tsoka?
Shin akwai wani a gida da ke fama da irin wannan alamun?
Shin kana da wasu alamun cutar?
Shin kana da wahalar numfashi?
Har yanzu kuna jin ciwon kirji?
Wannan shi ne saboda lokacin mura ne.
Amma kada mu yi watsi da ciwon zuciya na gaske.
Amma yanzu, matsala mafi girma ita ce ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa da suka yi tari a kaina.
Amma duk da haka, duk irin ciwon kirji da muke da shi, muna bukatar mu kula da shi sosai.
Amma kuna da numfashi, ba haka ba?
Na manta da ciwon kirji.
Kuna jin kamar wani yana matsawa kirjinku?
Har yanzu ina jin numfashi yana yi mini wuya.
Shin sun ce suna fama da irin wannan alamun?
Shin kuna da cutar hawan jini ko wani abu makamancin haka?
Shin yana da wasu cututtuka na kullum kamar ciwon sukari da kuma ciwon sukari?
Shin wannan ciwon kirji yana tare da wahalar numfashi?
Kana da hawan jini?
Shin yana da wuya a numfashi?
Waɗanne alamun cutar ne aka sani?
Kuna ganin hoton?
Ku sha ruwa da yawa yau.
Amma na yi gwajin ciwon sukari.
Amma yana da halaye iri ɗaya da ni.
Yaya yawan zafin jikinka yake?
Yaya yawan hawan jini naka yake?
Idan kana da zazzabi mai tsanani kuma ba za ka iya daina ba,
Idan kana da zazzabi 102 ko sama da haka,
Kuna ganin ya kamata mu kara duba alamun cutar da matsalolin da ke tattare da ita?
A jiya ina da zazzabi.
Ni ma ina da zazzabi kaɗan.
Na yi rashin lafiya jiya.
Ina jin ciwon kirji a nan.
Ina da wahalar numfashi.
Zan aiko muku da hoto.
Ina da ciwon kirji a yau.
Ina jin zafi da ciwon kai a yau.
Ina tsammanin ina da mura.
Ina tsammanin wannan ɗan mura ne.
Shin yana kama da wani mai nauyi yana zaune a kan kirjinka?
Ya fara da ciwon kai, kuma a lokaci guda, zazzabi ya tashi.
Yana riƙe da ni daidai a tsakiyar kirji.
Yana da wani nau'i na matsa lamba kamar ƙwanƙwasawa a kirji.
Yana cikin kirji na.
Na sanya shi a tsakiyar kirji na.
Shin a tsakiyar kirji ne?
Ina da ciwon kirji.
Na damu sosai game da wannan ciwon kirji.
Zan so in nuna muku yadda wannan ciwon kirji yake.
Wasu cututtuka kamar su hawan jini ko ciwon sukari.
A tsakiyar kirji, a wani wuri.
Yanzu, idan kuna da zazzabi, kuna iya cin takapirin.
Mary, kwana nawa ne yanzu da kake da wadannan alamun?
Yanzu kun ce kuna da ciwon kirji.
Wani lokaci ina jin ciwon kirji.
To, ban da ciwo, waɗanne alamun cutar kuke da su?
Ko kuma wani ya zauna a kan kirjinka?
Ba su da yawa, suna rashin lafiya, suna tari, suna ciwon kai, suna ciwon tsoka.
Ina tsaye a tsakiyar kirji.
A cikin wannan hoton, nuna mini inda na ke ciwo.
Idan kana da zazzabi,
Shin kuna ganin wasu daga cikin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mana game da ciwon kirjinka.
A daren, zazzabi yakan yi yawa.
Na yi zazzabi na kwana biyu yanzu.
Tun daren jiya, na fara jin zafin jiki.
Ya ce, "Muna da dakunan gaggawa uku a kan Dr.
To, za ku iya gaya mana game da ciwon kirjinku?
Haka ne, ina da wani abu a gabashin jiki, a nan a kirji.
Na'am, ina da ciwo a kirji.
"Haka ne, ina da ciwon kirji".
Yaya ciwon kirjinku yake?
A wane lokaci ne ciwon kirji ya soma?
A ina ne ƙirjinka yake ji?
A ina ne kake jin ciwon kirji?
Kuna jin kamar an matsa muku a kirji?
Ka sani, ina da ciwon sukari da kuma wasu abubuwa.
Ka ce kana da ciwon kirji.
Daga ranar 1 ga Janairu zuwa 15 ga Maris, 2020, yawan kamuwa da cutar coronavirus (COVID-19) ya karu cikin sauri a cikin ƙasashen EU / EEA da United Kingdom.
Ƙididdigar ƙaruwar kamuwa da cutar coronavirus (COVID-19) ta nuna cewa akwai irin wannan yanayin a cikin EU / ƙasashen da ke da alaƙa da Turai da United Kingdom, yana tabbatar da cewa cutar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe, tare da bambance-bambance a cikin ƙasa.
Bisa ga kwarewar da aka samu a Italiya, ƙasashe, asibitoci da cibiyoyin kulawa na musamman ya kamata su haɓaka shirye-shiryen su don saurin haɓaka yawan masu cutar COVID-19 da ke buƙatar kulawa ta musamman.
A ranar 31 ga Disamba, 2019, an bayar da rahoton barkewar cutar nimoniya da ba a san dalilin ta ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton gano wani abu da ke haifar da cutar coronavirus, wanda yanzu ake kira SARS-CoV-2 (Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar C
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
A yau, shaidu sun nuna cewa kusan kashi 80% na masu kamuwa da COVID-19 suna kamuwa da cutar huhu ko kuma cutar huhu ko kuma cutar cututtukan numfashi mai sauƙi, kuma yawancin suna murmurewa.
A cikin kusan kashi 14% na lokuta, COVID-19 ya canza zuwa wani yanayi mai tsanani wanda ke buƙatar asibiti, yayin da sauran kashi 6% na lokuta suka sami mummunan rashin lafiya wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke kwance a asibiti saboda COVID-19 ya kai kusan kashi 4 cikin dari.
A cikin wannan binciken, za mu bincika da kimanta yiwuwar yanayin yaduwar COVID-19 a cikin ƙasashen EU / EEA da United Kingdom ta kowace ƙasa, kuma mu kwatanta su da lardin Hubei na China.
Mun kuma kwatanta adadin adadin masu cutar COVID-19 a cikin EU / EEA da UK da adadin masu cutar a Italiya a cikin Janairu 31 zuwa Maris 15, 2020.
Cutar COVID-19 a cikin EU/EEA da UK
Bayan barkewar cutar a China, COVID-19 ya ci gaba da yaduwa zuwa wasu yankuna, kuma sauran ƙasashe a duniya sun sami ci gaba mai ƙarfi na cutar COVID-19.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin mujallar kiwon lafiya ta Eurosurveillance 2020, Spiteri et al. ta 5 ga Maris, an tabbatar da farkon cutar COVID-19 a cikin Turawa bisa ga ma'anar cutar WHO.
An gano mutane uku na farko da aka tabbatar da cutar a cikin EU/EEA a Faransa a ranar 24 ga Janairu, 2020, waɗanda suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano wasu cututtukan COVID-19 a cikin ƙasashe 30 na Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Ingila (UK), tare da samun mutane 39,768 da mutuwar 1,727 a tsakanin 31 ga Disamba, 2019, da kuma mutane 17,750 da suka kamu da cutar da mutuwar 1,441 a cikin Italiya.
Samun ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) tana sabunta adadin adadin kamuwa da cutar COVID-19 daga ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da kuma daga tushe na hukuma kamar WHO a kowace safiya 8:00.
An yi amfani da wannan bayanin don tantance yanayin COVID-19 a cikin EU/EEA da Burtaniya da kuma kwatanta yanayin ƙasashensu da na Italiya.
A matsayin samfurin sake fasalin shari'ar COVID-19 na yanzu, za mu lissafa ƙididdigar sake fasalin shari'ar COVID-19 a cikin kwanaki 14 da suka gabata a cikin EU / EEA da Burtaniya tsakanin Janairu 1 da Maris 15, 2020, kuma za mu ɗauka a matsayin ƙimar al'ada ta COVID-19.
Mun kuma kwatanta adadin adadin masu kamuwa da cutar da aka ruwaito a kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe da adadin masu kamuwa da cutar a Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Yawan kwanaki 14 na karuwar cutar COVID-19 a cikin ƙasashen Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya gabaɗaya yayi kama da adadin a lardin Hubei (China) (Hoto na 1).
A cikin duka EU/EEA da Burtaniya, ƙididdigar sake kamuwa da COVID-19 ta fara tashi a kusan 21 ga Fabrairu, sannan ta tashi sosai a kusan 28 ga Fabrairu, 2020 (a cikin ƙarin bayani).
Wannan ya fi yawaita ne saboda karuwar adadin masu cutar da aka ruwaito daga Italiya, wanda ya nuna irin wannan karuwa a cikin yawan masu cutar COVID-19 a duk ƙasashen EU / EEA da Burtaniya (bayanan biye).
Hoto na 2 ya kwatanta yawan adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya da adadin a Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
A cikin makonni 3 da ƙasa, sauran ƙasashe 15 na Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya sun ba da rahoton jimlar adadin masu kamuwa da cutar a ranar 15 ga Maris da ƙarfe 8:00 na safe, wanda ya yi daidai da adadin masu kamuwa da cutar a Italiya.
Sakamakonmu ya nuna cewa yawan masu kamuwa da COVID-19 a cikin EU/EEA da UK yana ƙaruwa cikin sauri.
Hanyoyin ci gaban cutar COVID-19 da aka lura da su sun nuna cewa annobar ta ci gaba da ƙaruwa a cikin ƙasashe iri ɗaya.
Amsoshin kiwon lafiyar jama'a na ƙasa a cikin ƙasashe suna kan matakai daban-daban, a cikin yanayi daban-daban, kuma suna ci gaba duk da bambance-bambance tsakanin ƙasashe a cikin hanyoyin zaɓar marasa lafiya waɗanda ke buƙatar yin gwaji don COVID-19, gami da ƙayyadaddun yanayin ɓarkewar cutar da gwaji.
A farkon watan Maris na 2020, likitoci a yankunan da ke da cutar a Italiya sun bayyana cewa kusan kashi 10% na marasa lafiya da ke fama da cutar COVID-19 suna buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da cibiyoyin kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar adadin marasa lafiya.
Bayanai na mutum-mutumi na cutar COVID-19 da ke asibiti da / ko dakunan kulawa na musamman a matakin EU (EU) / EEA (ba a bayyana bayanai) suna samuwa ne kawai a cikin kashi 6% da 1% na mutum-mutumi.
Amma ya kamata a tattara su cikin tsari don ƙarfafa bayanan sa ido na yanzu wanda ke mai da hankali kan yawan masu cutar da aka ruwaito da yawan mutuwar.
Wani bincike da aka yi a shekara ta 2010 zuwa 2011 ya nuna cewa adadin gadaje a Turai don kulawar gaggawa da na gaggawa ya bambanta sosai daga ƙasa zuwa ƙasa, tare da gado 29.2 a kowace mazaunin 100,000 a Jamus da 4.2 a Portugal.
Wannan yana nufin cewa suna da albarkatu da yawa ko ƙasa da na Italiya (wanda ke da gadaje 12.5 na kulawa mai tsanani da matsakaici a kowace mutum 100,000 a 2010-11).
An haɗa yanayin da aka tsara da ke da alaƙa da cikawar yawan kulawar kiwon lafiya da ke da alaƙa da haɗarin wucewa &gt; 90% na adadin gadajen kulawa a cikin ƙasashen EU / EEA da Burtaniya tare da ƙididdigar yaduwar masu cutar COVID-19 da ke asibiti a cikin sabuntawa na shida na ECDC Rapid COVID-19 Risk Screening Assessment.
A yayin da cutar ta bazu a cikin wasu yankuna a cikin EU/EEA da UK, asibitoci da dakunan jinya na musamman galibi suna kula da takamaiman yawan jama'a na gida, ya kamata a samar da bayanai game da cututtukan da yawan gadajen ICU ta hanyar tsarin sanya sunan cibiyar yanki na 2 (NUTS-2) don ƙididdigar ƙididdiga.
Kwarewar da aka samu daga Italiya da kuma halin da ake ciki yanzu a wasu ƙasashe ya nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da Burtaniya.
Don haka, ƙasashe, asibitoci da cibiyoyin kulawa na musamman ya kamata su kasance a shirye don kula da yaduwar cutar SARS-CoV-2 a cikin gida da kuma kula da kiwon lafiya, musamman don yawan masu cutar COVID-19 da ke buƙatar kulawa mai tsanani, kamar yadda ya faru a yankunan da cutar ta ɓarke a Italiya.
Kamar yadda aka nuna a cikin sabon kimantawa na haɗarin ECDC, jinkirta yaduwar SARS-COV-2 yana buƙatar saurin, shiri da kuma hanyar kula da cutar da ke da mahimmanci, tare da hanyar sauyawa daga hanawa zuwa sauƙaƙewa. Idan yawan marasa lafiya ya karu kamar yadda aka zata, rashin shiri na iya haifar da rashin isasshen lokaci ga masu yanke shawara da asibitoci don fahimtar yanayin cutar da amsawa yadda ya kamata.
A cikin wannan rahoton, an bayyana cewa, a cikin shekara ta 2020, mutane kusan miliyan biyu da ke fama da cutar sun kamu da cutar.
Akwai wata dama ta ɗan gajeren lokaci ga ƙasashe don ƙara haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan ba a yi nasarar wannan ba, tsarin kiwon lafiya na sauran ƙasashen EU / EEA na iya fuskantar hauhawar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19), wadda cutar sankarar bargo ta SARS (SARS-CoV-2) ta haifar, ta haifar da bala'in ɗan adam wanda ya kai mutuwar mutane sama da 3,000 da kamuwa da cutar sama da 80,000 a China da sauran sassan duniya.
Kamar yadda yake tare da SARS-CoV, wanda ya haifar da cutar SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama kamuwa da cutar daga malam buɗe ido kuma yana haifar da alamun bayyanar cututtuka iri ɗaya ta hanyar irin wannan ɓangaren jikin.
Koyaya, COVID-19 yana da ƙananan tsanani da ƙananan mutuwa fiye da SARS, amma yana yaduwa da sauri, yana shafar maza fiye da matasa, tsofaffi da mata fiye da mata.
A sakamakon karuwar wallafe-wallafen da ake samu game da cutar, wannan labarin ya yi ƙoƙari ya samar da cikakken bayani game da abubuwan da ke faruwa a cikin bincike mai sauri.
Za mu yi amfani da wannan don nazarin cututtuka, gano abubuwan da ke haifar da su, nazarin ƙwayoyin cuta, ganewar asali, magani, kimantawa da rigakafi.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan bita zai ba da ƙarin haske game da wannan cuta mai barazana kuma ya taimaka wajen kawar da ita.
Bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa ga duk Sinawa da ba a taɓa mantawa da su ba, waɗanda aka umurce su da su zauna a gida a lokacin hutu da kuma makonni bayan hutu saboda barkewar cutar kwayar cutar.
A ranar 11 ga Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta sanya wa kwayar cutar SARS-CoV-2 suna, kuma ta kira cutar da ke tattare da ita CoV Disease-19 (COVID-19), saboda kamanceceniyarta da kwayar cutar coronavirus (CoV) wacce ta haifar da mummunar cutar cututtukan numfashi (SARS) a 2003.
An fara bullar cutar a Wuhan, China, kuma ta bazu cikin sauri zuwa duk ƙasar Sin da kusan ƙasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, kwayar cutar ta haifar da ƙarin mutane 80,000 da aka tabbatar da cutar COVID-19, sama da 40,000 sun bar asibiti, kuma sama da 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine babban makiyin jama'a kuma yana iya zama mafi ƙarfi fiye da ta'addanci.
A cikin watanni biyu, bayan rahoton farko na bincike kan sarkar cutar da aka yi a ranar 7 ga Janairu, 2020, bayan ware mutane da yawa, kamar yadda aka bayyana a PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), an buga takardu sama da 200 da suka shafi nazarin cutar, nazarin cutar, gano asali, ganewar asali, da kuma maganin COVID-19.
Wannan bita ya yi ƙoƙarin taƙaita binciken da ake yi a kan sabon filin abun ciki mai saurin canzawa.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da SARS da sauran cututtukan da ke haifar da CoVs, kamar cututtukan numfashi na Gabas ta Tsakiya (wanda ya faru a cikin 2012 MERS).
A nan za mu tattauna game da duk abin da muka sani game da rigakafi da kuma tsinkaya, da kuma wasu batutuwa masu muhimmanci da suka rage.
CoVs galibi ba su da lahani ga ɗan adam kuma galibi suna haifar da kusan kashi 15% na yawan kamuwa da cutar sanyi ta 4.
Koyaya, a wannan karni, mun gano CoVs sau biyu waɗanda ke haifar da cutar a cikin mutane: SARS-CoV da MERS-CoVs waɗanda suka samo asali daga (China) a 2003 da (Saudi Arabia) a 2012 kuma nan da nan suka bazu zuwa wasu ƙasashe tare da mummunan kamuwa da cuta da mutuwar.
Saboda haka, cutar COVID-19 ta yanzu ita ce ta uku a cikin tarihin ɗan adam.
An fara bayar da rahoton barkewar cutar tarin fuka ta cutar mura da ba a san asalinta ba ga Hukumar Kiwon Lafiyar Kasa ta kasar Sin a ranar 31 ga Disamba, 2019, daga Wuhan, kamar yadda aka nuna a hoto 1.1.
Bayan kwana bakwai, an sanar da matsayin CoV.
A ranar 15 ga watan Janairun 2020, an samu rahoton mutuwar mutum na farko a Wuhan.
A wannan lokacin, annobar ta bazu cikin sauri zuwa birane, jihohi da ƙasashe kusa da iyaka.
A ranar 20 ga watan Janairu, an sanar da cewa ma'aikatan kiwon lafiya sun kamu da cutar, kuma an yanke hukuncin cewa ana iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, gwamnatin kasar ta dakatar da duk wata hanyar sufuri ta gari da ke birnin Wuhan, inda ta rufe birnin.
A ranar 24 ga Janairu, binciken farko na cutar ya nuna cewa daga cikin mutane 41 da aka tabbatar da kamuwa da cutar, mutum 21 ne kawai suka yi tafiya zuwa kasuwar abincin teku ta Wuhan, inda aka fara zargin cewa dabba ce da ba a san asalinta ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin da aka buga wannan rahoton, cutar ta riga ta bazu ko'ina cikin China da kusan wasu ƙasashe 50 a duniya (Hotuna (Hotuna-2).2).
A halin yanzu, yanayin yana canzawa, kuma ya rage a yanke shawarar yadda za a kawo karshen yaduwar cutar da kuma tsananin ta.
Cikakken bayanai game da cutar sun bayyana a cikin binciken cibiyoyi da yawa tare da marasa lafiya 8,866 da suka haɗa da mutane 4,021 da aka tabbatar da COVID-19 a ranar 11 ga Fabrairu, 2020. (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA)
SARS-CoV-2 yana kamuwa da cutar a kowane zamani, amma yana kamuwa da cutar musamman tsakanin shekaru 30 zuwa 65.
Kusan rabin masu kamuwa da cutar (47.7%) sun haura shekaru 50, kuma akwai ƙananan lokuta a cikin ƙasa da shekaru 20, tare da kamuwa da cutar 14 kawai a cikin ƙasa da shekaru 10.
Cutar SARS-CoV-2 ta fi yawa a cikin maza (0.27/100,000) fiye da mata (0.31/100,000).
COVID-19 ya bazu cikin manyan wurare a lardin Hubei da kewayenta.
COVID-19 yana ɗaukar kwanaki 5 (2-9) a matsakaita daga farawa zuwa lokacin da aka gano cutar.
Matsakaicin lokacin haihuwa ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga bayyanar cututtuka zuwa mutuwa shine kwanaki 9.5 (kwanaki 4.8 zuwa 13).
Ƙididdigar yawan yawan haifuwa (R0) shine 3.77 (95% CI, 3.51-4.05) da kuma R0 da aka gyara shine 2.23-4.82.
A ranar 23 ga watan Janairun 2020, lokacin da yawancin motocin sufuri ke gudana kafin bikin bazara na kasar Sin, yawan masu kamuwa da cutar ya karu sau da yawa.
Mutuwar marasa lafiya da aka tabbatar da cutar ya kai 1.44% (95% CI: 1.10-1.86%) kuma an daidaita yawan mutuwar ga dukkan marasa lafiya zuwa 3.06% (95% CI: 2.02-4.59%).
Mutanen da ke cikin manyan rukuni uku masu haɗarin kamuwa da COVID-19 sune maza, masu shekaru 60 zuwa sama, da waɗanda ke da cutar huhu mai tsanani.
CoVs wani ƙananan ƙwayoyin cuta ne waɗanda ke da babban RNA guda ɗaya kuma suna da DNA.
Ana iya rarrabe su zuwa ƙwayoyin cuta huɗu: alpha, beta, gamma, da delta, daga cikinsu alpha- da beta-CoVs suna iya sake haifar da cutar ga mutane.
A cikin SARS-CoV da MERS-CoV, furotin yana haɗuwa da membrane bayan haɗuwa da ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
An saki kwayar RNA ta kwayar cutar zuwa cikin cytoplasm: bayan musayar kwayar cutar, RNA na kwayar halitta wanda ya ƙunshi glycoprotein da nucleic acid ya zama mai saurin kamuwa da cuta wanda ya ƙunshi plasma, wanda ya haɗu da ƙwayar plasma kuma ya saki kwayar cutar.
A ranar 10 ga Janairu, 2020, an gano jerin kwayoyin halittar SARS-CoV-2 na farko.
An gano SARS-CoV-2 a cikin samfurori 10 na kwayoyin halitta da aka tattara daga kasuwar abincin teku ta Hunan, Wuhan, inda cutar ta fara, a matsayin sabon nau'in beta-CoV tare da daidaiton kwayoyin halitta sama da 99.98%.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
An gano ƙananan kwayoyin SARS-CoV-2 a cikin ƙananan ƙananan ƙananan ƙwayoyin fata na jikin mutum ta hanyar microscope na lantarki.
An gano cewa ACE2 na ɗan adam shine mai karɓar bakuncin SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 wanda ke ɗaure da ACE2 na ɗan adam ya fi rauni fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta fiye da SARS-CoV.
Kwayar cutar SARS-CoV-2 na iya zama ɗan gajeren ɗan littafin da aka ƙirƙira ta hanyar orf3b da kuma kwayar halitta mai fitar da ƙwayoyin cuta ta hanyar orf8.
Ko da yake orf3b na SARS-CoV-2 yana iya zama alamar cutar kwayar cutar kuma yana hana IFNβ, orf8 ba shi da wani yanki ko tsari na tasiri da aka sani.
A ranar 18 ga Fabrairun 2020, Zhou da sauransu sun gabatar da tsarin cryo-EM na cikakken mutum ACE2 wanda ya haɗu da B0AT1, mai jigilar amino acid, a ƙuduri na 2.9 Å.
An gano cewa rukunin da ke da tsari mai rufewa da buɗewa an kafa shi a matsayin dimer, kuma rukunin ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda zai iya zama hujja na gano cutar CoV.
B0AT1 na iya zama maƙasudin magani a gwajin magani don rage saurin kamuwa da SARS-CoV-2.
Mai watsa shiri na asali da mai watsa shiri na tsakiya
An gano cewa cutar SARS-CoV da MERS-CoV sun samo asali ne daga jemage kuma an watsa su ga mutane ta hanyar katantanwa da raƙuma.
Idan aka kwatanta juyin halittar SARS-CoV-2 da sauran CoVs, sabon kwayar cutar ta kasance daidai da kashi 96% na SARS-kamar CoVs da aka gano a cikin bat bat-SL-CoVZX45 da bat-SL-CoVZX21, wanda ya sa aka ɗauka cewa bat shine asalin SARS-CoV-2.
Koyaya, har yanzu ba a san mai karɓar baƙi na tsakiya wanda ya taimaka wa kwayar cutar ta tsallake shingen jinsuna zuwa mutane ba, kuma hanyar watsawa har yanzu ba a bayyana ba.
Ji da sauransu sun ba da shawarar cewa maciji na iya zama mai ɗaukar hoto yayin da kwayar cutar ta bazu daga Batman zuwa mutane, saboda duk maye gurbin da ke cikin furotin S suna da nau'ikan iri ɗaya.
Wani bincike na asali wanda ya gano daidaituwa na kwayoyin halitta na kashi 99 cikin ɗari tsakanin coronavirus (CoV) da SARS-CoV-2 a cikin kwakwalwan kwakwalwan kwakwalwa ya nuna cewa kwakwalwan kwakwalwan da ke da dogon baki da ake amfani da su a cikin maganin gargajiya na kasar Sin na iya zama mai karɓar ƙwayar cuta na SARS-CoV-2, in ji masu bincike a Guangzhou, China.
Duk da haka, bambancin 1% na yaduwa a cikin kwayoyin halitta biyu har yanzu yana da bambanci mai mahimmanci. Saboda haka, ana jiran sakamakon bincike na ƙarshe don shaidar tabbatacciya.
Har yanzu ba a san yawancin abubuwan da ke tattare da kwayoyin halitta da sunadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin bututun gwaji a cikin yanayin bushewa na tsawon awanni 48 da zafin jiki ƙasa da 20 °C da zafi daga 40% zuwa 50% har zuwa kwanaki 5.
SARS-CoV-2 na iya nuna irin wannan alamun.
SARS-CoV-2 ba zai iya jurewa UV da zafi na mintina 30 a zazzabi 56 ba, kuma maganin kashe ƙwayoyin cuta da ke ɗauke da ether, ethanol 75%, chlorine, peroxic acid, chlorophoron da sauran magunguna masu ƙoshin ƙwayoyin cuta suna kashe kwayar cutar.
A mafi yawan lokuta, dukkan mutane ba su da ƙarfin rigakafi ga SARS-CoV-2 kuma saboda haka ba su da ƙarfin rigakafi ga sabon kwayar cutar.
A halin yanzu, ba a buga cikakken binciken game da amsar rigakafi ga SARS-CoV-2 ba.
Saboda haka, zamu iya komawa ga binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. 4).
Yawancin lokaci, bayan kwayar cutar ta mamaye mai masaukin, tsarin rigakafin asalin mai masaukin yana fara gane shi ta hanyar masu karɓar karɓar hoto (PRRs), gami da masu karɓar nau'in C-type lectin-like, mai karɓar haraji (TLR), mai karɓar NOD-like (NLR), da mai karɓar RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da kumburi, yana haifar da haɓakar ƙwayoyin dendritic (tsarin rigakafi) da kuma iyakance yaduwar kwayar cutar, kuma yana haifar da nau'ikan I interferons (IFNs) wanda ke sa kwayoyin phagocyte su hanzarta narkar da ƙwayoyin cuta na kwayar cutar.
Duk da haka, furotin N na SARS-CoV na iya taimaka wa kwayar cutar ta tsira daga ƙwayoyin cuta.
Ba da daɗewa ba, amsawar rigakafin da ta dace ta shiga cikin yaƙi da kwayar cutar.
Kwayoyin T, ciki har da CD4 + da CD8 + T cells, suna taka muhimmiyar rawa wajen hana cutar MERS.
Kwayoyin CD4 + T suna motsa ƙwayoyin B don samar da maganin rigakafi da ke yaƙi da kwayar cutar, yayin da ƙwayoyin CD8 + T ke kashe ƙwayoyin da ke dauke da kwayar cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da wani kwayar halitta mai kumburi don taimakawa kwayoyin kariya.
Koyaya, CoVs na iya haifar da mutuwar ƙwayoyin T kuma ya hana ayyukan T.
Tsarin rigakafin jiki na cutar da ke cikin jini, gami da C3a, C5a da abubuwan ƙarfafawa kamar ƙwayoyin cuta, suna da mahimmanci don yaƙar kamuwa da cutar.
Alal misali, ƙwayoyin cuta da aka samo daga marasa lafiya da suka warke sun lalata MERS-CoV.
A wani ɓangare kuma, yawan amsawar tsarin garkuwar jiki yana haifar da ɓarnatar da magungunan da ke haifar da lalacewar huhu da gabobin ciki, wanda a cikin mafi munin yanayin zai iya haifar da lalacewar gabobin jiki da mutuwa.
Cutar SARS-CoV-2 a cikin nau'i na kamuwa da cuta mai yawa, tana da haɗari ga mata masu ciki da tsofaffi waɗanda ke da cutar.
A al'adance, mutane da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda ke da tsarin garkuwar jiki mai rauni suna iya kamuwa da cutar fiye da sauran mutane.
(Wuhan) Wani bincike da aka yi kan mutane 425 da suka kamu da cutar a Wuhan ya nuna cewa matsakaicin lokacin kamuwa da cutar SARS-CoV-2 ya kasance tsakanin kwanaki 1 zuwa 14, mafi yawan lokuta tsakanin kwanaki 3 zuwa 7.
Koyaya, binciken da aka yi akan marasa lafiya 1,099 ya nuna cewa matsakaicin lokacin farawa shine kwanaki 3, kuma lokacin farawa yana daga 0 zuwa 24 days.
Kamar yadda aka ambata a sama, wani binciken da aka yi kwanan nan wanda ya danganci mutane 8,866 da suka kamu da cutar ya nuna cewa tsawon lokacin warkewa shine kwanaki 4.8 (3.0-7.2).
Yana da mahimmanci ga jami'an kiwon lafiya su daidaita lokacin keɓewa mai tasiri dangane da ainihin lokacin ɓarkewar cutar, don haka za a iya hana yaduwar kwayar cutar daga waɗanda ba su da alamun cutar zuwa wasu.
A matsayinka na al'ada, duk wanda ya taɓa saduwa da ko ya taɓa kamuwa da cutar zai iya keɓe kansa na kwanaki 14.
Shin ya kamata a kara dokar hana zirga-zirga da killacewa zuwa kwanaki 24?
Yawancin lokaci, babban alamun bayyanar cutar a farkon lokacin COVID-19 shine rashin lafiya, amma ba tare da wasu alamun bayyanar cututtuka ba, amma tare da wasu alamun bayyanar cututtuka kamar tari, numfashi, ciwon tsoka, ciwon kai, ciwon kai, ciwon makogwaro, fitsari, ciwon kirji, tashin zuciya, tashin zuciya, tashin zuciya da amai.
Wasu marasa lafiya sun fara fama da rashin numfashi da / ko rashin isasshen oxygen a cikin huhu da jini mako guda bayan farawar cutar.
A cikin mawuyacin hali, marasa lafiya suna saurin kamuwa da cututtukan cututtukan numfashi, hawan jini, hawan acidic na ciki, da zubar da jini.
Ya kamata a gano cutar a farkon lokacin a cikin marasa lafiya da zazzabi da / ko masu nuna alamun cututtukan numfashi da marasa lafiya masu fama da rashin lafiya mai tsanani har ma da rashin daidaito na hoto na huhu.
Wani binciken asibiti na gida da aka gudanar a ƙarshen Disamba 2019, ya nuna cewa kashi 98% na alamun cutar sun kasance marasa lafiya, kashi 76% na tari, kashi 55% na numfashi da kashi 3% na zawo, kuma kashi 8% na marasa lafiya suna buƙatar taimakon numfashi.
A cikin binciken da aka yi a cikin shekaru da suka gabata, an gano irin wannan yanayin a cikin wasu mutane biyu da ke da alaƙa da iyali da kuma wanda ba shi da alamun cutar.
Don kwatanta, binciken alƙaluma na 2012 ya nuna cewa marasa lafiya da ke da MERS-CoV suna da rashin lafiya (98%), tari (47%), da wahalar numfashi (55%) a matsayin manyan alamun bayyanar cututtuka.
Koyaya, kashi 80% daga cikinsu suna buƙatar kayan aikin numfashi, wanda ya fi yawan masu cutar COVID-19 yawa, kusan daidai da MERS, wanda ke da haɗarin rayuwa fiye da COVID-19.
An kuma gano maƙarƙashiya (kashi 26%) da ciwon makogwaro (kashi 21) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, rashin lafiya (99% zuwa 100%), tari (29% zuwa 75%), numfashi (40% zuwa 42%), zawo (20 zuwa 25%) da ciwon makogwaro (13 zuwa 25%) sune manyan alamun bayyanar cututtuka, kuma kusan 14% zuwa 20% na marasa lafiya suna buƙatar taimakon numfashi.
A ranar 14 ga Fabrairu, akwai mutane 66,576 da aka tabbatar da kamuwa da cutar a duk duniya, yayin da mutuwar COVID-19 ta kai kashi 2%.
A cikin watan Nuwamba na shekara ta 2002, mutuwar SARS ya kai kashi 10 cikin dari na mutane 8,096 da aka tabbatar da cutar.
A cikin binciken da aka gudanar a watan Yunin 2012, an gano cewa kashi 37 cikin dari na mutane 2,494 da suka kamu da cutar MERS sun mutu.
Wani binciken da aka yi a baya ya nuna cewa R0 (matsakaicin kamuwa da cuta) na SARS-CoV-2 ya kai 6.47 tare da tabbataccen kashi 95% a cikin kewayon daidaito (CI) 5.71-7.23, yayin da R0 (matsakaicin kamuwa da cuta) na SARS-CoV ya kai 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun cututtukan su, yawan mutuwa da R0 (matsakaicin kamuwa da cuta) an nuna su a tebur 1.1.
A cewar ƙididdigar da ke sama, SARS-CoV-2 ya fi MERS-CoV da SARS-CoV yaduwa, amma yawan mutuwar ya fi waɗannan biyu ƙasa.
Saboda haka, cutar SARS-CoV-2 ta fi rikitarwa fiye da MERS-CoV da SARS-CoV.
Yawanci ana samun kamuwa da cutar a cikin iyali ɗaya ko kuma daga taron jama'a ko kuma ta hanyar motoci kamar jirgin ruwa.
Masu cutar sun kasance mutanen da suka yi tafiya a cikin makonni biyu kafin bayyanar cututtukan, mazauna Wuhan ko wani yanki mai yaduwa, ko kuma waɗanda suka taɓa saduwa da masu cutar ko marasa lafiya.
Koyaya, mutane na iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba sama da makonni biyu kuma ana iya samun ƙarin kamuwa da cutar a cikin marasa lafiya da suka warke kuma aka sallame su daga asibiti, wanda ke haifar da ƙarin lokacin keɓewa.
A farkon lokaci, yawan adadin ƙwayoyin cutar (musamman ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Misali, a cikin marasa lafiya 1,099 na COVID-19, an gano ƙarancin ƙwayoyin lymphocytes da ƙididdigar lymphocytes da ke ƙasa da 1×109/L, gami da ƙididdigar ƙwayoyin cutar Lymphocytes da ke ƙasa da 4×109/L, tare da ƙarancin ƙwayoyin cuta da ƙaruwa na enzyme na aspartate aminotransferase da kuma kasancewar kwayar cutar a cikin jini.
Wasu marasa lafiya sun sami karuwar myoglobin da enzymes na hanta da tsoka, kuma yawancin marasa lafiya sun sami karuwar sinadarin C-reactive da ƙwayoyin red cell.
A cikin marasa lafiya da ke fama da cutar, yawan D-dimer, wani sinadarin fibrin, yana ƙaruwa a cikin jini, kuma ƙididdigar ƙwayoyin jini suna raguwa a hankali.
Ana gano wasu abubuwa marasa kyau a cikin hotunan kirji na yawancin marasa lafiya na COVID-19 waɗanda ke da alamun alamun inuwa ko kuma haske kamar gilashi a ɓangarorin biyu na huhu.
Masu fama da cutar suna fama da cututtukan huhu da ba a saba gani ba, mummunan rauni na huhu da kuma cututtukan numfashi mai tsanani (ARDS).
A lokacin ARDS, ƙonewa da rashin kulawa, ƙwayoyin cuta da ƙwayoyin cuta suna haifar da mummunan sakamako ga tsarin metabolism.
Rashin aiki na nau'in-I da nau'in-II na numocytes yana haifar da raguwa a cikin matakan ƙarfin ƙarfin jiki kuma yana ƙara ƙarfin jiki, wanda zai rage ƙarfin ƙwayar huhu kuma zai iya haifar da lalacewar huhu da sauri.
Saboda haka, mafi munin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A cikin binciken farko na nazarin cututtukan COVID-19 wanda ya mutu daga kamuwa da cutar a ranar 18 ga Fabrairu, 2020, an gano alamun cutar pneumocytes a cikin huhu, ɓarkewar membrane na hyaline, haɓakar leukocytes tsakanin jijiyoyin jini, da kuma ciwon ƙwayar cuta a cikin huhu. Ya dace da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Ana amfani da tsarin gano SARS-CoV-2 RNA ta hanyar aikin haɗin gwiwa na enzyme-generating enzyme da polymerase enzyme chain reaction (RT-PCR) daga samfurin RNA a matsayin babban ma'auni don gano COVID-19.
Duk da haka, yawan kuskuren gwajin ya haifar da saurin yaduwar cutar, kuma an fara amfani da fasahar kiwon lafiya don ganewar asali (ba ta dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
A cikin wata sanarwa da aka fitar a watan Janairun 2020, an gano cewa cutar SARS ta kamu da cutar a cikin shekaru biyar da suka gabata.
Don haka, nazarin hadewa wanda ya hada da tarihin cutar, binciken asibiti, gwaje-gwaje na asibiti da binciken radiyo yana da mahimmanci kuma yana da mahimmanci don gudanar da ingantaccen bincike.
A ranar 14 ga Fabrairun 2020, ƙungiyar Feng Zhang ta bayyana wata hanya don gano SARS-CoV-2 ta amfani da hanyar CRISPR mai amfani da fasaha ta SHERLOCK, wanda ke gano ɓangarorin RNA na SARS-CoV-2 na wucin gadi tare da zurfin amfani da kayan aiki, ta hanyar amfani da ma'aunin dipstick a cikin ruwa a cikin ƙasa da awa ɗaya, tare da ƙimar 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafin 10-100 a kowace microliter da aka ƙara).
Da fatan, idan aka tabbatar da shi a cikin gwajin gwaji na asibiti, wannan sabon tsarin zai iya inganta tasirin amsawa da kwanciyar hankali.
Saboda babu wani sabon kamuwa da cutar coronavirus, likitoci na iya ba da kulawa ta musamman ga marasa lafiya na COVID-19 yayin da suke gwada magungunan da aka yi amfani da su a baya ko kuma waɗanda aka ba da shawarar don magance wasu cututtukan coronavirus, kamar cutar SARS-CoV, cutar MERS-CoV da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Wadannan magungunan sun hada da maganin riga-kafi na yanzu da kuma na gaba, masu hana rigakafi, steroids, plasma daga marasa lafiya da suka dawo, maganin gargajiya na kasar Sin, da kuma taimakon tunani.
A cikin wata sanarwa da aka fitar a watan Janairun, an ce, "Muna da wasu mutane da ke da alaka da cutar da ke da alaka da cutar da kuma wasu da ke da alaka da cutar".
Kamfanonin harhada magunguna suna gasa da maganin rigakafi da ke yaki da cutar.
Kwayar cutar SARS-CoV-2 da farko tana kai hari ga huhu, amma tana iya kai hari ga wasu gabobin ciki waɗanda ke nuna enzyme ACE2, kamar tsarin hanji da kodan.
Ko ta yaya, rashin lafiyar numfashi da lalacewa sune babban barazana ga marasa lafiya kuma babban dalilin mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don sauƙaƙe bayyanar cututtuka da ceton rayuka, kuma ya dogara da tsananin cutar, yana iya haɗawa da maganin oxygen na gaba ɗaya, haɓakar oxygen, inhaler da ba a saka shi cikin jiki ba, da kuma inhaler da aka saka a cikin jiki.
Marasa lafiya da ke fama da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Bugu da ƙari, kiyaye daidaiton lantarki yana da mahimmanci ga masu cutar SARS-CoV-2 don hanawa da magance kamuwa da cuta ta biyu da hawan jini, tare da kare ayyukan gabobin jiki masu mahimmanci.
An gano cewa guguwar cytokine wani sakamako ne na tsananin amsawar tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS.
Cutar hyperparathyroidism na kwayar halitta wani nau'i ne na tsarin kumburi wanda ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wannan lalacewar kwayar halitta ta kwayar halitta tana ƙarfafa ƙwayoyin rigakafi don samar da adadi mai yawa na magungunan ƙwayoyin cuta, wanda shine babban dalilin da ya sa ARDS da sauran lalacewar gabobin jiki.
A cikin cututtukan cututtuka, maganin cututtukan cututtuka yana da mahimmanci don magance Cytokine Storms.
An yi amfani da kwayoyin halitta, tucillus, da anti-IL6 monoclonal antibodies don magance cutar da ke haifar da yawan adadin cytokines a jiki (cytocyanin syphilis).
Sauran magungunan rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rig
Ana amfani da steroids a matsayin maganin rigakafi don magance cutar SARS don rage tsananin kumburi.
Koyaya, ba a sami sakamako ba yayin da aka ba da allurai masu yawa don cutar huhu mai tsanani a cikin marasa lafiya na SARS da COVID-19.
A maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman mutuwar ƙwayoyin kashi, wanda ke shafar tsinkayar ganewar asali.
Koyaya, ana ba da shawarar yin amfani da maganin corticosteroids a cikin ƙananan allurai da kuma tsawon lokaci don marasa lafiya masu cutar COVID-19 waɗanda ke da ciwo mai tsanani.
Har yanzu, babu maganin rigakafi mai tasiri da aka amince da shi.
Koyaya, allurar intravenous na remdesivir, analog na nucleotide, an gano yana da tasiri a cikin wani mai cutar Amurka wanda ke fama da COVID-19.
Remdesivir wani sabon magani ne na rigakafin cutar da Gilead ta fara samarwa don magance cututtukan da ƙwayoyin cuta na Ebola da Marlburg ke haifarwa.
Daga baya, an nuna cewa remdesivir yana hana sauran ƙwayoyin cuta na RNA guda ɗaya, gami da ƙwayoyin cuta na MERS da SARS.
Bisa ga waɗannan abubuwan, Gilead ta ba da kayan aikin ga China don yin gwaji tare da mutanen da ke fama da cutar SARS-CoV-2, kuma tana da babban fata game da sakamakon.
Bugu da ƙari, baricetinb, interferon-alpha, lufenabar / ritonabar, da ribavirin an bincika su a matsayin magunguna masu yiwuwa ga marasa lafiya da ke nuna alamun cututtukan numfashi na yanzu.
Maƙarƙashiya, tashin zuciya, amai, lalacewar hanta da sauran mummunan halayen na iya faruwa bayan maganin haɗin gwiwa tare da maganin lopinavir / ritonavir.
Ya kamata a lura da hulɗar tsakanin waɗannan hanyoyin magani da sauran magungunan da ake amfani da su a cikin marasa lafiya.
Samun jini da kuma rigakafin cutar daga marasa lafiya da suka warke
A cikin tarihin, an yi amfani da maganin plasma na marasa lafiya da suka warke daga kamuwa da cuta don magance wasu marasa lafiya da ke fama da cutar ko kuma hana kamuwa da cutar ga wani wanda ba shi da cutar.
A gaskiya ma, marasa lafiya da suka warke suna da yawan adadin ƙwayoyin cuta a cikin jinin su.
Kwayoyin rigakafin rigakafi sune sunadarai masu kariya na rigakafi waɗanda aka samar da su ta hanyar kwayar cutar ta jini, nau'in kwayar cutar ta jini don yaƙi da masu cutar da sauran masu shigowa waje, suna gane kwayoyin da ke cikin masu cutar kuma suna lalata su kai tsaye.
Bisa ga wannan, an cire plasma daga marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi ga marasa lafiya 10 da ke fama da rashin lafiya mai tsanani.
A cikin sa'o'i 24, alamun sun ragu tare da raguwar kumburi, raguwar adadin kwayar cutar da ƙaruwa a cikin jini.
Amma kafin a samar da takamaiman magunguna, ana buƙatar tabbatarwa da bayyanawa don tabbatar da aikace-aikacen don amfani da hanyar a ko'ina.
A cikin wannan labarin, an nuna cewa a cikin wasu lokuta, cutar tana da tasiri a kan ƙwayar jini.
Misali, ƙwayoyin cuta suna haifar da halayen rigakafi wanda zai iya zama mai guba da haɗari ga rayuwa.
Yawan maganin rigakafi a cikin jini yana da ƙarancin ƙwayoyin cuta kuma ana buƙatar babban adadin jini don kula da marasa lafiya masu ciwo.
A halin yanzu, akwai ƙalubale wajen samar da maganin rigakafi mai inganci da sauri don magance cutar.
Saboda haka, yana da mahimmanci kuma mai yiwuwa a ware ƙwayoyin cuta daga marasa lafiya da suka warke kuma a bincika su don gano ƙwayoyin cuta masu tasiri don yaƙar ƙwayoyin cuta masu mahimmanci na kwayar cutar, ko kuma gano lambar kwayoyin halitta da ke haifar da ƙwayoyin cuta masu tasiri.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin rigakafi.
(China) An yi amfani da TCM a kasar Sin don magance cututtuka daban-daban na dubban shekaru.
Duk da haka, tasirinsa ya dogara da haɗuwa da sinadarai daban-daban waɗanda za a haɗa su cikin maganin, wanda zai bambanta dangane da yadda ake gano cutar dangane da ka'idodin TCM.
Yawancin abubuwan da suka fi tasiri ba a san su ba tukuna, ko kuma ba a san su ba saboda rashin tabbas, yana da wuya a rarrabe da kuma tabbatar da irin waɗannan abubuwa ko kuma mafi kyawun haɗin su.
A kwanan nan, saboda rashin ingantacciyar magani don cutar COVID-19, TCM ta zama ɗayan manyan hanyoyin maye gurbin marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda ke murmurewa daga mawuyacin hali.
Misali, an gano cewa Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules suna da tasiri a maganin COVID-19.
An gano mafi yawan adadin warkewar marasa lafiya na COVID-19 a larduna da dama a China, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), inda 87% na marasa lafiyarsu suka yi amfani da TCM, yayin da mafi ƙarancin adadin warkewa (13%) ya kasance a lardin Hubei, inda kusan 30% na marasa lafiyar COVID-19 suka yi amfani da TCM.
Amma wannan kwatancen ne kawai, saboda ana buƙatar yin la'akari da wasu dalilai masu tasiri kamar yawan marasa lafiya da tsananin cutar yayin yin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga wani bincike don kwatanta maganin magungunan Yammacin Turai (WM) da WM da TCM.
An gano cewa lokutan da ake buƙata don dawo da zafin jiki, warkar da bayyanar cututtuka, da kuma asibiti sun fi guntu a cikin rukunin da ke amfani da WM + TCM fiye da rukunin da ke amfani da WM kawai.
Mafi ban sha'awa, yawan ciwon alamun cutar (daga mai laushi zuwa mai tsanani) ya ragu sosai a cikin rukunin WM + TCM fiye da rukunin WM guda ɗaya (7.4% da 46.2%), kuma yawan mutuwar ya ragu a cikin rukunin WM + TCM fiye da rukunin WM guda ɗaya (8.8% da 39%).
Koyaya, gwaji mai kyau da aka sarrafa akan inganci da amincin TCM har yanzu yana jiran gwaji mai yawa da yawa a cikin cibiyoyi da yawa.
Zai kuma zama mai ban sha'awa don gano ainihin tsarin aikin da kuma bayyana abubuwan da ke da tasiri na maganin TCM ko kuma idan ya yiwu, amfani da shi.
Masu cutar COVID-19 da ake zargi ko tabbatacce galibi suna cikin matsanancin damuwa game da cutar mai saurin yaduwa da cutar da ke iya kashe rayuka, yayin da waɗanda ke da ƙuntataccen tafiya ke fuskantar baƙin ciki, kaɗaici da fushi.
Bugu da ƙari, alamun cututtuka kamar rashin lafiya, rashin isasshen oxygen a cikin jini da tari, da kuma sakamako masu illa na magani kamar rashin bacci wanda corticosteroids ke haifar da, na iya haifar da ƙarin damuwa da damuwa.
A farkon lokacin kamuwa da cutar SARS, an bayar da rahoton ɓarkewar cututtukan ƙwaƙwalwa da yawa, gami da yawan damuwa, damuwa, matsanancin firgici, rashin motsin rai, bayyanar cututtukan autism, hauka, da ƙoƙarin kashe kansa.
Tsarin bin diddigin hulɗa da ƙuntata zirga-zirga da keɓewa, wanda ake aiwatar da shi a matsayin ɓangare na maganin lafiyar jama'a ga yaduwar COVID-19, na iya ƙara damuwa ga jama'a, yana sa su zargi kansu da cutar da danginsu da abokansu, tare da keɓewa da wulakanci.
Don haka, ya kamata a samar da kulawar lafiyar kwakwalwa ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, waɗanda ke da alaƙa da su, da kuma jama'a waɗanda ke buƙatar taimako.
Taimako na motsin rai ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiya na hankali da yawa, sadarwa ta yau da kullun da kuma sanarwar da ta dace game da ɓarkewar SARS-CoV-2 da shirye-shiryen magani, da kuma amfani da kayan lantarki da aikace-aikace masu fasaha don guje wa kusanci da juna.
Alluran rigakafi masu tasiri suna da mahimmanci don yanke hanyar watsawa daga dabbobi da mutane masu kamuwa da cuta zuwa masu karɓar cuta masu saurin kamuwa da cuta, kuma suna da mahimmanci kamar maganin rigakafin cutar don sarrafa barkewar cutar da ƙwayoyin cuta ke haifarwa.
Ana ci gaba da yin ƙoƙari don samar da allurar rigakafi mai tushen furotin S don samar da maganin rigakafi mai tasiri na dogon lokaci da / ko rigakafin SARS-CoV.
An gwada alluran rigakafi da aka canza daga kwayar cutar SARS ta hanyar amfani da dabbobi.
Amma har sai an fara gwajin asibiti, ba za a iya tabbatar da ingancin waɗannan alluran rigakafi a cikin dabbobi masu gwaji don tantance haɗarin rai da tsofaffi ba, kuma ba za a iya tabbatar da ko waɗannan alluran rigakafin za su iya hana kamuwa da cutar daga dabba zuwa mutum ba.
Wannan na iya faruwa, saboda ba a sami sabon mutum ba tun bayan shekaru 17 da SARS ya ɓace.
A gefe guda, an samu barkewar cutar MERS a wasu lokuta da kuma barkewar cutar ta MERS a Gabas ta Tsakiya, kuma ci gaba da barkewar cutar ta dabbobi zuwa mutane a yankunan da cutar ta barke ya sa cutar ta bazu zuwa wasu yankuna.
An aiwatar da dabarun allurar rigakafin MERS ta amfani da alluran rigakafi waɗanda suka haɗa da ƙwayoyin cuta da aka kashe, da filastik na DNA, masu ɗaukar hoto, ƙwayoyin cuta masu kama da ƙwayoyin cuta, ƙwayoyin cuta masu kama da ƙwayoyin cuta da ƙwayoyin cuta da aka yi amfani da su don yin maganin ƙwayoyin cuta da kuma wasu alluran da aka gwada a kan dabbobi.
Samar da allurar rigakafi mai lafiya da tasiri ga mutanen da ba su da rigakafi ga SARS-CoV-2 yana ɗaya daga cikin gaggawa da mahimman ayyuka don sarrafa annobar da ke faruwa.
Koyaya, akwai ƙalubale don shawo kan wannan ƙalubalen saboda lokaci mai tsawo (a matsakaita watanni 18) don samar da allurar rigakafi da kuma canjin CoVs.
A matsayin sabon cuta, COVID-19 ya fara nuna cikakkiyar hanyar cutar ne kawai bayan ya kamu da dubban mutane.
A mafi yawan lokuta, marasa lafiya suna murmurewa a hankali ba tare da wata illa ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da haɗari da mutuwa a cikin marasa lafiya masu kamuwa da cutar.
Don haka, hukumomin kiwon lafiya suna buƙatar ci gaba da gina samfurin tsinkayar yanayin cutar don ba da fifiko ga magani, musamman a yankunan da ke da iyakantaccen albarkatu.
Binciken asibiti ya zuwa yanzu ya nuna cewa waɗannan abubuwan masu zuwa suna da tasiri ko alaƙa da yiwuwar cutar a cikin marasa lafiya na COVID-19 (Table (Table33)):
Shekaru: Shekaru sune mahimmin ma'auni a cikin tantance yanayin SARS kuma suna da inganci ga COVID-19.
Kamar yadda aka ambata a sama, binciken da aka yi akan marasa lafiya 8,866, ya nuna cewa COVID-19 ya fi kamuwa da mutane masu shekaru 30-65, tare da kashi 47.7 cikin dari na marasa lafiyar da suka haura shekaru 50.
Marasa lafiya da ke buƙatar kulawa mai tsanani galibi marasa lafiya ne, kuma cututtukan da ke biyo baya suna faruwa sosai a cikin tsofaffi (mafi yawan lokuta suna faruwa a matsakaicin shekaru 66 idan aka kwatanta da shekaru 51).
Jima'i: SARS-CoV-2 ya fi kamuwa da maza fiye da mata kamar yadda aka nuna a sama (0.31/100,000 da 0.27/100,000).
Yanayin cutar da kuma yanayin da ke biyo baya: Marasa lafiya na COVID-19 da ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da mummunan bugun zuciya da bugun zuciya.
Cutar zuciya ita ce babbar hanyar mutuwa a cikin masu cutar SARS.
SARS-CoV-2 na iya ɗaure kansa ga cholangitis mai ɗauke da ACE2-base kuma an ba da rahoton cewa yana iya haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da kuma rigakafi ba su da alaƙa kuma suna iya shafar juna.
Binciken C-reactive protein (CRP) a cikin jini - wanda ke nuna ciwon kumburi ko tsananin lalacewar nama kuma an ba da shawarar a matsayin mai yiwuwa mai yiwuwa ga yanayin cutar, amsawa ga magani, da kuma farfadowa.
An kuma ba da shawarar alaƙar da ke tsakanin tsananin cutar COVID-19, kimanta yanayin cutar da matakan CRP.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna yaduwa a cikin gabobin jiki da yawa, musamman a zuciya da hanta, kuma ana samar da su a lokacin lalacewar nama.
Saboda haka, alamun da ke nuna cewa hanta ko koda ba ta aiki yadda ya kamata.
Babban alamomi: Ya kamata a yi la'akari da hotunan kirji da ci gaban alamomi a kan lokaci, a tsakanin sauran batutuwa, don hango sakamakon COVID-19 da kuma ƙarin ƙarin kamuwa da cuta.
Amfani da Steroids: Kamar yadda aka ambata a sama, steroids magunguna ne masu rage karfin jiki waɗanda galibi ana amfani da su azaman magani na gaba don rage ciwo mai saurin kumburi.
Saboda yawan amfani da maganin corticosteroid a cikin marasa lafiya masu tsanani na SARS, yawancin waɗanda suka tsira sun sami cutar osteonecrosis ta hanyar cutar, wanda ya haifar da nakasa na rayuwa da kuma lalacewar lafiya.
Saboda haka, idan ya cancanta, ya kamata a ba da ƙaramin ƙwayar steroid ga marasa lafiya na COVID-19 na ɗan gajeren lokaci.
Matsin lamba: Kamar yadda aka ambata a sama, yawancin marasa lafiya a lokacin annobar COVID-19 suna fuskantar damuwa fiye da yadda aka saba saboda ƙuntatawa na tafiya na dogon lokaci, mutuwar dangi da abokai da rashin tabbas game da rayuwa.
Shawarwari da tallafi na dogon lokaci suna da mahimmanci don taimakawa marasa lafiya su warke daga damuwa da komawa rayuwarsu ta yau da kullun.
Har zuwa yanzu, nazarin yawan jama'a a yankuna da yankuna ya nuna cewa COVID-19 yana da alamun cututtukan cututtuka daban-daban da SARS.
Baya ga shiga cikin ƙananan hanyoyin numfashi, SARS-CoV-2 yana iya shiga cikin hanyoyin numfashi na sama kuma yana iya haifar da kamuwa da cuta kamar sauran CoVs waɗanda ke haifar da sanyi na yau da kullun tare da bayyanar cututtuka masu sauƙi ko babu alamun bayyanar cututtuka a farkon lokacin.
Saboda haka, mutane masu kamuwa da cutar suna iya yada adadin kwayar cutar a farkon lokacin cutar ko lokacin da suke tafiya a kullum, wanda ke sa sarrafa cutar ta zama da wahala.
Koyaya, ana tsammanin kamuwa da cutar SARS-CoV yana faruwa ne lokacin da marasa lafiya ke cikin mummunan rashin lafiya kuma ba su da cutar a farkon matakan.
Saboda haka, barkewar cutar COVID-19 ta yanzu ta fi barkewar SARS tsanani kuma yana da wahalar sarrafawa.
A halin yanzu, kasar Sin tana aiwatar da kyawawan ayyuka, gami da kulle Wuhan da biranen da ke kewaye da shi da kuma takunkumin ci gaba da zirga-zirga da ke tattare da kusan dukkanin al'umma, don hana yaduwar cutar SARS-CoV-2.
Duk da cewa waɗannan matakan sun yi tasiri sosai ga tattalin arzikin ƙasar da sauran sassa, yawan sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
A cewar wani mai hasashen, cutar za ta ƙare a watan Maris, kuma za a ci gaba da raguwa har tsawon watanni uku zuwa huɗu.
Amma wasu masana ba su da irin wannan kwarin gwiwar.
Paul Hunter da wasu sun yi hasashen cewa cutar COVID-19, wadda ta fi SARS saurin yaduwa, ba za ta ƙare ba a shekara ta 2020.
Ira Longini, et al., sun gina samfurin da ke hasashen sakamakon annobar, suna ƙaddara cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wani rukunin Kanada ya ba da rahoton gano SARS-CoV-2 a cikin tsakiyar iska da kuma cikin makogwaro da kuma ƙwayoyin cuta na marasa lafiya da suka warke kuma suka bar asibiti fiye da makonni biyu da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano tana da alamun sake dawowa kamar yadda mura take.
Duk da haka, akwai alamun kyakkyawan fata a China, tare da raguwar yawan sabbin kamuwa da cutar, kuma ayyukan dabarun da ake yi yanzu suna da tasiri.
A baya an yi hasashen cewa cutar Ebola za ta iya kaiwa mutum miliyan daya, kuma rabin wannan adadin zai iya zama mutuwa.
Amma, a hankali za a iya sarrafa cutar ta hanyar sanya takunkumin hana zirga-zirga da killace mutane.
Kamar SARS-CoV, SARS-CoV-2 na iya zama mai saurin kamuwa da cuta kuma daga ƙarshe ya ɓace ko kuma ya zama wata cuta mai saurin kamuwa da cuta a cikin mutane.
A ƙasa akwai kwatancen yaduwar COVID-19 da yaduwar SARS da MERS (Fig. 55).
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko hancinsa, amma kuma yana iya yaduwa ta hanyar tuntuɓar abubuwan da ke dauke da kwayar cutar kai tsaye.
An kuma gano kwayar cutar a cikin ƙazanta, wanda ke haifar da sabon yiwuwar yaduwar cutar ta hanyar ƙazanta da hannu zuwa baki.
Wani binciken da aka yi kwanan nan na kamuwa da kamuwa da cuta 138, gami da wasu mutane 17 da masu kula da lafiya 40, ya nuna cewa kashi 41% na kamuwa da cuta na iya kasancewa daga asibiti.
Saboda haka, ya kamata a yi amfani da rigakafin rigakafi na musamman don kare mutane, musamman ma masu ba da kiwon lafiya, ma'aikatan zamantakewa, dangin su, abokan aiki, da marasa lafiya ko ma waɗanda suka taɓa saduwa da waɗanda ke da cutar.
Hanya ta farko ta kariya da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce sanya abin rufe fuska. Amfani da abin rufe fuska na tiyata da abin rufe fuska na N95 (jerin # 1860s) na iya taimakawa wajen sarrafa yaduwar kwayar cutar.
Abubuwan rufe fuska na tiyata na iya hana abubuwa daga mai yuwuwar kamuwa da cutar daga yaduwa cikin iska da kuma mannewa da fuskoki da abubuwa, hanyoyin da za a iya yadawa ga wasu.
Koyaya, kawai abin rufe fuska na N95 (jerin #1860) na iya kare ƙananan ƙwayoyin cuta daga 10 nanometers zuwa 80 nanometers, yayin da kashi 5% na ƙwayoyin cuta ke da ƙarancin ƙwayoyin cuta. SARS-CoV-2 yayi kama da girman SARS-CoV, tare da ƙwayoyin cuta biyu masu girman 85 nanometers.
Ƙananan ƙananan abubuwa suna iya fashewa har ma da mashin din tiyata guda biyar da aka haɗa tare, don haka masu kula da lafiya da ke hulɗa da marasa lafiya kai tsaye suna buƙatar yin amfani da N95 (jerin # 1860s) maimakon yin amfani da mashin din tiyata.
Masu ba da kiwon lafiya suna buƙatar sanya abin rufe fuska da tufafin kariya na musamman don rage haɗuwa da kwayar cutar.
Kwayar cutar na iya yaduwa ga mutum ta hanyar idanu.
A ranar 22 ga Janairun 2020, an gano likitan da ya kamu da SARS-CoV-2 yayin da yake sanye da abin rufe fuska na N95. Wataƙila kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Don haka, masu ba da kiwon lafiya ya kamata su sanya abin rufe fuska ko tabarau yayin kula da marasa lafiya.
Mutanen da ke cikin yankunan da ke da cutar ko kuma waɗanda ke da yiwuwar kamuwa da cutar, ana ba da shawarar cewa kowa ya wanke hannayensu da sabulu sau da yawa, ya kasance a gida, ya yi ƙoƙari ya iyakance motsi da keɓe kansa, kuma ya iyakance hulɗa da waɗanda ke da yiwuwar kamuwa da cutar.
A cikin mutane, ana ganin nesa mai kyau daga mai haƙuri ita ce tazarar ƙafa uku.
Waɗannan ayyuka sune ingantattun hanyoyi don rage haɗarin yaduwar cutar da kuma hana yaduwar kwayar cutar.
SARS-CoV-2 ya zo ne a matsayin sabon kwayar cuta ga ɗan adam, amma rahoto na 7 ga Janairu, 2020 ya nuna cewa yana da alaƙa da SARS-CoV, yana faɗakar da China cewa tana cikin halin gaggawa, wanda ke nuna mummunan abin da ya faru a lokacin barkewar cutar SARS a 2003.
Amma har zuwa ranar 19 ga Janairun 2020, Cibiyar Kula da Cututtuka ta Wuhan ta tabbatar wa jama'a cewa sabon kwayar cutar ba ta da matsala wajen hanawa da sarrafa cutar saboda rashin saurin yaduwa da kuma iyakancewar yaduwar mutum zuwa mutum.
Wannan sakon ya rage wayar da kan jama'a musamman a lokacin da ake shirin bikin bazara a kasar, kuma ya rasa wannan muhimmin lokaci na rage cutar a Wuhan.
Cibiyar Kula da Cututtuka ta kasar Sin ta koyi darasi daga wannan mummunan lamari kuma za ta iya samun ci gaba mai mahimmanci a nan gaba.
Misali, waɗannan hukumomin ya kamata su (1) yi hankali sosai yayin yin sanarwa ga jama'a, saboda kowace kalma tana da mahimmanci ga jama'a kuma tana iya canza ra'ayoyinsu da yanke shawara; (2) ya kamata su kasance masu hankali game da bayanan da ba na yau da kullun ba daga wuraren shan magani maimakon jiran sanarwar hukuma daga likitoci ko jami'ai; (3) ya kamata su kasance masu ƙuntatawa don sarrafa yiwuwar barkewar cutar tun daga farkon matakan; (4) ya kamata su ba da ƙarin sanarwa game da hanyoyin da suka dace da kuma inganta tsarin amsawar jama'a akai-akai.
Cutar COVID-19, wadda cutar SARS-CoV-2 ke haifarwa, ta fara a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu da na rubuta wannan sakon, ya yadu a duk fadin kasar Sin da kuma kusan kasashe 50 a duniya.
Ban da kamanceceniya da cutar SARS-CoV, akwai kamanceceniya tsakanin bayyanar cututtuka tsakanin COVID-19 da SARS, wanda ke sa barkewar COVID-19 ta zama kamar sake barkewar SARS.
Koyaya, akwai wasu mahimman bambance-bambance tsakanin COVID-19 da SARS waɗanda ke da mahimmanci don sarrafa cutar da kuma kula da marasa lafiya.
COVID-19 ya fi yawaita a cikin manya fiye da matasa, maza fiye da mata, kuma yana da mafi girman mawuyacin hali da yawan mutuwa a cikin tsofaffi fiye da matasa.
SARS yana da yawan mace-mace fiye da COVID-19 (10.91% da 1.44%).
Masu cutar COVID-19 na iya watsa kwayar cutar daga wasu har ma da rashin nuna alamun cutar. A cikin SARS, marasa lafiya galibi suna kamuwa da cutar a lokacin da suke fama da zazzabi mai tsanani. Saboda haka, yaduwar kamuwa da cutar COVID-19 ta ruwa yana da wahalar sarrafawa fiye da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa SARS-CoV-2 ya fi sauri da yaduwa fiye da SARS-CoV.
Wasu marasa lafiya na COVID-19 ba su da SARS-CoV-2 kuma gwajin RNA na yau da kullun zai iya nuna rashin lafiya.
A gefe guda kuma, marasa lafiya da suka warke suna iya sake kamuwa da cutar.
Wadannan binciken sun kara yawan hadarin yaduwar cutar.
Wannan ci gaba mai ban mamaki a cikin binciken COVID-19 ya haifar da wasu mahimman batutuwa waɗanda dole ne a ci gaba da magance su kamar haka:
Daga ina ne SARS-CoV-2 ya fito?
Ko da yake an gano daidaiton kwayoyin halitta tsakanin SARS-CoV-2 da SARS CoV na bat, an gano daidaiton kwayoyin halitta na 96%, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya samo asali daga jemage ba.
A cikin wannan labarin, an gano cewa wasu daga cikin masu cutar sun kamu da cutar a cikin shekarun da suka gabata.
Idan ba mu san amsoshin tambayoyi na 1 da 2 ba, ba za mu iya dakatar da yaduwar cutar ba, kuma cutar za ta iya sake barkewa a kowane lokaci.
Ko da yake yawancin nazarin kwayoyin halitta da nazarin ilmin halitta sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin cuta na numfashi kuma ta haifar da canje-canje na cututtuka?
Shin kwayar cutar tana haɗuwa da ƙwayoyin ACE2 a wasu gabobin jiki?
Idan ba tare da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu sami saurin ganewar asali da ingantaccen magani ba.
A lokacin da ake samun cutar, mutane da yawa suna yin addu'a don a magance ta.
A lokacin da cutar ta kamu da cutar daga mutum zuwa mutum, ta yaya kwayoyin halitta ke canzawa?
Zai iya zama annoba, ya ɓace kamar SARS, ko kuma ya sake dawowa a kai a kai kamar mura?
Ko da yake yana da muhimmanci, amma zai iya ɗaukar lokaci kafin a sami amsoshin wannan tambayar da kuma wasu da yawa.
Amma ba mu da wani zaɓi idan muna son a kawo ƙarshen cutar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullun, ko da menene farashin.
A cikin wannan labarin, an gano cewa cutar coronavirus ta fara ne a cikin shekarun da suka gabata.
Juyin halitta da daidaitawa sun ba da damar kwayar cutar coronavirus (CoVs) da kuma mahalarta su, gami da mutane, su ci gaba tare har tsawon shekaru.
A shekara ta 2003, an gano cewa wasu ƙwayoyin cuta guda biyu na mutum (HCoVs) suna haifar da rashin lafiya mai sauƙi kamar sanyi.
A cikin ɓarkewar cutar SARS da MERS, cutar HCoV ta zama mai rikitarwa da haɗari ga rayuwa.
Fitowar SARS-CoV-2 a babban yankin China a ƙarshen 2019 kamar ya ba da ƙarin haske ga CoVs, yana ba mu mamaki da yawan kamuwa da cutar amma yana da ƙananan cututtuka idan aka kwatanta da takwaransa na SARS-CoV.
Cutar HCoV tana yaduwa daga dabba zuwa mutum, kuma fahimtar asalin dabbobi na HCoVs zai ba mu damar yin aiki sosai.
Yawancin HCoVs da aka fara kamuwa da su daga ƙuda sun samo asali ne daga ƙudaje marasa cutar.
An kuma gano masu karɓar baƙi na wasu HCoVs.
Gano dabbobi masu karɓar baƙi yana da alaƙa kai tsaye da rigakafin cututtukan ɗan adam.
Binciken hulɗar masu karɓar COVID-19 a cikin dabbobi na iya samar da mahimman bayanai game da cutar COVID-19 a cikin mutane.
A cikin wannan bita, mun gabatar da cikakken nazarin ilimin game da nau'ikan HCoVs guda bakwai da ke akwai, tare da mai da hankali kan tarihin binciken su da kuma asalin su na dabbobi da kuma yaduwar jinsuna.
Yana da mahimmanci cewa mun kwatanta da kuma tattauna bambancin HCoVs daban-daban daga yanayin juyin halitta na kwayar cutar da sake haɗuwa da kwayoyin halitta.
Wannan labarin ya tattauna game da annobar cutar COVID-19 (Covid-19) ta yanzu.
Bugu da ƙari, ya nuna mahimmancin buƙatun don nasarar sauye-sauye daga mai karɓar baƙi da kuma tasirin juyin halitta na kwayar cutar akan tsananin cutar.
Kwayoyin cuta na corona (CoVs) suna cikin dangin coronaviruses waɗanda ke da nau'ikan ƙwayoyin cuta na RNA guda ɗaya tare da garkuwar garkuwar.
Waɗannan ƙwayoyin cuta suna da girman kilobases 26 zuwa 32 kuma sun sami mafi girman jinsuna tsakanin ƙwayoyin cuta na RNA, waɗanda ake kira CoVs saboda siffar su ta hanyar microscope.
A tsarin, CoVs suna da kwayoyin halitta marasa rarrabuwa waɗanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta sun ƙunshi manyan allon biyu (ORF1a da ORF1b) waɗanda ke fassara juna a matsayin pp1a da pp1ab polyproteins masu kwafi.
Polyproteins suna aiki don samar da sunadarai 16 marasa tsari, wanda aka ƙaddara nsp1-16.
Sauran sassan tsarin ORFs tare da kwayoyin halitta sun hada da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Yawancin ƙwayoyin cuta na musamman na kwayoyin halitta suna ƙunshe da ƙwayoyin cuta daban-daban na CoVs.
Dangane da tasirin kwayoyin halitta daban-daban, an rarraba kwayoyin cuta na CoVs zuwa gida huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV), waɗanda ke da ƙwayoyin cuta na beta-CoV da ke da ƙwayoyin cuta na HCoVs da yawa, kuma an rarraba su cikin gida huɗu (A, B, C da D).
A cikin shaidar nazarin kwayoyin halitta, tsuntsaye sun kasance manyan wuraren tattara gamma-CoVs da delta-CoVs, yayin da jemage da masu cizon sauro ke aiki a matsayin tushen asalin yawancin alpha-CoVs da beta-CoVs.
Ko da a cikin dubunnan shekaru, CoVs sun kasance cikin jerin ƙuntatawa na jinsuna, wasu daga cikinsu sun fito da gaggawa don haifar da barkewar cutar ɗan adam.
A yau, an gano nau'ikan HCoVs guda bakwai da ke cutar ɗan adam.
Daga cikin su, HCoV-229E da HCoV-NL63 sune masu cutar alpha-CoVs.
Sauran cututtukan ƙwayoyin cuta guda biyar da aka haɗa sune HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV da SARS-CoV-2.
Cutar cututtukan HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da alamun rashin lafiya kamar sanyi da / ko amai.
Idan aka kwatanta, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 wanda aka gano, suna da ƙarancin kamuwa da cuta ta hanyar kwayar cuta, wanda ke haifar da mummunan kamuwa da cuta ta hanyar numfashi tare da haɗarin kamuwa da cututtukan numfashi mai tsanani (ARDS) da cututtukan huhu masu tsanani a cikin marasa lafiya da yawa.
An ware HCoV-229E na farko, B814, daga hanci daga mai cutar sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin HCoV-229E da HCoV-OC43, waɗanda ke haifar da iyakancewar alamun cutar.
A gaskiya ma, kafin barkewar SARS, an yarda da cewa kamuwa da cutar HCoVs ba ta da haɗari.
Cutar SARS da ta ɓarke a shekara ta 2003 ta kasance ɗaya daga cikin mummunar annoba a tarihin zamani, ta kamu da mutane fiye da 8,000 kuma ta kashe kusan 10%.
Shekaru goma bayan haka, cutar MERS ta Gabas ta Tsakiya ta haifar da barkewar annoba a yankin Larabawa, kuma ta bazu zuwa sauran duniya a cikin keɓewa.
HCoV (2019-nCoV) wanda ya bayyana a cikin 2019, wanda daga baya aka sake masa suna SARS-CoV-2, shine babban dalilin cutar coronavirus ta 2019 (COVID-19), wanda ya haifar da mutuwar mutane 3,120 da kamuwa da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
A cewar rahoton, duniya tana shirin kamuwa da cutar SARS-CoV-2.
Dukkanin nau'ikan HCoVs guda bakwai da ke da damar yaduwa daga dabba zuwa mutum an fara su ne daga jemage, beraye, ko dabbobin gida.
Akwai shaidu da yawa da ke nuna cewa dukkanin HCoVs sun samo asali ne daga naman alade, wanda ya nuna bambancin kwayoyin halitta mai kyau, amma ba tare da cutar ba.
Cutar COVID-19 ta haifar da manyan ƙalubalen likita, kimiyya, zamantakewa da ɗabi'a ga China da sauran duniya.
Binciken asalin zoonotic na HCoVs yana ba da tsarin don fahimtar tarihin halitta, gami da abubuwan da ke haifar da juyin halitta da kuma iyakancewar jinsuna.
Hakanan yana iya aiki don gano mai karɓar baƙi, jagora ko tallafawa dabbobi masu karɓar baƙi waɗanda ke da matsakaiciyar cutar SARS-CoV-2, da kuma abubuwan da ke da mahimmanci don hana kamuwa da cutar nan gaba.
A cikin wannan bita, mun gabatar da kimantawa game da asalin cutar daga dabba zuwa mutum, haɗuwa da cutar, da kuma cutar HCoVs.
Musamman, mun nuna alamun da suka fi dacewa da ƙwayoyin cuta na HCoVs waɗanda ba su haifar da cututtuka a cikin mahalarta na halitta amma suna haifar da cututtuka bayan sun kamu da cutar cikin jinsuna zuwa sabon mai karɓar.
Mun kuma sake nazarin yanayin juyin halitta na HCoV wanda ke haifar da raguwar cutar da kuma karuwar kamuwa da cuta.
An kuma tattauna sakamakon yaduwar cutar SARS-CoV-2 a halin yanzu a cikin wannan mahallin.
An san cutar CoVs ta hanyar dabbobi tun daga ƙarshen 1930s.
Kafin a ware HCoV-229E B814 na farko, an ware wasu CoVs daban-daban a cikin dabbobin da ke dauke da cutar, gami da zakuna, beraye, aladu, kuliyoyi da karnuka, saboda ɓoyayyen hanci na marasa lafiya da ke fama da sanyi.
A cikin shekarun da suka gabata, an gano nau'ikan HCoV bakwai.
A cikin jerin shekaru biyu na tarihin gano HCoVs (Table 1), an ba da taƙaitaccen tarihin ganowa don wadatar bayanai da ilimi.
An ware asalin HCoV-229E na farko daga marasa lafiya da ke fama da cutar ta sama a cikin 1966, kuma daga baya ya zama mai rayuwa a cikin ƙwayoyin huhu na WI-38.
Marasa lafiya da ke dauke da cutar HCoV-229E suna nuna alamun sanyi, gami da ciwon kai, hancinsa, tashin zuciya da tari, zazzabi da tari, wanda ke faruwa a kashi 10 zuwa 20% na kamuwa da cutar.
Bayan 1967, an ware HCoV-OC43 daga ƙwayoyin halitta masu tasowa a cikin kwakwalwar beraye.
Alamun gwaji na kamuwa da HCoV-OC43 ta hanyar HCoV-229E suna da kamanceceniya kuma ba za a iya rarrabe alamun cutar daga wasu cututtukan numfashi kamar cutar mura A da cutar rhinovirus ba.
Dukansu HCoV-229E da HCoV-OC43 suna da yaduwa a duniya kuma ana yaduwa a cikin hunturu a cikin yanayin zafi da sanyi.
A cikin yanayin, lokacin haifuwa na waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, kuma bayan haka, rashin lafiya yana ɗaukar makonni biyu.
Wani gwajin da aka yi da masu sa kai a cikin mutane ya nuna cewa mutane masu lafiya da ke fama da cutar HCoV-229E suna da alamun sanyi mai sauƙi.
Wasu marasa lafiya da ke da rauni na jiki sun kamu da mummunan kamuwa da cutar na numfashi.
SARS, wanda aka fi sani da cutar huhu ta farko, shine farkon barkewar cutar da aka rubuta a tarihin ɗan adam wanda ya haifar da cutar HCoV, wanda ya haifar da cutar SARS-CoV, kuma an gano HCoV na uku.
An gano barkewar cutar SARS ta farko a lardin Guangdong na kasar Sin a karshen shekarar 2002.
Cutar SARS ta bazu zuwa kasashe da nahiyoyi a duniya, inda ta haifar da mutuwar mutane 774 da kamuwa da cutar mutane 8,096.
An kiyasta cewa akwai kusan mutane biyu da ke fama da cutar a cikin kwanaki 4 zuwa 7 na lokacin farawa, ban da masu kamuwa da cutar da yawa, kuma ana tsammanin lokacin mafi girma na kamuwa da cutar shine ranar 10th bayan kamuwa da cutar.
Marasa lafiya da ke dauke da cutar SARS-CoV sun nuna alamun cututtukan numfashi bayan ciwon tsoka, ciwon kai, zazzabi, tashin zuciya da tashin hankali, da numfashi da tari.
Rashin ƙwayoyin lymphocytes, rikitarwa a cikin gwajin aikin hanta, da haɓakar enzymatic sune manyan abubuwan da aka gano a cikin dakin gwaje-gwaje na SARS.
An kuma lura da lalacewar ƙananan jakar iska, haɓakar ƙwayoyin epithelial a cikin huhu, da haɓakar ƙwayoyin cuta a cikin marasa lafiya tare da SARS.
Kimanin kashi 20 zuwa 30 cikin dari na marasa lafiya suna buƙatar kulawa da marasa lafiya da kuma na'urar numfashi ta atomatik a matsayin mai biyo baya.
Cutar tana iya shafar ƙananan hanyoyin numfashi da gabobin jiki da yawa, gami da hanta da kodan, kuma galibi tana tare da mummunan yanayin maye gurbin ƙwayoyin cuta da ake kira cytocin guguwa, wanda zai iya zama mai mutuwa ga masu fama da cutar, musamman marasa lafiya masu rauni.
An fara ware kwayar cutar daga wani mutum mai cutar da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi gagarumin ƙoƙari wajen gano HCoV.
An ware HCoV-NL63 a ƙarshen shekara ta 2004 a Netherlands tun yana ɗan wata bakwai.
An gano cewa cutar ta fara yaduwa a cikin yara da tsofaffi da marasa lafiya masu fama da cutar cututtukan numfashi.
Cutar da HCoV-NL63 ke haifarwa ta ƙunshi cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wani bincike mai zaman kansa ya bayyana irin wannan kwayar cutar daga hancin wani yaro dan wata takwas da ke fama da cutar huhu a Netherlands.
An gano cutar a Netherlands amma a zahiri ta bazu ko'ina cikin duniya.
HCoV-NL63 yana da kusan kashi 4.7% na cututtukan numfashi, kuma ana samun saurin kamuwa da shi a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da ciwon makogwaro, wanda aka fi sani da ciwon makogwaro.
A wannan shekarar, an ware HCoV-HKU1 daga wani mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti don cutar huhu da cutar huhu a cikin Hong Kong.
Baya ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An gano HCoV-HKU1 a duk duniya wanda ke haifar da cutar numfashi mai sauƙi, wanda yayi kama da HCoV-NL63, HCoV-229E da HCoV-OC43.
Dukkanin HCoVs huɗu da ke cikin al'umma sun zama masu jituwa da mutane kuma suna da ƙananan ƙarancin jini don haifar da ƙarin cututtukan da ke haifar da cutar, amma an gano wani sabon kamuwa da cutar HCoV-NL63 mai saurin yaduwa wanda ke haifar da mummunan rauni na ƙananan numfashi a cikin China, a cikin wani yanayi mai wuya ta hanyar haɗari, kodayake ba a san ainihin dalilin ba.
A cikin yanayin, waɗannan HCoVs suna da ƙarancin tsanani ko rashin lafiya yayin da suke samun damar yaduwa da ci gaba da kasancewa tsakanin mutane.
An fara ware MERS-CoV a cikin 2012 daga huhu na wani mutum mai shekaru 60 da ke nuna alamun cutar huhu da rashin cin abinci a Saudiyya.
A gaskiya, yawancin cututtukan da aka tabbatar da su a cikin dakin gwaje-gwaje sun samo asali ne daga Gabas ta Tsakiya, kuma an ba da rahoton a cikin ƙasashen Turai da Tunisia game da wasu cututtukan da aka shigo da su daga wasu wurare inda cutar ta ɓarke ta hanyar kusanci.
Wani sabon kamuwa da cutar ya faru a Koriya ta Kudu a shekarar 2015 inda aka samu mutum 186.
A cikin yanayin da ya dace, MERS, wanda yake kama da SARS, yana da alamun bayyanar cututtuka kamar cutar huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS sun sami mummunan lalacewar koda, wanda ya sanya MERS keɓewa tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na masu cutar suna nuna alamun cututtukan ciki da cututtukan hanji kamar zawo da amai.
Har zuwa 14 ga Fabrairu, 2020, an ba da rahoton fiye da gwaje-gwaje 2,500 na tabbacin cutar tare da babban mutuwar 34.4%, yana mai da MERS-CoV ɗaya daga cikin ƙwayoyin cuta mafi haɗari da aka sani ga ɗan adam.
An gano wasu ƙwayoyin cuta na huhu da aka gano suna da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China tsakanin tsakiyar Disamba da ƙarshen 2019.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar sankarar numfashi ta SARS-CoV-2 a matsayin gagarumar matsalar lafiyar jama'a ta duniya, wanda kuma ake kira COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duk duniya, tare da mutuwar mutum 3.4 cikin ɗari.
A cikin birnin Hubei na kasar Sin, yawan mace-macen ya kai kashi 4.2 cikin dari, inda a wasu wurare ya kai kashi 1.2 cikin dari.
Cutar SARS-CoV-2 tana da mummunan kamuwa da cuta ta hanyar numfashi kamar SARS-CoV da MERS-CoV, wanda ke nuna alamun zazzabi, tari da wahalar numfashi.
Wasu daga cikin marasa lafiyar suna fama da zazzabi.
Ciwon huhu yana daya daga cikin alamun cutar da ke da tsanani kuma yana iya saurin ci gaba zuwa mummunan cututtukan numfashi.
Koyaya, SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan kwayoyin halitta na 82% na kwayoyin halitta, kuma an rarraba su zuwa rassa daban-daban na bishiyar ƙungiyar halittu.
SARS-CoV-2 yana da ƙananan cututtuka, amma yana da yawa fiye da SARS-CoV da MERS-CoV.
An kuma gano wasu mutane marasa alamun kamuwa da cutar SARS-CoV-2, wanda zai iya zama sanadi na saurin yaduwar cutar a duniya.
Akwai kamanceceniya da bambance-bambance tsakanin SARS-CoV-2 da sauran HCoVs shida masu tasowa.
Da farko, lokacin farawa na kwayar cutar ya yi kama da lokacin kamuwa da cutar HCoV.
A cewarsa, SARS-CoV-2 yana bin tsarin sauran HCoVs guda shida.
Na biyu, tsananin alamun cutar COVID-19 ya kasance tsakanin SARS-CoV da HCoVs huɗu da ke cikin mutane (HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna alamun cututtukan da aka saba gani a cikin kamuwa da HCoVs a cikin mutane, gami da rashin alamun bayyanar cututtuka ko rashin ƙarfi ko rashin alamun bayyanar cututtuka.
A wasu kalmomin, ana iya samun ƙananan ƙananan lokuta na COVID-19 mai tsanani a cikin SARS-CoV, kodayake a cikin ƙananan ƙananan.
Na uku, yana nuna wasu siffofin ban sha'awa na HCoVs da SARS-CoVs da ke da alaƙa da zamantakewa a cikin yaduwar SARS-CoV-2.
A gefe guda, SARS-CoV-2 yana da haɗari sosai, aƙalla kamar yadda HCoVs ke a cikin mutane.
A wasu kalmomin, ba a san ko cutar SARS-CoV-2 ta ragu ba bayan kamuwa da cutar ga mutane, kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, kamar HCoVs, SARS-CoV-2 ana iya gano shi a cikin samfuran ƙwayoyin cuta.
Nazarin gwaji na gaba yana buƙatar bayyana ko yaduwar SARS-CoV-2 ta baki yana taka muhimmiyar rawa a cikin yaduwar SARS-CoV.
Ana iya samun SARS-CoV-2 da ke haifar da yanayi kamar yadda HCoVs ke haifar da kamuwa da cuta ta hanyar motsi na jama'a.
Koyaya, halayen SARS-CoV-2, gami da haɓakarsa, cutarwa, da kuma iyawar hana yaduwa bayan ɓarkewar mutum, zai iya yin tasiri kan makomar ƙarshen barkewar cutar ta COVID-19.
Dukkanin HCoVs huɗu da ke cikin al'umma suna haifar da alamun rashin lafiya mai sauƙi kuma suna da kyau ga mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun saba da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya zama ragowar cutar HCoV, waɗanda suka kasance annoba a baya.
HCoVs da ke haifar da kamuwa da cuta mai tsanani a cikin mutane da kuma mutanen da ke fama da cutar HCoVs da ke haifar da kamuwa da cuta mai tsanani an cire su.
Don yin wannan, HCoVs suna iya yin kwafi a cikin mutane don ba da izinin jinkiri mai yawa don haɗuwa da maye gurbin da ke hana abubuwan hanawa.
A wannan yanayin, tsawon lokacin da SARS-CoV-2 ke yaduwa, yawancin mutane za su kamu da cutar kuma mafi kusantar yiwuwar daidaitawa da ɗan adam.
Idan ya daidaita, zai yi wuya a hana yaduwar cutar tsakanin mutane ta hanyar keɓewa ko wasu matakan kula da yaduwar cuta.
A cikin shekaru da yawa, CoVs na al'umma sun kasance suna yaduwa tsakanin mutane kuma suna haifar da sanyi a cikin mutanen da ke da ƙarancin rigakafi.
Wannan cutar ba ta bukatar dabbobi masu daukar marasa lafiya.
Idan aka kwatanta, SARS-CoV da MERS-CoV, waɗanda ke da yawan kamuwa da cuta, ba su da jituwa sosai a cikin mutane kuma ba za su iya hana yaduwar cutar ga mutane ba.
Suna buƙatar kiyayewa da yaduwa a cikin dabbobi masu cutar, suna neman damar watsawa ga mutane masu rauni ta hanyar matsakaici ɗaya ko fiye da masu karɓar cuta.
SARS-CoV-2 yana da alamun bayyanar da suka yi kama da SARS-CoV/MERS-CoV da HCoVs huɗu da ke cikin mutane.
A halin yanzu, yana da irin wannan saurin yaduwa kamar sauran HCoVs huɗu da ke cikin mutane.
Koyaya, ya fi saurin yaduwa fiye da HCoVs da aka samu ta hanyar hulɗa da jama'a kuma yana da ƙarancin kamuwa da cuta fiye da SARS-CoV ko MERS-CoV.
A cikin wannan labarin, an gano cewa cutar ta kamu da cutar a cikin mutane, kuma ba ta da wata hanyar da za ta iya ɗaukar hoto ko kuma ta hanyar dabbobi.
Kafin tattauna asalin dabbobi na HCoVs, muna ba da shawarar tattauna abubuwan da suka shafi juyin halitta na HCoVs, yanayin halitta, yanayin cutar, ma'anar matsakaici da haɓaka, da kuma halaye na musamman.
Idan dabba ta gaji wani kakan dangi wanda ke da alaƙa da juna sosai a matakin tsarin kwayoyin halitta, wannan yana aiki a matsayin juyin halitta na HCoV.
Kwayar cutar ta zamani tana da kyau kuma ba ta da cutar a wannan wurin.
Hakazalika, mai karɓar baƙon da ke riƙe da kwayar cutar yana ɗaukar HCoV a kai a kai na dogon lokaci.
A cikin duka lamura, masu karɓar baƙi sun kamu da cutar ta hanyar halitta kuma sun kasance asalin asalin HCoV ko kuma asalin asalin su.
Bambanci shine, idan HCoV ya fara a matsayin mai karɓar baƙi na matsakaici kafin ya zama mai yaduwa ga mutane, ba zai iya daidaitawa da sabon mai karɓar ba kuma yana iya zama mai saurin kamuwa da cuta.
Wannan mai karɓar baƙi ba kawai yana aiki azaman tushen zoonotic na kamuwa da cuta tsakanin mutane ba amma kuma babban mai karɓar cuta wanda ke haifar da kwayar cutar ta hanyar haɓaka ɗan lokaci kuma yana haifar da kamuwa da cutar tsakanin mutane.
HCoVs suna iya haifar da kamuwa da cuta idan ba za a iya hana su yaduwa a cikin mai karɓar ba.
A gefe guda, HCoVs na iya rayuwa a cikin mai karɓar mai karɓar, har ma yana haifar da ɓarkewar cutar mai tsawo.
A wannan yanayin, matsakaiciyar rashin lafiya ta zama ta al'ada.
Bayanai game da yaduwar cutar da rigakafin cutar sun nuna cewa a cikin tarihin, akwai alamun haɗuwa da dabbobi masu farauta a farkon farkon cutar SARS.
Binciken da aka yi bayan cutar ta hanyar gwajin jini ya nuna cewa masu sayar da dabbobi suna da mafi girman yaduwar antigen mai hana SARS-CoV (SARS-CoV IgG) fiye da sauran jama'a.
An fara gano cewa fararen fata (Paguma larvata) da beyar gizo-gizo a cikin kasuwar dabbobi suna dauke da kwayar cutar kamar SARS-CoV, wanda yayi kama da SARS-CoV.
Wannan ya nuna cewa babu wani labari game da yaduwar cutar SARS bayan an kashe dukkan 'yan kasuwa.
Koyaya, an nuna cewa katantanwa daga daji ko gonaki ba za su iya kamuwa da SARS-CoV ba tare da haɗuwa da kayan dabbobi masu rai ba, kuma katantanwa na iya aiki azaman mai karɓar mai karɓar cutar mai tsaka-tsakin gaske maimakon mai karɓar SARS-CoV.
Musamman a Guangzhou, ana iya ƙin yarda da yiwuwar cewa dabbobi daban-daban a cikin kasuwanni suna da kashi 80% na ƙwayoyin cuta da ke hana SARS-CoV, kuma wasu ƙananan nau'ikan dabbobi masu shayarwa suna iya zama masu karɓar SARS-CoV kai tsaye.
Duk waɗannan suna nuna cewa sune sabbin masu karɓar SARS-CoV.
Binciken da aka yi na juriya na SARS-CoV a cikin dabbobi ya nuna cewa yana da alaƙa da cutar CoV na bat da kuma cutar Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3) da ke da alaƙa da SARS a cikin madarar dawakai na China.
Wadannan kwayoyin sun ƙunshi kwayoyin da ke kare cutar SARS-CoV kuma suna da kamanceceniya da tsarin kwayoyin SARSr-Rh-BatCoV HKU3.
Yana da kusan kashi 88-92% na daidaituwa tsakanin tsarin kwayoyin halitta da SARS-CoV da sauran CoVs na Batman.
Wannan binciken ya samar da sabon ra'ayi cewa jemage masu dauke da cututtuka ne da ke iya cutar da mutane.
An gano wasu cututtukan SARS daban-daban, kamar CoVs (SL-CoVs), waɗanda ke haifar da bat, amma ba a iya ware su a matsayin ƙwayoyin cuta masu rai ba, ban da takamaiman WIV1.
An san cewa kwayar cutar SARS-CoV tana da ƙwayar cuta ta hanyar kwayar halitta ta mutum (ACE2).
WIV1 ya samo asali ne daga ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
A wani labari mai ban sha'awa, cutar SARS, cutar da ke haifar da cutar sankarar bargo, ta sa plasma na marasa lafiya na cutar ya rage tasirin WIV1.
Har zuwa yanzu, WIV1 ya nuna cewa yana da alaƙa mafi kusa da SARS-CoV a cikin jemage tare da 95% na haɗin tsarin kwayoyin halitta.
Duk da irin kamanceceniyar kwayoyin halitta tsakanin ƙwayoyin cuta biyu, an yarda cewa jemage ba magungunan SARS-CoV bane, kamar yadda WIV1 ba shine asalin SARS-CoV ba.
Tsarin halittu na Phylogenetic ya nuna cewa yawancin MERS-CoVs suna da jinsin kama da na CoV-HKU4 na Batman da CoV-HKU5 na Batman.
CoV-HKU4 da MERS-CoV suna yada cutar ta hanyar mai karɓar mai karɓar dipeptidyl peptidase 4 (DPP4), wanda shine hanyar da ke hana cutar.
Sakamakon RNA-dogara RNA polymerase enzymes na MERS-CoV yana da kusanci da kwayoyin halitta tare da abubuwan da ke dauke da beta-CoVs na madara da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a gano MERS-CoV a cikin dabbobi ba.
MERS-CoV da danginsa na kusa, CoV-HKU25, suna da kusan kashi 87% na daidaiton tsarin kwayoyin halitta.
Saboda haka, ba zai yiwu ba cewa jemage ne ke da damar kai tsaye na MERS-CoV.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra
An ware samfurin MERS-CoV mai rai wanda yayi kama da kwayar cutar da ake samu a cikin mutane daga hancin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙ
Ya kamata a lura cewa raƙuman da aka gwada da MERS-CoV galibi ba su da alamun cutar, amma suna da babban damar ɗaukar kwayar cutar ta hanyar su.
Ba wai kawai raƙuman da ke dauke da cutar ke fitar da kwayar cutar ta hanyar numfashi ba, amma ta hanyar hanyar bayan gida-bakin, wanda shine babban hanyar fitar da ƙwayoyin cuta daga jemage.
Koyaya, babu tarihin kamuwa da cutar MERS tare da raƙuman raƙumi kafin mummunan kamuwa da cutar, kuma har yanzu akwai tambayoyi game da yiwuwar yaduwar mutum zuwa mutum ko yaduwar rashin sani wanda ya shafi nau'ikan dabbobi marasa iyaka waɗanda ke dauke da cutar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na rabon kwayoyin halitta tare da CoV RaTG13 wanda aka ware daga jemage Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin sakamako tsakanin SARS-CoV-2 da RaTG13 yana da kyau don tantance yadda ya dace da asalin.
Idan ba a gano CoVs na bat ba a nan gaba, ba za a iya cewa bat ba masu karɓar SARS-CoV-2 ba.
Ana tsammanin cewa matsakaiciyar ƙwayar cutar ta SARS-CoV-2 na iya kasancewa tsakanin yankan da sayar da nau'ikan dabbobin daji a kasuwar siyar da abincin teku ta Hunan, wanda ke nuna cewa akwai wasu cututtukan farko da ke da alaƙa da COVID-19 da kuma abubuwan da ke faruwa na dabbobi zuwa mutane.
Yawancin binciken da aka yi kwanan nan, dangane da sakamakon binciken kwayoyin halitta, sun nuna cewa ƙananan dabbobi masu shayarwa, waɗanda aka sani da ƙwayoyin cuta masu haɗari (Manis javanica), na iya ɗaukar nauyin tushen beta-CoVs da ke da alaƙa da SARS-CoV-2.
Wannan sabon kwayar cutar ta CoV yana da kashi 85-92% na rabawa tsakanin SARS-CoV-2 da kwayoyin halitta.
Duk da haka, suna da kusan kusan 90% na dangantaka da RaTG13 a cikin tsarin tsarin kwayoyin halitta.
Sun haɗu cikin ƙananan ƙwayoyin cuta guda biyu a cikin bishiyar juyin halitta na SARS-CoV-2, ɗaya daga cikinsu yana da kamanceceniya da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
Bambanci mai mahimmanci shine cewa RBDs na SARS-CoV-2 da RaTG13 sun bambanta sosai, kodayake suna da babban digiri na daidaiton tsari a cikin kwayoyin halitta.
Wani binciken farko akan allunan da ke dauke da cutar ya nuna cewa cire kwayar cutar daga samfurori na huhu ya canza zuwa yanayin da ya dace da SARS-CoV-2.
Wannan binciken ya kasance hanyar haɗuwa da hanyoyin bincike daban-daban, yana ƙoƙarin samar da maganin cututtukan mutane don haifar da sakamako na halitta a kusan kashi 86.3% na asalin kwayar cutar.
Wannan samfurin ya nuna cewa SARS-CoV-2 yana da tasiri a cikin dabbobi.
Koyaya, a halin yanzu babu wata hanyar tabbatar da cewa SARS-CoV-2 ya samo asali ne daga asalin asalin SARS-CoV-2 ta hanyar bambancin sakamakon bincike tsakanin SARS-CoV-2 da beta-CoVs na SARS-CoV-2.
Bugu da ƙari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi tazara tsakanin SARS-CoV-2 da SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Ana buƙatar tabbatar da ci gaban kamuwa da cutar SARS-CoV-2 a cikin jemage, tsuntsaye da sauran dabbobi masu shayarwa.
An gano mafi girman daidaituwa na kwayoyin halitta a cikin RBDs tsakanin SARS-CoV-2 da kuma SARS-CoV-2, kuma beta-CoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13, suna da mafi girman daidaituwa na kwayoyin halitta.
Akwai ƙarin zato cewa babban adadin kamanceceniya tsakanin RBDs na SARS-CoV-2 da beta-CoVs da kuma dangantakar SARS-CoV-2 an ƙaddamar da su ta hanyar zaɓin-ƙaddamar da juyin halitta.
Maganar da aka yi ta nuna cewa ana son maye gurbin kwayoyin halitta tsakanin beta-CoV da ke da alaƙa da SARS-CoV-2 da kuma RaTG13 a cikin nau'in daji na uku.
A cikin juyin halitta, juyin halitta yana da tasiri a cikin beta-CoVs.
Abin da za a yanke shawara shi ne asalin dabba na SARS-CoV-2 na asali.
Baya ga HCoVs da ke haifar da cutar da ke haifar da cutar ta hanyar kwayar cutar, an gano asalin zoonotic na HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar kwayoyin halitta ta nuna cewa asalin asalin kwayoyin cuta, HCoV-OC43 da HCoV-HKU1, an gano su a cikin dabbobi masu saurin cizon dabbobi, yayin da duka HCoV-NL63 da HCoV-229E ke nuna cewa duka sun samo asali ne daga CoVs na Batman.
An ba da rahoton cewa an gano kwayar cutar a cikin kiwo mai launin toka na Arewacin Amurka wanda aka nuna yana da alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da kwayoyin halitta tare da wani CoV na Batman da aka gano a Ghana, wanda aka kira Hipposideros/GhanaKwam/19/2008, kuma ana tsammanin manyan raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman
Don ƙarin haske, an taƙaita ilimin yanzu game da asalin dabbobi, waɗanda aka fi sani da HCoVs a cikin Hoto 1 da Tebur na 2.
Binciken juyin halitta ya nuna shaidar cewa a tarihi akwai yaduwar HCoVs tsakanin jinsuna daban-daban.
A cikin shekarun 1890, an rubuta barkewar cutar cututtukan numfashi lokacin da HCoV-OC43 ya wuce jinsuna kuma ya haifar da kamuwa da cuta ga mutane ta hanyar dabbobi.
Tarihin yaduwar HCoV-229E tsakanin jinsuna ba shi da cikakken bayani.
An gano alpha-CoVs na Batman wanda ke da alaƙa da HCoV-229E.
Daga cikin su akwai kwayar cutar alpha-CoV da aka samo a cikin dabba mai launin fata mai kama da raƙumi.
Akwai shaidu da dama da ke nuna cewa dabbobi suna yaduwa daga dabbobi masu shayarwa zuwa mutane.
A cikin wannan yanki, mutane sun fara hulɗa da bat, ba alpacs ko alpacas ba.
Maimakon haka, mutane suna da kusanci da alpaca camels.
Na biyu, alpha-CoVs na malam buɗe ido da ke da alaƙa da HCoV-229E sun bambanta kuma ba su haifar da cutar a cikin malam buɗe ido, yayin da alpha-CoV na malam buɗe ido ke haifar da cututtukan numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a taɓa samun ƙwayar cutar alpha-CoV a cikin dabbobi masu launin fata ba.
Saboda wannan dalili, ba za a iya kawar da yiwuwar cewa wani mai kama da raƙumi ya kamu da cutar HCoV-229E mai alaƙa da alpha-CoV daga ɗan adam ba.
A gaskiya, jemage sune tushen kai tsaye na ƙwayoyin cuta da za su iya kamuwa da mutane, ciki har da kwayar cutar cutar Ebola, cutar cutar Ebola, cutar Nevirovirus, da cutar kwayar cutar kwalara.
Saboda haka, ba abin mamaki ba ne cewa jemage na iya yada HCoV-229E kai tsaye ga mutane.
A wasu kalmomin, alpha-CoVs a zahiri suna aiki a matsayin kwayar halittar HCoV-229E, yayin da raƙuma da garken raƙuma ke aiki a matsayin matsakaiciyar mai karɓar cutar daga ƙwayoyin cuta zuwa mutane, musamman a cikin kamuwa da cutar MERS-CoV.
MERS-CoV shine mafi kyawun misali na watsawa tsakanin jinsuna, ba kawai daga jemage zuwa raƙuma ba, amma daga raƙuma zuwa mutane.
MERS-CoV, wanda ya samo asali daga jemage, an san shi da farko a matsayin mai rarrabewa kuma bayanan da aka samu sun ƙarfafa shi.
A bayyane yake cewa jemage suna rarraba nau'ikan ƙwayoyin cuta da yawa waɗanda ke ba da damar musayar abubuwan haɗin kwayoyin halitta tsakanin nau'ikan da kuma yaduwar jinsuna.
Tsayin daka, ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen ƙawancen.
A wasu kalmomi, MERS-CoV ya kasance a cikin ɗakunan ajiya na shekaru da yawa.
Wannan ya dace da yanayin raƙuman da ke da canji daga mai karɓar cutar kai tsaye zuwa mai karɓar cutar mai ɗorewa da ɗorewa.
MERS-CoV yana haifar da rashin lafiya mai rauni a cikin waɗannan dabbobin kuma an sarrafa shi don ƙarancin maye gurbi.
A cikin ƙananan lokuta, kamuwa da cutar ga mutane ba zato ba tsammani ne, kuma saboda cutar ba ta da iyaka, mutane suna zama masu karɓar baƙi waɗanda ba za su iya yadawa ga sauran masu karɓar MERS-CoV ba.
Idan akwai wani abu, kwatanta ya bambanta tsakanin rawar raƙuman raƙumi a cikin yaduwar MERS-CoV da rawar da takalman raƙumi ke takawa a cikin yaduwar SARS-CoV-2.
Musamman, ƙwayar cuta ta beta-CoVs ta haifar da yawan kamuwa da cuta a cikin ƙwayar cuta.
Suna iya zama masu karɓar ƙarshen hanya don SARS-CoV- da ke da alaƙa da cutar COVID-19 da kuma beta-CoVs da ke da alaƙa da cutar COVID-19 kamar SARS-CoV-2 da ke da alaƙa da cutar COVID-19.
Ya kamata a yi la'akari da lissafin da kuma cire wasu daga cikin yiwuwar yaduwar SARS-CoV-2 daga dabbobi zuwa mutane a cikin gwaji na gaba.
Da farko, jemage na iya zama mai karɓar cutar SARS-CoV-2, kwayar cutar da ke da alaƙa da kusan kusan SARS-CoV-2.
A cikin wannan yanayin, mutane suna iya raba sararin samaniya tare da bat, ko dai ta hanyar kashe ƙudan zuma ko kuma hakar ma'adinai.
Na biyu, filayen za su iya zama masu karɓar masu karɓar watsawa waɗanda suka haifar da cutar da ke da alaƙa da SARS-CoV-2.
Mutane na kamuwa da cutar ta hanyar sayar da naman da aka yanka da kuma cinyewa.
Akwai yiwuwar cewa dabbobi masu shayarwa da yawa, gami da dabbobin gida, suna da saukin kamuwa da SARS-CoV-2.
Wannan ya tabbatar da binciken da aka yi kan rashin lafiyar dabbobin gida da na daji.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya haifar da haɗuwa da duka bat da kuma nau'in tsuntsaye a cikin nau'in na uku.
Ana ci gaba da bincike kan asalin SARS-CoV-2 a cikin dabbobi.
Baya ga nau'ikan karɓar baƙi na dabbobi, manyan ayyuka uku na kwayar cutar suna da mahimmanci don sauƙaƙe ƙetare shingen tsakanin jinsuna don CoVs.
Na farko, suna da ƙwarewar maye gurbi a lokacin kwafin RNA.
Idan aka kwatanta da ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar maye gurbi na CoVs za a iya bayyana a matsayin matsakaicin matsakaici na matsakaici na ~10-4 sauyawa a kowace 2 shafukan yanar gizo a shekara dangane da yanayin da ke cikin sabon mai karɓar CoV.
CoVs suna da enzyme mai karantawa da gyarawa, exoribonuclaese, wanda hana shi zai iya haifar da canjin kwayoyin halitta mai yawa, har ma da rage nauyi ko rashin rayuwa.
Abin sha'awa, an gano cewa Remdesivir yana hana kwayar cutar CoV ta hanyar hana wannan isoburonuclease da RNA-dogara RNA polymerase enzymes.
Remdesivir wani magani ne da aka gwada don magance SARS-CoV-2.
Amma, CoVs na ƙwari suna da yawan maye gurbi sau miliyan fiye da waɗanda suke karɓar bakinsu.
Bugu da ƙari, yawan canjin yana ƙaruwa idan CoVs ba su da kyau ga mai ɗaukar cuta.
Idan aka kwatanta da SARS-CoV mai yawan maye gurbi, an ba da shawarar cewa SARS-CoV-2 yana da ƙananan canjin yanayi kuma yana da mafi girman matakin jituwa a cikin mutane.
Wannan shine dalilin da ya sa ya kamata a yi la'akari da cewa cutar ta riga ta kamu da wasu masu karɓar baƙi kusa da mutane.
Baya ga SARS-CoV-2, yana da alaƙa da MERS-CoV wanda ke da kyau a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
A ka'idar, maye gurbi ba zai iya haifar da rashin tasiri ga alluran rigakafin SARS-CoV-2 da masu rage cutar ba da sauri.
Abu na biyu, babban RNA genome a cikin CoVs yana ba su damar zama masu sassauƙa don maye gurbi da sake haɗuwa yayin gyaran kwayoyin halitta, don haka haɓaka yiwuwar coevolution tsakanin jinsuna, wanda ke ba da damar fitowar sabon CoVs a wani lokaci.
Ana tallafawa ta da yawa daga cikin nau'ikan karatun buɗe da kuma tsarin sunadarai da ke ƙayyade ƙarshen 3 'na chromosome.
Na uku, CoVs suna canzawa sau da yawa yayin yin kwafin RNA ta hanyar wani abu mai banbanci na kwafin-zaɓin-zaɓin.
Canjin yanayin zaren yana faruwa yayin kwafin RNA na CoV a cikin mai karɓar wanda ke aiki azaman mai ɗaukar hoto.
Haɗin babban damar samun asalin asali da sake haɗuwa da kwayar RNAs na kwayoyin halitta na iya haifar da sababbin cututtukan CoVs.
An gano hujjojin juyin halitta na halitta a cikin HCoVs HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar SL-CoV na Batman da CoV-HKU9 na Batman.
Wannan ya nuna cewa cutar ta fi yawa a cikin mutane fiye da yadda ake tsammani.
Baya ga waɗannan dalilai guda uku na kwayar cutar da aka ambata a sama, wurin da mai karɓar cutar yake da kuma hulɗar kwayar cutar wani babban mahimmin abu ne wanda ke tasiri ga yaduwar kwayar cutar tsakanin jinsuna.
A cikin wannan mahallin, sake haɗuwa da SARS-CoV an nuna shi a matsayin misali na yau da kullun wanda ke nuna tabbacin zaɓi a cikin yaduwar kwayar halitta.
Dangane da bincike na mutum da na SARS-CoVs na cat, an yi tunanin cewa SARS-CoV na iya haifar da saurin haɗuwa tsakanin masu karɓar baƙi daban-daban tare da maye gurbi a cikin RBD na furotin S na musamman.
A cikin furotin S na CoV, RBD yana hulɗa ta hanyar zaɓaɓɓu ta hanyar mai karɓar mai karɓar cutar da ƙwayoyin cuta masu hana cutar.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 a cikin S1 sashi, wanda shine mahaɗar mahaɗar cutar a cikin cutar da ke cikin ɗan adam ACE2.
RBD na SARS-CoV yana iya gano wasu dabbobin da ke da ƙwayar cutar ACE2, gami da jemage, caterpillars, beraye da beyar gizo-gizo waɗanda ke haifar da kamuwa da cutar.
A zahiri, an bincika ragowar amino acid guda shida daban-daban daga ƙwayoyin cuta na mutum da na cat da aka ware a cikin RBD, kuma huɗu daga cikinsu suna cikin wuri mai kusanci da mai karɓar ACE2 don hulɗa da mai karɓar.
SARS-CoV na siririn cat yana da maye gurbi K479N da S487T a cikin RBD wanda zai iya haɓaka haɗin gwiwar mai karɓar mai karɓar ACE2 na ɗan adam da furotin mai ɗauke da ƙwayoyin cuta.
A wasu kalmomi, waɗannan maye gurbin amino acid biyu na iya zama mahimmanci ga yanayin rashin lafiya a cikin mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da mai karɓar ƙwayar halitta kamar SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin rukunin S1 na furotin S ya nuna cewa furotin S na iya canzawa cikin haɗin kai tare da ACE2 na ɗan adam.
A zahiri, nazarin cryo-EM ya nuna cewa akwai haɗin gwiwa tsakanin ACE2 na ɗan adam da kuma sunadaran SARS-CoV S wanda ya ninka haɗin gwiwa sau 10 zuwa 20.
Hakanan yana da ban sha'awa don sanin ko akwai wasu manyan wuraren da ake buƙatar yaduwar SARS-CoV-2.
Abin sha'awa, HCoV-NL63 yana da dangantaka da ACE2 amma tare da wani sashi na S.
Akwai wasu masu kula da cututtukan HCoV da yawa, kamar su N aminopeptidase don HCoV-229E da 9-O-acetylated silylic acid don HCoV-OC43.
Hakanan ana iya ɗaukar su don nasarar dacewa da waɗannan CoVs a cikin mutane bayan yaduwar cikin jinsuna daga masu karɓar dabbobi.
Baya ga ƙwayoyin halitta, akwai wasu dalilai da ƙuntatawa da ke haifar da sakamakon kamuwa da kwayar cutar HCoVs tsakanin jinsuna, wanda ya dogara da mai karɓar baƙi.
Bambancin karɓar furotin tsakanin mutane da kuma wuraren karɓar HCoVs na halitta kamar su jemage, raƙuma da beraye na iya zama shinge don shiga cikin kamuwa da cuta.
Don samun nasarar yaduwar cutar, HCoVs suna buƙatar ɗaukar wuraren karɓar baƙi da kuma lalata wuraren da aka ƙayyade don karɓar cutar.
A wannan yanayin, har yanzu akwai buƙatar gano abubuwan da ke cikin kwayoyin halitta da kuma gano yanayin a cikin yankin hulɗar wannan kwayar cutar mai mahimmanci da mai masaukin baki.
A cikin binciken da ba na son kai ba, amfani da mafi kyawun matakan CRISPR na iya zama da amfani ga masu karɓar baƙi da ƙuntatawa ga SARS-CoV-2.
An gano cewa wasu ƙwayoyin HCoVs sun sake fitowa.
Bambancin nau'in CoVs na Batman yana ba da dama da yawa don fitowar sabon HCoVs.
A wannan yanayin, CoVs na Batman suna aiki azaman akwatin halittar HCoVs.
Bugu da ƙari, saurin maye gurbi da haɗuwa da kwayoyin halitta suna haifar da juyin halittar HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, ajiya ko asarar kwayoyin halittar da ke ɓoye furotin na sabon abu na iya canza yanayin bayyanar kwayar cutar sosai.
Daga cikin kwayoyin SARS-CoV, an gano cewa ƙwayoyin cuta masu haɗuwa da SARS-CoV sun rabu da kansu amma suna ɓoye sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sun
An gano siffofin SARS-CoVs na ƙwayoyin halitta 29 a cikin bambance-bambancen da aka ware a farkon kamuwa da cutar a cikin mutane.
Wannan kawarwa yana iya zama kamar maye gurbi mai dacewa wanda ya canza daga ORF8 zuwa ORF8a da ORF8b da kuma sauyawa zuwa mai karɓar cuta.
Bugu da ƙari, akwai yiwuwar cewa SARS-CoVs yana da tarihin sake haɗuwa tare da jerin sunayen alpha- da gamma-CoVs tare da ƙananan ƙananan yankuna da aka gano a cikin RNA-daidaitaccen RNA polymerase enzyme.
Ana iya rarrabe wuraren sake haɗuwa a cikin nsp9, mafi yawan nsp10, da kuma cikin sassan nsp14.
Hakazalika, cutar MERS-CoV da ta samo asali a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Baya ga SARS-CoV da MERS-CoV, an gano wasu lokuta na sake haɗuwa a cikin sauran HCoVs, wanda ya nuna cewa HCoVs sun sake haɗuwa da sauran CoVs na dabbobi a cikin kwayoyin halitta ba tare da tsarin tsarin su ba.
Ya kamata a lura cewa zaɓin da ba na halitta ba zai iya haifar da canje-canje da ba a so a cikin kwayoyin halitta na kwayar cutar, wanda zai iya haifar da sauyawar zaɓuɓɓukan da ke haifar da su, kamar tsarin rigakafin mai karɓar baƙi.
Misali na irin wannan tasirin shine asarar ORF4 gaba ɗaya a cikin kwayar halittar HCoV-229E wanda ke haifar da lalacewar kwayar halittar biyu.
Ana iya gano ORF4 mara lalacewa a cikin ƙwayoyin cuta na bat da camel-virus da ke da alaƙa da HCoV-229E, yayin da alpha-CoV na alpha-camel-virus ya nuna shigar da kwayar halitta guda ɗaya wanda ke haifar da canjin yanayi.
A ƙarshe, amma ba mafi mahimmanci ba, HCoVs suna da ci gaba da haɓaka ta hanyar zaɓar yanayi a cikin rukunin masu karɓar su.
Lokacin da bats suka kamu da CoVs, kawai ba a gano alamun bayyanar cututtuka ko kuma alamu masu laushi waɗanda ke nuna bambancin CoVs da bat.
Wannan ya nuna cewa jemage suna da kyau a cikin jiki da kuma ilimin lissafi tare da CoVs.
Alal misali, a cikin jemage, rashin aiki a cikin motsawar amsawar ƙonewa yana rage yawan kamuwa da cutar da ke haifar da CoVs.
Bugu da ƙari, aikin ƙwayoyin cuta a cikin ƙwayoyin cuta yana da damuwa saboda karuwa a cikin mai karɓar mai karɓar NKG2/CD94 da kuma ƙananan ƙididdigar ƙwayoyin ƙwayoyin ƙwayoyin cuta na matakin I.
Bugu da ƙari, ƙwayoyin oxygen masu karɓa (ROS) suna haifar da aikin rayuwa na ƙwayoyin cuta a cikin bat, suna hana kwafin CoV kuma suna tasiri duka karatun da kuma aiki da enzyme exoribonuclease, sabili da haka, lokacin da aka gabatar da su cikin sabon mai karɓar cuta, suna da zaɓi don samar da ƙwayoyin cuta masu cutarwa.
Hakanan, wasu nau'ikan CoV masu cutarwa na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da adana sabbin sunadarai ko kuma nau'ikan sunadarai don daidaitawa da mai karɓar baƙi.
Saboda haka, ba zato ba tsammani ba ne cewa sababbin ƙwayoyin cuta na HCoVs sun bayyana a cikin shekaru 20 da suka gabata.
CoVs ba su nuna alamun cutar ko kuma suna haifar da alamun cutar mai laushi a cikin masu karɓar masu riƙewa kamar su bat da raƙuma.
Suna yin kwafi sosai, ba tare da cire amsawar rigakafi daga mai karɓar ba.
Wannan shine dalilin da ya sa masu dauke da cutar ba su nuna alamun cutar ba, amma suna kamuwa da cututtuka masu tsanani a cikin mutane.
A cikin mummunan yanayin, alamun cutar na haifar da tashin hankali na tsarin rigakafi da kuma mummunan cututtukan numfashi, wanda idan tsarin rigakafi ya fi karfi, cutar ta fi tsanani.
Akasin haka, akwai bambanci tsakanin amsawar rigakafi da kwafin CoV yayin rashin nuna alamun ɗaukar cuta.
Hanyar yankewa ta hanyar amsawar rigakafi, wata dabara ce da ke tasiri ga maganin rigakafin SARS-CoV-2, na iya zama mai amfani.
Wannan ya sa mutane da yawa suka soma yin amfani da maganin nan.
Saboda haka, ciyar da mai hana jini na I zai iya zama da amfani, aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin mutane.
Ƙari ga haka, ƙwayoyin NLRP3 ba su da cikakkiyar ƙarfin aiki a cikin ƙwari.
Saboda wannan dalili, masu hana MCC950 da NLRP3 na iya zama masu amfani a lokacin maganin COVID-19.
An fara amfani da cutar SARS-CoV-2 a cikin tsari na yau da kullun kamar yadda aka yi amfani da cutar SARS-CoV da MERS-CoV.
A zahiri, an gano cewa beta-CoV na malam buɗe ido yana da kashi 95% na rayuwa tare da SARS-CoV, kuma beta-CoV na malam buɗe ido yana da kashi 96% na rayuwa tare da SARS-CoV-2.
A zahiri, an gano cewa wasu ƙwayoyin cuta masu kama da SARS-CoV sun kasance a cikin caterpillars da sauran dabbobi a kasuwa, kuma ba a gano masu karɓar masu karɓar kai tsaye don SARS-CoV-2 ba.
An gano cewa beta-CoVs masu rarrafe suna da alaƙa da SARS-CoV-2, wanda ke nuna cewa beta-CoVs na iya zama masu karɓar baƙi na matsakaici ko kuma suna iya samar da wani ɓangare na kwayoyin halitta zuwa SARS-CoV-2 a matsayin sigar ƙarshe.
Ko da yake ana ci gaba da yin tambayoyi, babu wata shaida da ta nuna cewa SARS-CoV-2 an yi shi ne da gangan ko kuma ba da gangan ba.
A cikin sabon barkewar cutar SARS-CoV-2, CoVs sun sake bayyana.
Nazarin CoVs a cikin jemage da sauran dabbobi ya canza fahimtarmu game da mahimmancin cututtukan asalin dabbobi da kuma HCoVs a cikin dabbobi a cikin yaduwar cutar ga mutane.
Akwai shaidu da yawa cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 suna da asalin doki kuma suna iya yadawa ga mutane ta hanyar masu karɓar cuta na matsakaici.
Idan aka ɗauka cewa kamuwa da SARS-CoV ya samo asali ne daga haɗuwa tsakanin mutane da ƙwayoyin cuta a kasuwanni, rufe kasuwanni da ke sayar da kifi da kashe ƙwayoyin cuta na iya kawo ƙarshen barkewar cutar SARS.
Don irin wannan dalili, an gano beta-CoVs a cikin SARS-CoV-2, dangin kwayar cuta da ke da alaƙa da SARS-CoV-2, don hana yaduwar cutar ta hanyar dabbobi, ya kamata a cire kwayar cuta daga kasuwar kayayyaki.
Koyaya, ƙarin bincike ya rage don bayyana ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar squirrels da sauran dabbobi masu shayarwa.
A wasu kalmomi, MERS-CoV ya kasance a cikin tukwane na raƙuman ruwa na tsawon lokaci.
A cikin shekarar 2013, an samu karin mutane dubu biyu da suka mutu a sakamakon wannan mummunar cutar.
A cikin watan Agusta, an yi wa 'yan bindiga allurar rigakafi a cikin yankunan da ke kusa da birnin.
Ba za a iya barin dukkan tukwane a cikin ƙoƙarin kawar da MERS ba, kamar yadda aka yi a kasuwar namun daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da kamuwa da cutar MERS, ya kamata a yi amfani da hanyar da ta dace don inganta ingantaccen samar da allurar rigakafin MERS-CoV don raƙuma tare da haɗa wasu matakan kula da kamuwa da cuta.
A halin yanzu, ba a iya kawar da waɗannan ƙwayoyin cuta ba kuma sabon kwayoyin halitta na iya haifar da cutar.
CoVs da ke kamuwa da dabbobi daban-daban suna yawo a cikin daji.
A cikin wannan labarin, an gano cewa cutar ta CoV ta ɗan adam tana da haɗari ga mutane da yawa.
Akwai yiwuwar cewa waɗannan CoVs na zoonotic zasu iya canzawa da haɗuwa don haifar da sabon CoVs wanda zai iya zama mai saurin yaduwa da / ko kisa a cikin mutane a nan gaba.
Wasu wuraren da ake cin namun daji a kasar Sin ya kamata a rufe su don rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
Tare da gwaji mai wahala na SARS, MERS da COVID-19, shirye-shirye da shirye-shiryen amsawa mafi kyau suna buƙatar kasancewa.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a duniya na dogon lokaci.
Suna ci gaba da rayuwa a cikin gidajen su har sai an bar su su fita daga jikin su.
Ko da yake akwai wasu halaye da ke sa kwarkwata su kara yada kwayar cutar, mutane za su iya rage kamuwa da cutar idan suka san yadda za su nisanta kansu da kwarkwata da sauran dabbobin daji.
Ci gaba da lura da halittu masu rai yana da mahimmanci don ƙarin fahimtar alaƙar muhalli tsakanin CoVs da masu karɓar cututtukan su na halitta, wanda zai iya tabbatar da amfani wajen hana kamuwa da cutar dabba zuwa mutum da kuma yaduwar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana yaduwar cutar ta hanyar dabbobi ita ce nisantar wuraren da mutane ke da alamun cutar ta dabbobi.
Akwai wasu ɓangarorin da ba a bayyana ba game da asalin asalin SARS-CoV-2 wanda ke yaduwa daga dabbobi zuwa mutane.
Da farko, yana da ban sha'awa a lura da ko malam buɗe ido da malam buɗe ido suna da yanayin rayuwa iri ɗaya idan jemage suna iya watsa kwayar cutar asalin SARS-CoV-2 zuwa ƙwayoyin cuta.
Na biyu, idan har dabbobi masu rai suna da hannu kai tsaye wajen yada cutar ga mutane, ya kamata a yi bincike kan yadda mutane ke yada cutar daga dabbobi masu rai.
A matsayin na uku, idan dabba ta uku ita ce ainihin mai karɓar cutar ta matsakaici, muna buƙatar bayyana yadda ta ke hulɗa da wasu nau'ikan halittu, ciki har da mutane, jemage da kuma tsuntsaye.
A ƙarshe, dabbobi masu shayarwa da yawa, gami da dabbobin gida, suna iya zama masu saurin kamuwa da SARS-CoV-2, kuma ya kamata a ci gaba da lura da gwaji don kamuwa da cutar.
Ana sa ran a nan gaba za a gano SARS-CoV-2 ko kusan irin wannan kwayar cutar asalinsa a cikin mai karɓar ta na halitta, ko dai daga jemage, squirrel, ko wani dabba mai shayarwa.
Binciken da ya biyo baya zai ba da cikakken bayani game da hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, tare da mahimman abubuwan da ke tattare da rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar haɓaka ƙa'idodin bincike na marasa lafiya da aka tabbatar da COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagororin shawarwari masu kyau don ganewa da maganin kamuwa da cutar Novel Coronavirus (2019-nCoV) na 2019, waɗanda ke ɗauke da kwarewarmu da kuma kyakkyawan tushe don magance wannan annobar a duk duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce kuma, bisa ga binciken da muke yi a yanzu da kuma kwarewar aikin jiyya, hankalinmu da fahimtarmu suna ci gaba da ƙaruwa. Duk da haka, hanyoyin bincike da magani suna ci gaba da haɓakawa.
Wannan wasikar tana amsawa ne ga tsokaci game da jagororinmu, kuma tana bayyana sabon tsarin bincike na marasa lafiya masu shakku da marasa lafiya masu tabbatarwa bisa ga Sabbin Jagororin Ganowa da Kula da Cutar COVID-19 da Hukumar Kiwon Lafiya ta Jamhuriyar Jama'ar Sin ta fitar (Buga na bakwai).
A watan Disamba na 2019, an sami sabon coronavirus na 2019 (2019-nCoV), wanda yanzu ake kira cutar coronavirus ta 2019 (COVID-19), kuma an ba da sunan cutar coronavirus mai tsanani mai tsanani 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta rubuta jagorar shawarwari masu sauƙi kuma ta buga ta kan layi a cikin binciken likitancin soja a ranar 6 ga Fabrairu, 2020.
Tun bayan fitowar ta, ta jawo hankalin mutane da yawa.
Ko da yake COVID-19 sabuwar cuta ce, iliminmu da iliminmu game da cutar yana ƙaruwa a hankali bisa ga binciken da ke gudana da kuma ƙwarewar masana'antar kiwon lafiya, wanda ke haifar da ci gaba da haɓaka hanyoyin bincike da hanyoyin magani.
Jagororin bincike da magani na COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin ya bayar tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020 (http://www.nhc.gov.cn/) sun ba da jimlar gyare-gyare guda bakwai game da wasu abubuwa da ke canzawa kamar yadda suke.
A cikin wannan labarin, an bayyana cewa, "Muna da wasu abubuwa da yawa da za mu iya yi don magance matsalar rashin lafiya da kuma ciwon kai".
Wannan ya kara mana wata muhimmiyar shaida da za ta taimaka mana wajen magance cutar a fadin duniya.
Muna godiya da wannan aiki mai ban mamaki da suke yi.
Koyaya, sabbin jagororin bincike da magani na COVID-19 (Fassara ta bakwai ta bita) da kuma nazarin jagororin sun nuna cewa aikin su yana buƙatar sabuntawa.
A karkashin gyara ta bakwai (Maris 3, 2020), don tabbatar da yanayin da ake zargi, a cikin rashin bayyanannen tarihin kamuwa da cuta, don yin cikakken bincike, ana buƙatar haɗuwa da ɗayan abubuwan rikodin kamuwa da cuta waɗanda ke ƙunshe da alamun asibiti guda biyu, ko kuma ya dace da alamun asibiti guda uku:
Tarihin yaduwar cutar: (1) Tarihin tafiya ko zama a cikin kwanaki 14 da suka gabata a cikin Wuhan da kewayensa, ko wasu wuraren da aka ruwaito cutar COVID-19, ko wasu wuraren da aka ruwaito cutar COVID-19, (2) Tarihin haɗuwa da cutar SARS-CoV-2 (wanda ke da gwajin kwayar nucleic acid mai kyau) (3) Tarihin haɗuwa da cutar a cikin kwanaki 14 da suka gabata a cikin Wuhan da kewayensa, ko wasu wuraren da aka ruwaito cutar COVID-19, ko kuma (4) Tarihin haɗuwa da cutar ta hanyar hanyar iska (kamar a gida, makaranta, ko ɗakin karatu) ko kuma a cikin ƙananan wurare da aka ruwaito cutar ta hanyar iska ≥ 2 / 2
Alamun bayyanar cututtuka: (1) cututtuka da / ko cututtukan numfashi, (2) bayyanar cututtuka a cikin hoton da aka yi wa COVID-19 na hoto, (3) jimlar adadin kwayoyin cutar Lymphocyte a matakin farko na cutar, wanda ke nuna al'ada, raguwa, ko raguwa.
Ya kamata a kafa abubuwan da aka tabbatar a kan abin da ke haifar da cutar ko kuma wani abu da ake zargi da shi a cikin binciken plasma kamar yadda aka nuna a cikin binciken bincike: (1) gwajin PCR na ainihi don SARS-CoV-2 ya zama mai sauƙi, (2) wani abu mai ban mamaki game da kwayar cutar wanda ya nuna babban kamannin da aka sani da coronavirus, (3) rashin ƙarfi a cikin gwajin plasma don rigakafin IgM na musamman da IgG na SARS-CoV-2, ko canji daga mummunan zuwa mara kyau a cikin rigakafin IgG na SARS-CoV-2, ko kuma ƙaruwa a cikin matakan dawowa mai kyau ≥4.
An haɗa gwajin PCR na lokaci-lokaci don gano ƙarancin nucleic acid a cikin samfurori na numfashi ko jini a cikin bita na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
An ƙara samfurin jini don gano abin da ke haifar da cutar a cikin bita na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020), sannan an ƙara shaidar nazarin plasma a bita na bakwai.
Waɗannan gyare-gyare suna ba da gudummawa ga ci gaba da aikin masu bincike don gano mafi kyawun ganowar nucleic acid don saurin ganewa, da kuma samar da kyakkyawan sakamako na ƙwayoyin cuta na musamman bisa ga ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙwayoyin cuta bisa ga samfurin numfashi wanda ke haɓaka samuwar samfurori daban-daban, gami da ɗaukar jini.
Bugu da kari, akwai karin shaidu da ke gargadin mu da mu yi taka tsantsan da marasa lafiya da ke nuna alamomi daban-daban da kuma marasa alamomi.
Saboda haka, ya kamata a gyara tsarin tafiyar da Zhou et al. saboda sun sanya mutum ba tare da alamun asibiti a matsayin mai haɗari ba.
A cikin wannan labarin, an bayyana cewa, a cikin shekaru shida da suka gabata, an yi amfani da takaddun shaida na musamman don tabbatar da cewa an yi amfani da takaddun shaida na musamman don tabbatar da cewa an yi amfani da takaddun shaida na musamman don tabbatar da cewa an yi amfani da takaddun shaida na musamman don tabbatar da cewa an yi amfani da takaddun shaida na musamman.
A ƙarshe, muna son ƙarin shaida kai tsaye da kuma tsokaci daga masu karatu.
Don bincika duk wani mutum da ake zargi da cutar ko kuma wanda aka tabbatar da cutar, muna ba da shawarar cewa ya bi umarnin da aka bayar a ƙasashen da ya fito.
A halin yanzu, muna da wasu 'yan kasuwa da ke da hannu a cikin wannan shirin.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar a matsayin mafi girma a kowace rana.
A jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar a rana guda daga COVID-19.
Wannan shi ne adadin mutane da cutar ta kashe a rana guda.
A ranar Talata, adadin mutanen da aka gano da cutar da cibiyar nazarin cututtuka ta Bangladesh ta ruwaito sun hada da 114 da ke jinya da kuma 33 da suka warke da ke gida.
A cikin watan Agusta, mutane 17 ne suka mutu a sakamakon wannan mummunar hatsari.
A wani rahoto da aka wallafa a shafin yanar gizo, Daraktan IEDCR, Dakta Meerjady Sabrina Flora ta ce mutum hudu maza da mace daya ne suka mutu.
Dokta Meerjady ya ce, akwai marasa lafiya biyu da suka wuce shekaru 60, biyu da ke tsakanin shekaru 51 zuwa 60, da kuma daya da ke tsakanin shekaru 41 zuwa 50.
Ta ce duka mutanen biyu da suka mutu 'yan birnin Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu cewa, Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengali, wanda aka yi wa jinya a asibitin Kuwait Maitree, na cikin wadanda suka mutu.
A cikin wata sanarwa ta bidiyo a ranar Asabar, ministan sufuri da gadaje na Bangladesh Obaidul Quader ya ce za a rufe zirga-zirgar jama'a har zuwa Asabar mai zuwa, fiye da yadda aka tsara.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya za a kawo karshen shi a ranar Asabar, 4 ga Afrilu.
A halin yanzu, an ci gaba da ba da izinin jigilar kayayyaki na asali, magani, man fetur da abinci.
Abubuwan farko da aka fara ba da rahoto game da COVID-19 a Bangladesh sun kasance mutane biyu da suka dawo daga Italiya a ranar 8 ga Maris, ɗaya daga cikinsu matarsa.
A ranar 19 ga watan Maris, dukkansu uku sun warke.
SARS-CoV-2 ya riga ya kai mutane miliyan daya a duniya.
A ranar Alhamis, bayanan Jami'ar Johns Hopkins sun nuna cewa jimlar adadin masu kamuwa da cutar coronavirus SARS-CoV-2 ya zarce miliyan a duk duniya.
Akalla mutane 52,000 sun mutu sakamakon cutar COVID-19, wadda cutar ta haifar da cutar coronavirus.
Wannan sabon tarihi ne a ranar da aka tabbatar da kamuwa da cutar coronavirus ta farko a Malawi da kuma ranar da aka fara samun mutuwar da ke da alaƙa da cutar coronavirus a Zambia a rana ɗaya.
A ranar Alhamis, Koriya ta Arewa ta ce tana daya daga cikin kasashe kalilan da ba su da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar, gami da mutane 79,332 da aka tabbatar a cikin awanni 24 da suka gabata a karfe 10 na safe (UTC 0800) na tsakiyar Turai a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar coronavirus, wanda ya haifar da mutuwar akalla 5,900.
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa cutar coronavirus ta kashe mutane sama da 1,000 a Amurka a ranar Laraba, in ji CBS.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakan hana yaduwar cutar.
A ranar Alhamis, gwamnan Moscow Sergei Sobyanin ya tsawaita dokar hana fita ta birnin har zuwa ranar 1 ga Mayu.
A fadin kasar, Shugaba Vladimir Putin ya sanar da cewa za a biya 'yan kasar Rasha albashi ba tare da sun je aiki ba har zuwa 30 ga watan Afrilu.
A ranar Talata, majalisar dokokin Portugal ta kada kuri'ar kara wa'adin dokar ta baci na tsawon kwanaki 15 da kuri'u 215 a kan, 10 a kan, da kuma daya a kan.
Saudiyya ta tsawaita dokar hana fita a cikin biranen Makka da Madina a duk tsawon yini, inda a baya dokar hana fita ta kasance tsakanin karfe 3 na rana da karfe 6 na safe.
A lokacin da ake shirin aiwatar da dokar hana fita daga karfe 10 na dare zuwa 4 na safe, Thailand ta ce za ta dakatar da yin hakan.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa an kara wa dokar dokar ta hana fita daga gida har zuwa ranar 1 ga watan Mayu.
A Australia, an rage adadin takarda bayan gida da ake iya saya a lokaci guda.
A ranar Asabar da Lahadi da yamma, manyan kantunan sayar da takarda na Woolworths da Coles a Australia sun sanya takunkumin kasa da kasa kan takunkumin takarda na bayan gida a duk shagunan da suke sayarwa.
A ranar Litinin, ALDI ta fara aiwatar da dokar da ta tanadi sayar da kwalba daya a kowacce.
An sanya waɗannan ƙuntatawa a kan akwatunan ajiya da kuma a ƙarƙashin shafukan Facebook na tashoshin samarwa a matsayin saƙonni.
Masu sayen sun ce suna ajiye kayayyaki idan ya zama dole, yayin da suke zaune a keɓewa saboda tsoron COVID-19.
A ranar Laraba, Woolworths ta kuma iyakance sayayya ta takarda bayan gida zuwa tsari guda daya a kowane tsari.
Wannan canjin ya biyo bayan dokar da Woolworths da Coles suka kafa a ranar 4 da 5 ga Maris, ta sayar da 'ya'yan itacen guda hudu a kowane sayayya.
Coles ya ruwaito a cikin wani rahoto da ya wallafa a ranar 8 ga watan Maris cewa yawancin shagunan da ke sayar da abubuwa hudu ne kawai a kowane mutum suna cinyewa cikin sa'a guda bayan shigowar kayayyaki, yana mai cewa wannan bukatar "ba ta taɓa faruwa ba", amma a cikin wani sakon Facebook, ALDI ta kira wannan bukatar "ba zato ba tsammani".
A cikin watan Agusta, kamfanin ya sanar da cewa, ya fara sayar da kayayyakin da aka yi amfani da su a cikin masana'antar sayar da kayayyaki ta duniya.
A makon da ya gabata, wani babban kanti mai suna Cosco a birnin Canberra ya rage adadin da aka yarda da shi zuwa guda biyu.
Don rage rashin kayan aiki, Coles ya ƙara yawan umarni daga masu samar da kayan aiki kuma ya haɓaka jigilar kaya sau da yawa. Woolworths ya yi odar kayayyaki da yawa, kuma ALDI ta tabbatar da samun kayan da wuri don shirin na musamman na Laraba.
Shugaba na kungiyar masu sayar da kaya ta Australiya, Russell Zinman, ya ce masu sayar da kayayyaki na son kara yawan kayayyaki da suke ajiyewa, amma hukumomin yankin sun takaita lokacin da manyan motoci ke tafiya.
Ya ce, "Muna da tabbacin cewa masu samar da kayayyaki za su ci gaba da kokarin biyan bukatar, kuma a wasu lokuta, farashin zai tashi".
A ranar Talata, ALDI ta sanar da cewa wasu shaguna ba za su iya gudanar da tallace-tallace na musamman na ranar Laraba ba bayan tallace-tallace na farko.
A wani rahoto da News.com.au ta wallafa, Dokta Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce shagunan sayar da kayayyaki suna cika kayayyaki a kowane dare.
Ya ce, takardar bayan gida abu ne mai daukar wuri, kuma ana iya adana ta a cikin adadi kadan, kuma idan aka sayar, akwai sarari da yawa a kan dandamali, wanda hakan ke sa mutane rashin jin daɗi.
"Idan akwai wadataccen kayan aiki a kan allon Coles da Woolworths, idan akwai kayayyaki kamar takarda na bayan gida da kayan wanki, kuma idan akwai adadi mai yawa, za ku iya rage yawan barazanar", in ji Russell Zinman, na ABC News.
Kamfanin Who Gives a Crap, wanda ke sayar da takarda na bayan gida, ya ce a ranar Laraba cewa sun gaza samar da kayayyaki.
A cewar wani rahoto daga News.com.au, Kamfanonin kera takarda na Kimball da Solaris da ke kera takarda na Kleenex da Sorben suna aiki tukuru a duk tsawon kwanaki 24 don ci gaba da samar da takarda.
A wani taron gwanjo a Melbourne, gidan yanar gizon sayar da gidaje Domain.com ya fara ba da takardar gidan wanka kyauta don masu siye da ke da dogon hutu na ranar aiki.
A cikin jaridar NT da ake buga a yau a Darwin, a ranar Alhamis, an saka takarda takwas da aka yanke don amfani a matsayin takardar bayan gida.
ABC Australia ta ruwaito a ranar 3 ga Maris cewa a farkon, shagunan sun yi jinkirin sanya takunkumi, amma sun ce ba su da niyyar sanya takunkumi ga masu siye.
A cikin watan Agusta, mutane da yawa sun yi ta yin zanga-zanga a kan batun cin hanci da rashawa a cikin birnin San Francisco, inda aka yi zanga-zangar a kan batun cin hanci da rashawa.
Hakazalika, a waje da Ostiraliya, babban kantin sayar da kayayyaki na Burtaniya Okido ya rage sayen takardar bayan gida Andres zuwa fakiti 12 a ranar Lahadi.
Hukumar Lafiya ta Duniya ta ayyana cutar COVID-19 a matsayin annoba.
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 da ke faruwa a halin yanzu, wanda cutar coronavirus SARS-CoV-2 ke haifarwa, a matsayin annoba.
A cewar WHO, cutar ta shafi mutane da yawa, amma ba ta shafi yadda cutar ta yadu ba.
Kowace kasa tana iya canza yanayin annobar.
"Idan kuma a matsayin martani, kasashe za su iya ganowa, gwadawa, magance, warewa, bin diddigin mutane da kuma motsa su", in ji Sakatare Janar na WHO Tedros Adhanom Ghebreyesus.
"Muna ba da kulawa ta musamman ga matakan gargadi da matakan gargadi don zaman lafiya bisa ga yaduwar cutar da mahimmancinta".
A cewar tsohon darektan cibiyar kula da cututtuka da rigakafin cutar Amurka, Dr. Tom Frieden, annobar ta kasance "ba a taɓa ganin irinta ba".
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce babu wata cutar da ta kamu da cutar numfashi da ta yi yaduwa a duniya ba tare da cutar mura ba.
Gabriela Saphira ta yi magana a kan wannan batun, "Ba mu taɓa ganin annobar cutar coronavirus ba".
Ya ci gaba da cewa, "Ba mu taba ganin irin wannan annoba ba, wadda za a iya sarrafawa".
A watan Janairu, Hukumar Lafiya ta Duniya ta yanke shawarar ayyana wannan sabon annobar a matsayin gagarumin matsalar lafiyar jama'a a duniya.
Dr. Anthony Fauci, darektan Cibiyar Kula da Magungunan Allergy da Cututtuka a Amurka, ya ce, "A cikin yanayin da ake ciki, yanayin zai iya zama mafi muni".
A ranar Alhamis, kamfanin dillancin labarai na AP ya ce aƙalla mutane 126,000 ne suka kamu da COVID-19 a duniya kuma sama da 4,600 sun mutu.
Cutar annobar coronavirus ta 2019-20 annobar cutar coronavirus ta 2019 (COVID-19) ce da ke gudana kuma ta haifar da kamuwa da cutar cututtukan numfashi mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Disamba na 2019, kuma an ayyana gaggawa ta lafiyar jama'a a duniya a ranar 30 ga Janairu, 2020, kuma an bayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 da mutuwar mutane 97,000 a cikin kasashe da yankuna 210 aka ruwaito.
A halin yanzu, an warkar da mutane 364,000.
An kiyasta yawan mutuwar da aka tabbatar a China ya kai kashi 4 cikin dari, kuma a duniya, tsakanin kashi 13.04 cikin dari a Aljeriya da .08 cikin dari a New Zealand.
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma numfashi mai wuya.
Wasu cututtuka na gaba sun haɗa da ciwon huhu da kuma ciwon numfashi mai tsanani.
A lokacin kamuwa da cutar, lokaci na bayyanar cututtuka yawanci kwanaki biyar ne, amma zai iya wucewa daga kwanaki biyu zuwa 14.
Har yanzu ba a san allurar rigakafi ko magani da zai iya kawar da cutar ba.
Babban hanyoyin magani sune alamun alamun cututtuka da kuma maganin taimako. Hanyoyin rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki idan kun tari, nisantar da kanku daga wasu, da keɓewa idan kuna da cutar.
Hukumomi a duk duniya sun amsa da takunkumin hana zirga-zirga, keɓewar gida, dokar hana fita, kula da haɗarin aiki da rufe wuraren aiki.
Cutar ta haifar da rushewar tattalin arzikin duniya, wanda ya haifar da jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu.
A cikin kasashe 193, an rufe makarantu da jami'o'i a matakin ƙasa ko na yanki, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Bayan da labarin karya game da cutar ya bazu a yanar gizo, tsoro da nuna bambanci game da mutanen yankin da cutar ta fi yaduwa, da mutanen da ke da asalin Gabas da kudu maso gabashin Asiya da kuma Sinawa.
A cewarsa, wannan ya sa ba a samu ci gaba a harkokin sufuri ba, kuma hakan ya rage yawan gurbataccen iska da kuma gurbataccen iskar gas.
Hukumomin kiwon lafiya na Wuhan, babban birnin lardin Hubei na kasar Sin, sun ba da rahoton barkewar cutar nimoniya a cikin wani yanayi da ba a san dalilin ba a ranar 31 ga Disamba, 2019, kuma sun fara bincike a farkon Janairu, 2020.
Yawancin masu cutar sun kasance suna da alaƙa da kantin sayar da kayayyaki na Hunan, wanda ke nuna cewa kwayar cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ke haifar da cutar ita ce SARS-CoV-2, sabon nau'in kwayar cutar da aka gano, wanda ke da alaƙa da kwayar cutar bat, kwayar cutar coronavirus da SARS-CoV. An gano cewa mutumin da aka fara ganowa da alamun cutar ya kamu da zazzabi a ranar 1 ga Disamba, 2019.
A watan Disamba na 2019, kashi biyu bisa uku na farkon kamuwa da cutar da aka ruwaito ya danganci kasuwa.
Wani rahoto da ba a tabbatar da shi ba a ranar 13 ga Maris, 2020 a cikin South China Morning Post ya nuna cewa, bayan gano barkewar cutar zuwa 17 ga Nuwamba, 2019, mai yiwuwa mutum mai shekaru 55 a lardin Hubei ne ya fara kamuwa da cutar. Ko da yake sabon yanayin ya ragu sosai a China, akwai tashin hankali a Italiya, Iran da Koriya ta Kudu, kuma a karon farko, adadin sabbin cututtukan da ke faruwa a wajen China ya zarce adadin sabbin cututtukan da ke faruwa a China, in ji WHO a ranar 26 ga Fabrairu, 2020.
Akwai yiwuwar a rage yawan wadanda suka kamu da cutar da ke nuna alamun rashin lafiya.
A ranar 26 ga watan Fabrairu, an ba da rahoton ƙananan cututtukan tsakanin matasa masu shekaru 19 zuwa ƙasa, wanda ya kai ƙasa da kashi 2.4 cikin ɗari na cututtukan a duniya.Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su sami rigakafin garken bayan sun kamu da cutar.
Ana kiran mutane da ke da cutar da cutar COVID-19 waɗanda aka gwada su kuma aka tabbatar da tabbatacce a ƙarƙashin hanyoyin hukuma.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma waɗanda ke hana yin gwajin cutar ga mutanen da ke da alamun rashin lafiya.
Wani bincike da aka buga a ranar 16 ga Maris ya nuna cewa kimanin kashi 86% na masu kamuwa da COVID-19 a China ba a gano su ba har zuwa 23 ga Janairu, kuma waɗannan cututtukan da ba a lissafa ba sune tushen kamuwa da kashi 79% na masu kamuwa da cutar.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin masu kamuwa da cutar a Italiya ya fi adadin wadanda aka bayar da rahoton.
Hasashen asali na lambar asali ta haihuwa (R0) don COVID-19 shine 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya kammala cewa zai iya zama 5.7.
Yawancin mutane da ke fama da COVID-19 suna murmurewa.
Ga waɗanda ba su yi hakan ba, lokacin daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, kuma yawanci kwanaki 14 ne don bayyanar cututtuka.
A ranar 10 ga Afrilu, 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A ranar 5 ga watan Fabrairu, kashi 80% na mutanen da suka mutu a China sun haura shekaru 60 da haihuwa, kuma kashi 75% suna da wasu cututtukan da suka gabata, gami da cututtukan zuciya da ciwon sukari.
Wannan ba ya haɗa da mutuwar da ba a bincika ba, kamar waɗanda suka mutu a gida, gidajen tsofaffi, da sauransu. Saboda haka, ainihin adadin mutuwar COVID-19 na iya zama mafi girma.
Wani ɓangare na bayanan da aka samu daga Italiya ya nuna cewa adadin mutuwar a lokacin annobar ya ninka ainihin mutuwar COVID sau 4 zuwa 5.
Wata mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta yarda cewa mun san cewa yawan mutanen da suka mutu an rage su. Ana yin ƙididdiga a Amurka kuma rahotanni marasa tabbas suna tabbatar da wannan da'awar. Irin wannan ƙididdigar ba ta da yawa a lokacin annobar, kamar lokacin annobar cutar alade ta H1N1.
An samu mutuwar farko a waje da kasar Sin a Philippines a ranar 1 ga watan Fabrairu, kuma an samu mutuwar farko a waje da Asiya a Faransa a ranar 14 ga watan Fabrairu.
A wasu kasashen waje da ke da alaka da kasar Sin, kamar Iran, Koriya ta Kudu da Italiya, an samu mutuwar mutane fiye da dozin kafin ranar 28 ga watan Fabrairu.
A ranar 13 ga watan Maris, an samu rahoton mutuwar mutane a kasashe da yankuna sama da 40 a kowace nahiya sai dai Antarctica.
Waɗannan ƙididdigar sun bambanta a cikin lokaci daga yanki zuwa yanki, kuma yawancin abubuwan da ke shafar su sune yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin kamuwa da cuta, da kuma yanayin alƙaluma kamar shekaru, jinsi, da yanayin gaba ɗaya.
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa a ranar 10 ga Afrilu, 2020, adadin mace-mace da cutar a duniya ya kai kashi 6.0% (97,039/1,617,204).
Yawan ya bambanta daga yanki zuwa yanki.
A cikin kasar Sin, kimantawa na yawan kamuwa da cutar da mace-mace ya ragu daga kashi 17.3% (ga wadanda ke nuna alamun cutar a tsakanin Janairu 1 da 10, 2020) zuwa kashi 0.7% (ga wadanda ke nuna alamun cutar bayan Fabrairu 1, 2020).Sauran kimantawa sun hada da yawan kamuwa da cutar da ke nuna yawan kamuwa da cutar da ke haifar da mutuwa da cutar (CFR) da kuma yawan kamuwa da cutar da ke nuna yawan kamuwa da cutar da mutuwa (ko an gano cutar ko a'a).
Wannan ba wani lokaci ba ne, amma bayanan da aka samo daga bin sawun mutane da suka kamu da cutar ta hanyar abubuwan da aka gano.
A cikin wannan labarin, an gano cewa a cikin shekarun da suka gabata, yawancin mutane sun yi amfani da wannan hanyar don yin amfani da su.
Cibiyar Nazarin Magunguna ta Oxford ta yi hasashen cewa yiwuwar mutuwa daga cutar a gaba ɗaya ya kasance tsakanin 0.1% da 0.39%.
Babban kimantawa don wannan sikelin ya dace da binciken da aka yi a farkon gwajin da aka yi a cikin Jamus don COVID-19 da kuma tasirin gwajin akan kimantawar mutuwar.
Hukumar lafiya ta duniya ta ce an samu nasarar dakile cutar.
Ba a san lokacin da cutar ta kai kololuwa ba kuma ta iya bambanta dangane da wuri.
Massiboni, daga Jami'ar Jihar Peshawar, ya ce idan aka saki cutar, cutar za ta ci gaba da yaduwa kamar yadda ta saba, kuma za ta iya fara raguwa yayin da magungunan ke karewa.
A halin yanzu, ba za a iya hango ko wane lokaci ne hakan zai faru ba.
Babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin, Zhong Nanshan, ya ce cutar za ta iya karewa a watan Yuni idan dukkan kasashen duniya suka hada kai don bin shawarar WHO kan matakan da za su iya dauka don dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magungunan Yankin London ya ce SARS-CoV-2 na iya ci gaba da yaduwa na tsawon shekara ɗaya zuwa biyu.
Wani binciken da kwalejin Imperial ta gudanar karkashin jagorancin Neil Ferguson ya nuna cewa ana bukatar nisantar jama'a da sauran matakan kariya har sai an samu allurar rigakafin (watakila watanni 18 ko sama da haka).
William Schnapper na Jami'ar Vanderbilt ya ce "Babu wata alama ta yadda cutar coronavirus za ta ƙare gaba ɗaya saboda yawan yaduwar cutar, kuma yana iya zama wata cuta ta coronavirus da ke dawowa kowace shekara".
Rashin yiwuwar sake kamuwa da cutar ya dogara da ƙarfin rigakafi da kuma yawan maye gurbin kwayoyin halitta.
COVID-19 ba shi da alamun bayyanar cututtuka, kuma mutane da ke fama da cutar ba za su iya nuna alamun cutar ba.
Alamomin biyu da aka fi sani da su sune zazzabi (88%) da tari (68%).
Alamu da ba a saba gani ba sun hada da gajiya, ɓarkewar ruwa a cikin hanyoyin numfashi, rashin wari, numfashi, ciwon makogwaro, ciwon jijiyoyin tsoka, ciwon kai, rawar jiki, amai, toshewar jijiyoyi, amai da ƙura da kuma ƙura. A cewar rahoton WHO, ɗaya cikin mutane shida da suka kamu da cutar sun kamu da rashin lafiya mai tsanani kuma suna numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar neman kulawar likita nan da nan idan akwai alamun. Ci gaban cutar na iya zuwa ciwon huhu mai tsanani, ciwon kirji ko damuwa, tashin hankali, wahalar farkawa, da kuma shan iska daga jini.
Wasu mutane da ke dauke da cutar ba su nuna alamun cutar ba, amma an tabbatar da cewa suna da cutar a lokacin gwajin. Don haka, masu binciken sun ba da shawarar cewa ya kamata a lura da kuma gwada mutanen da ke da alaƙa da cutar don kawar da kamuwa da cutar.
A cewar China, adadin marasa alamun cutar ya kai kashi 44 cikin dari.
Lokacin farawa na yau da kullun (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa 14, yawanci yana nuna alamun a cikin kwanaki biyar. Misali mara tabbas shine cewa ƙididdigar asarar ƙanshi da dandano a cikin marasa lafiya da ke fama da COVID-19 ya fara da kashi 30% kuma daga baya ya ragu zuwa 15%.
A cewarta, akwai wasu abubuwa da za a yi la'akari da su kafin a san yadda cutar ke yaduwa.
Ana ganin cewa cutar tana yaduwa ne ta hanyar kusanci da ƙananan ƙwayoyin ruwa da ke fitowa daga tari, hancin ko magana. Kusanci yana nufin a tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Bincike ya nuna cewa tari ba tare da rufewa ba zai iya haifar da ƙananan ƙwayoyin ruwa daga mita 4.5 zuwa mita 8.2.
Wasu sun ba da shawarar cewa kwayar cutar za ta iya yaduwa ta hanyar ƙwayoyin magana da ke cikin iska na dogon lokaci. Ƙwayoyin numfashi da aka samar yayin numfashi yayin magana ma suna iya yaduwa, amma ba a cikin iska ba gaba ɗaya.
Wasu mutane suna iya samun ruwa a cikin hanci ko baki, ko kuma su sha iska zuwa cikin huhu.
Wasu hanyoyin kiwon lafiya, kamar shigar da bututun jini da kuma aikin gaggawa na zuciya (CPR), na iya haifar da ɓarkewar ruwa a cikin hanyoyin numfashi, wanda ke haifar da ƙwayoyin cuta a cikin iska da kuma yaduwa ta hanyar iska.
Ana iya yadawa idan mutum ya taɓa wani abu mai lamba, gami da fata, sannan ya taɓa idanunsa, hanci ko bakinsa.
A cewar wani mai bincike, cutar ta kamu da cutar ta hanyar fitsari, amma ana ganin cewa hakan ba zai yiwu ba.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da SARS-CoV-2 daga bayan mutum zuwa abincin wani. Ko da yake ana iya kamuwa da cutar kafin bayyanar cututtuka da kuma a cikin matakan cutar, kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka.
A cewar wani mai bincike, cutar ta kamu da cutar ne bayan an yi mata gwajin cutar kwana uku kafin a fara nuna alamun cutar.
Akwai rahotanni kaɗan na ƙwayoyin cuta marasa alamun da aka tabbatar a cikin dakin gwaje-gwaje. Koyaya, an gano wasu ƙasashe yayin da ake bin diddigin waɗanda ake zargi da kamuwa da cutar, duk da cewa ba su da alamun cutar.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Turai (ECDC) ta bayyana cewa ko da yake ba a san yadda cutar ke yaduwa ba, mutum ɗaya yana iya cutar da mutane biyu zuwa uku. Kwayar cutar na iya rayuwa a kan fuskoki na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cewa kwayar cutar na iya rayuwa har zuwa kwanaki uku a kan filastik (propylene foil) da ƙarfe 304, kwana ɗaya a kan kwali, da har zuwa awanni huɗu a kan tagulla.
An gano cewa dabbobi da sauran dabbobin gida suna da cutar COVID-19.
Ko da yake babu wata hujja da ta nuna cewa dabbobi na iya yada cutar ga mutane, hukumomin Burtaniya sun ba da shawarar wanke hannu bayan kowane hulɗa da dabbobi, da kuma yin aiki daidai da kowane hulɗa da wuraren da mai cutar zai iya haɗuwa.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin bayyanar sabon kwayar cutar SARS-CoV-2 suna cikin kwayar cutar coronavirus ta halitta. A waje da jikin mutum, kwayar cutar tana mutuwa a cikin kayan shafawa wanda ke narkar da murfinta na kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa cutar ta samo asali ne daga dabbobi zuwa mutane.
Nazarin kwayoyin halitta ya nuna cewa coronavirus yana cikin rukuni ɗaya tare da nau'ikan kwayoyin halitta guda biyu na bat, tare da nau'in kwayar cutar sauro (nau'in B) da kuma nau'in beta viruses.
Wannan ya yi daidai da kashi 96% daidai a matakin kwayoyin halitta tare da sauran samfuran kwayar cutar coronavirus na bat (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambancin amino acid guda daya a wasu sassan tsarin kwayoyin halitta tsakanin kwayar cutar da ke cikin kwayar cutar da ke cikin mutum.
Zuwa yanzu, kwatancen dukkanin kwayoyin halitta na halitta ya gano kamanceceniya ta fiye da kashi 92 cikin dari tsakanin kwayar halittar kwayar cutar coronavirus na kwari na Afirka da SARS-CoV-2, wanda hakan bai isa ya tabbatar da cewa kwari na Afirka shine mai daukar kwayar cutar ba.
Ko da yake ana iya gano cutar ta hanyar bayyanar cututtuka, tabbatarwa kawai ta hanyar kwafin kwayar cutar da kuma jujjuyawar amsa (rRT-PCR) ko CT scan.
A cikin binciken da aka kwatanta PCR da CT a Wuhan, CT ya fi ƙarfin PCR hankali sosai amma ba shi da daidaito, saboda yawancin alamun hoto suna haɗuwa da sauran cututtukan huhu da cututtuka.
A watan Maris na 2020, Kwalejin X-ray ta Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwaji na farko ko gwaji na farko don cutar COVID-19.
WHO ta ba da sanarwar aiwatar da gwaje-gwaje na RNA da yawa don SARS-CoV-2, tare da sanarwar farko a ranar 17 ga Janairu.
Gwajin yana amfani da maganin sake kwafin sarkar polymerase a ainihin lokacin (rRT-PCR).
Ana iya yin gwajin ta hanyar numfashi ko kuma a cikin jini.
Sakamakon gwajin yana samuwa a cikin sa'o'i kadan zuwa kwanaki.
A cikin wannan gwajin, ana amfani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
A ranar 6 ga Afrilu, 2020, ba a tabbatar da ingancin su ba har sai an tabbatar da cewa suna da amfani sosai.
A wani gwajin plasma na Amurka da Cellex ta gudanar, an tabbatar da cewa dakunan gwaje-gwaje da aka amince da su ne kawai za su ba da izinin amfani da gaggawa.
Ana yin amfani da hotunan hoto na X-ray da na kwamfuta (CT) don gano halaye na musamman na mutane da ke nuna alamun cuta, ciki har da bayyanar da ƙananan wurare masu kama da madubi a cikin babban huhu da kuma ruwa a cikin huhu.
Ƙungiyar likitocin ruwan tabarau ta Italiya tana tattara bayanan hoto na marasa lafiya da aka tabbatar da su kuma suna gina wani shafin yanar gizo na duniya.
Saboda alamun bayyanar cututtuka kamar su kwayar cutar numfashi, ba zai yiwu a tantance COVID-19 ba tare da tabbatarwa ta hanyar PCR ba.
Wani babban gwaji a China ya kwatanta sakamakon CT na kirji da sakamakon PCR, ya nuna cewa hotunan hoto na iya zama mai sauri da sauƙi, kodayake ba su da cikakkun bayanai game da kamuwa da cutar, kuma ya ba da shawarar cewa ya kamata a yi amfani da shi azaman kayan aikin gwaji a yankunan da ke fama da cutar.
Ana ci gaba da haɓaka cibiyoyin sadarwa masu rikitarwa da ke da hankali kan ilimin kere kere don yin hoton hoto da gano siffofin cutar ta hanyar duka X-ray da CT.
Dabaru don hana yaduwar cutar sun haɗa da kiyaye tsabtar jiki mai kyau, wanke hannu, taɓa idanu, hanci ko baki da hannayen da ba a wanke ba, da yin tari da hancin da aka yi a cikin kyallen takarda kuma a jefa kyallen takarda kai tsaye cikin kwandon shara.
An shawarci masu kamuwa da cutar da su sanya abin rufe fuska a cikin jama'a.
An kuma ba da shawarar yin nesa da juna don hana kamuwa da cutar. Gwamnatoci da yawa sun hana ko kuma ba da shawarar duk balaguron da ba dole ba zuwa ko daga ƙasashe da yankuna da ke fama da cutar.
Duk da haka, cutar ta riga ta kai matakin yaduwa a cikin al'ummomi a sassa da dama na duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'ummomi, kuma mutane a cikin waɗannan al'ummomin ba su san inda suka kamu da cutar ba. Ma'aikatan kiwon lafiya da ke kula da wani wanda ke da cutar suna ba da shawarar yin amfani da ƙa'idodin rigakafi, rigakafin haɗuwa da rigakafin ido. Binciken haɗuwa yana da mahimmanci ga hukumomin kiwon lafiya don ƙayyade tushen kamuwa da cuta da hana sake kamuwa da cuta.
A cikin wata sanarwa, Amnesty International da wasu kungiyoyi sama da 100 sun yi kira ga gwamnati da ta kawo karshen irin wannan leken asiri.
An gabatar da aikace-aikacen wayar hannu da yawa don aiwatarwa ko don amfani da sa kai, kuma a ranar 7 ga Afrilu, 2020, sama da rukunin masana goma sha biyu suna aiki kan magance sirrin bayanan sirri, kamar amfani da Bluetooth na mai amfani don samun damar shiga kusa da wata wayar hannu.
Masu amfani za su sami sanarwar idan sun kasance kusa da wanda aka tabbatar da cutar ta COVID-19. Yawancin hanyoyin da aka saba amfani da su don hana kamuwa da cuta, kamar wanke hanci da wanke baki da ruwan wanke baki, ba su da tasiri.
Ko da yake akwai ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci.
A cewarsa, an yi amfani da maganin rigakafin cutar a cikin gidajen abinci da kuma gidajen abinci.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu sau da yawa na aƙalla dakika ashirin, musamman bayan sun je bayan gida ko idan hannayensu suna da datti sosai, kafin cin abinci da bayan hanci, tari ko hancin.
Wannan ya faru ne saboda cutar tana waje da jikin mutum, kuma yana haifar da fashewar kumfa da aka rufe da sabulu na gida wanda ke kashewa.
CDC ta kuma ba da shawarar yin amfani da maganin wanke hannu na barasa wanda ya ƙunshi aƙalla kashi 60% na barasa, idan ba za ku iya wanke hannu da sabulu da ruwa ba.
Hukumar Lafiya ta Duniya ta shawarci mutane da kada su taba idanunsu, hanci da bakinsu ba tare da wanke hannayensu ba.
Fuskokin suna iya cire yawancin narkewa, gami da 62% zuwa 71% na barasa, 50% zuwa 100% na isoprosanol barasa, 0.1% sodium hydrochloride, 0.5% hydrogen peroxide, da 0.27% zuwa 7.5% na povidum-iodine (ta hanyar fallasa ruwa mai kashe kwayoyin cuta a cikin minti daya don farfajiyar ƙarfe mai ƙarfi).
Wasu magungunan kashe ƙwayoyin cuta kamar su benzalkonium chloride da chrohexidine gluconate ba su da ƙarfi sosai.
CDC ta ba da shawarar cewa idan akwai wasu abubuwan da ake zargi ko tabbatar da cutar COVID a cikin gine-gine kamar ofisoshi ko makarantun yara, to a kashe duk wuraren da ke cikin haɗuwa da marasa lafiya, kamar ofisoshi, dakunan wanka, wuraren jama'a, allunan, fuskokin taɓawa, kayan lantarki na jama'a kamar mabuɗan rubutu, na'urorin ATM da sauransu.
Kungiyoyin kiwon lafiya sun shawarci mutane da su rufe bakinsu da hancinsu da gwiwoyi, rufe su da kyallen takarda, da kuma zubar da kyallen takarda nan da nan idan sun yi tari ko hancin.
Ana ba da shawarar masu saurin kamuwa da cutar su sanya abin rufe fuska na tiyata, saboda sanya abin rufe fuska yana rage yawan adadin da nesa da ƙwayoyin ruwa ke kaiwa daga magana, hancin, da tari.
Hukumar Lafiya ta Duniya ta fitar da wasu ka'idoji kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin kwayar cuta a Jami'ar Leeds, sanya abin rufe fuska na iya rage haɗuwa da fuskokinsu, babban tushen kamuwa da cuta, ga mutanen da ba su da tsabtace hannu.
Ko da yake WHO ta ba da shawarar cewa mutane masu lafiya su sa abin rufe fuska ne kawai a lokacin da suke cikin haɗari, kamar waɗanda ke kula da mai cutar COVID-19, ta ce sanya abin rufe fuska zai taimaka wa mutane su guji taɓa fuskokinsu.
A wasu kasashe, an fara kamfen na karfafawa jama'a su sanya abin rufe fuska da kuma fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na roba wanda ba na likita ba. A China, an ba da shawarar musamman cewa masu lafiya su yi amfani da abin rufe fuska na likita na yau da kullun idan suna hulɗa da jama'a fiye da mita 1.
A Hong Kong, ana ba da shawarar yin amfani da abin rufe fuska na tiyata yayin amfani da sufuri na jama'a ko kuma a wuraren da mutane ke yawan tafiya.
Jami'an lafiya a Thailand sun bukaci mutane su sanya abin rufe fuska a gida kuma su wanke su a kullum.
A cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta, a cikin watan Agusta.
A ranar 16 ga watan Maris, an bukaci kowa da kowa a Vietnam da ya sanya abin rufe fuska don kare kansa da wasu yayin da suke tafiya a wuraren jama'a.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga manyan kantunan kasuwanci ya sanya abin rufe fuska.
A Isra'ila, an umurci duk wanda zai je wuraren jama'a da na jama'a da su sanya abin rufe fuska.
A ranar 1 ga watan Afrilu, an sanar da cewa matafiya a jiragen kasa da kuma bas na birni da ke Taiwan, inda aka samar da abin rufe fuska miliyan 10 a rana tun tsakiyar watan Maris, za su buƙaci saka abin rufe fuska.
Panama ta ba da shawarar sanya abin rufe fuska a duk lokacin da za a fita waje, kuma ta ba da shawarar samar da abin rufe fuska na gida ga waɗanda ba za su iya ba.
A wasu wurare a kasar, kamar Japan, Korea ta Kudu, Malaysia da Singapore, ana amfani da abin rufe fuska sosai.
Nisa ta zamantakewa (nisan jiki) ya ƙunshi ayyukan da ke sarrafa yaduwar cutar da nufin rage saurin yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Matakan sun hada da killace mutane, hana zirga-zirga, da rufe makarantu, wuraren aiki, wuraren wasanni, gidajen sinima ko manyan kantuna.
Kowane mutum na iya yin amfani da hanyoyin zamantakewar da ba ta tuntuɓar mutane kamar zama a gida, tafiya cikin iyaka, guje wa wuraren taron jama'a, amfani da hanyoyin magana ba tare da tuntuɓar juna ba, da kuma guje wa hulɗa da wasu.
Gwamnatoci da dama yanzu suna tilasta ko kuma karfafa dokar nisantar jama'a a yankunan da cutar ta shafa.
Ƙididdigar yawan jama'a da hukumomin gwamnati da cibiyoyin kiwon lafiya na Amurka suka ba da shawarar daga 250 (idan babu yaduwar COVID-19 a cikin gida) zuwa 50 da sauri, sannan zuwa 10 daga baya.
A ranar 22 ga Maris, 2020, Jamus ta hana tarurruka na mutane fiye da biyu. CDC ta ba da shawarar cewa tsofaffi daga yankunan da ke fama da cutar ta hanyar haɗuwa da marasa lafiya su kasance a gida idan za su iya, da kuma waɗanda ke da yanayin rashin lafiya na asali kamar su masu ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da waɗanda ke da haɗarin kamuwa da cututtukan cututtukan jiki. A ƙarshen Maris, 2020, WHO da sauran cibiyoyin kiwon lafiya sun maye gurbin kalmar "keɓewa" da "keɓewa" don sauƙaƙe fahimtar manufar rage hulɗa ta jiki tare da mutane da yawa, ko da yake suna ci gaba da hulɗa da mutane da yawa.
A cikin wata sanarwa da aka wallafa a ranar Talata, mai wallafa ta wallafa cewa, "A cikin wannan sanarwa, an yi amfani da kalmar 'distancing' a cikin zamantakewar jama'a, wanda hakan ya haifar da ma'anar cewa mutane su zauna a cikin cikakken kadaici, ba tare da hulɗa da wasu ba, maimakon ƙarfafa su su yi hulɗa da wasu ta hanyoyi marasa kyau".
Wannan ya hada da karfafawa mutane su yi jima'i da wanda ba shi da cutar ko kuma wanda ba shi da alamun cutar.
Ana ba da shawarar keɓewa a gida ga waɗanda suka gwada tabbatacce ga COVID-19 da waɗanda ake zargi da kamuwa da cutar.
Masu ba da sabis na kiwon lafiya sun ba da cikakkun bayanai don bin ƙa'idodin keɓe kai da suka dace. Gwamnatoci da yawa suna ƙarfafa ko ba da umarnin hana keɓewa ga duk waɗanda ke zaune a yankunan da cutar ta kamu.
A cikin watan Agusta, an ba da umarnin keɓe kai da keɓewa ga waɗanda ke cikin manyan kungiyoyi masu haɗari.
Duk wanda ya taɓa saduwa da mutumin da ke da cutar COVID-19 ko ya ziyarci yanki ko ƙasa mai saurin yaduwa ana ba da shawarar keɓe kansa na kwanaki 14 daga lokacin da aka taɓa saduwa da shi.
A cikin dabarun da za a iya amfani da su wajen dakile yaduwar cutar, akwai iyakancewar ko kuma hanawa da kuma ragewa.
Manufar ita ce a fara sarrafa cutar a farkon lokacin yaduwar cutar, gano masu cutar da ke cikin cutar da ke cikin keɓewa, da kuma aiwatar da wasu matakan kula da cutar don hana yaduwar cutar zuwa sauran mutanen da ke cikin yankin.
Idan ba za a iya sarrafa yaduwar cutar ba, dole ne a canza zuwa matakan rage yaduwar cutar: matakan da za su rage yaduwar cutar da rage tasirin ta ga tsarin kiwon lafiya da al'ummomi.
A cikin wannan labarin, za mu tattauna game da yadda za a magance matsalar rashin cin abinci da kuma yadda za a magance matsalar rashin cin abinci.
Don juyawa yaduwar cutar a duniya, ana buƙatar tsauraran matakai na hanawa, ta hanyar rage yawan kamuwa da cuta zuwa ƙasa da lamba 1. Don rage ƙimar kamuwa da cuta a matsayin ɓangare na kula da yaduwar cutar mai yaduwa, ƙoƙarin rage ƙimar kamuwa da cuta a matsayin aiki don daidaita yaduwar cutar.
Wannan zai rage hadarin da ke tattare da ayyukan kiwon lafiya da ke cikin ruwa kuma zai ba da karin lokaci don binciken magani da hanyoyin warkewa.
Matakan da ba na likita ba da na waje don sarrafa yaduwar cutar sun haɗa da hanyoyin kariya na mutum kamar tsabtace hannu, sanya abin rufe fuska da keɓewa, matakan ƙungiya don rage haɗuwa ta jiki kamar rufe makarantu da guje wa tarurruka na jama'a, ɗaukar matakin gaggawa na al'umma don karɓar abubuwan da ke sama da kuma motsawa don shiga cikin aikin, da kuma tsabtace muhalli kamar tsabtace farfajiya. An fara barkewar cutar a China kuma an aiwatar da tsauraran matakan rufewa da keɓewa da kuma rufe birni gaba ɗaya don hana yaduwar cutar.
A wasu kasashe ma, an yi amfani da wasu matakai daban-daban don dakile yaduwar cutar.
Koriya ta Kudu ta fara gwajin mutane da yawa da keɓewa a wuraren da aka yi musu allurar rigakafi, kuma ta ba da gargaɗi game da motsin mutane da suka kamu da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda ke keɓe kansu don cutar kuma ta ci tarar waɗanda suka kasa yin hakan.
Taiwan ta kara samar da abin rufe fuska da kuma sanya takunkumi kan adana kayayyakin kiwon lafiya.Kasuwancin da aka yi a Burtaniya da Amurka sun nuna cewa akwai manyan kalubale wajen rage kamuwa da cutar (rage saurin yaduwar cutar amma ba dakatar da ita ba) da kuma rage ta (juyawa ci gaban cutar).
Ko da yake manufofin da suka fi dacewa na sauƙaƙewa za su iya rage yawan bukatun kiwon lafiya da kashi biyu bisa uku kuma rage mutuwar da rabi, amma akwai daruruwan dubban mutuwar kuma tsarin kiwon lafiya yana fama.
Ana iya ƙara ƙarfafa matakan rage gudu, amma idan an rage matakan a duk lokacin da cutar ke yaduwa a cikin al'umma (idan akwai magani a cikin farko), kamuwa da cuta na iya sake yaduwa cikin sauri kuma yana buƙatar kiyayewa.
Wannan cuta tana da matukar muhimmanci a duniya, saboda haka, akwai bukatar a dauki lokaci mai tsawo don dakile ta, kuma hakan na iya haifar da mummunan tasiri a zamantakewa da tattalin arziki.
Har yanzu babu maganin rigakafin cutar COVID-19, amma ana aiki sosai kan samar da magani, gami da gwajin magunguna na yanzu.
Yin amfani da maganin sanyi, shan ruwa da hutawa na iya rage alamun.
Ya danganta da tsananin kamuwa da cutar, za a iya buƙatar maganin oxygen, maganin hana numfashi da taimakon injin numfashi.
A wasu lokuta, ana iya yin amfani da kwayoyin cutar ta hanyar amfani da kwayoyin cutar ta hanyar amfani da kwayoyin cutar.
Yawancin magunguna da aka yarda da su don magance wasu cututtukan ƙwayoyin cuta suna cikin gwaji don maganin COVID-19.
WHO ta kuma ce maganin gargajiya da na gida na iya taimakawa wajen rage alamun cutar SARS-CoV-19.
WHO ta bayyana cewa inganta inganci da daidaita kiwon lafiya don dacewa da bukatun marasa lafiya na COVID-19 shine babban aikin mayar da martani ga yaduwar cutar.
Ofishin Yankin WHO da ECDC sun ba da jagororin ga asibitoci da ayyukan kula da kiwon lafiya na yanki don canza albarkatu a matakai da yawa, gami da mayar da hankali kan gwajin gwaji na gwaji na COVID-19, kawar da ayyukan jefa kuri'a idan ya yiwu, keɓewa da keɓewar marasa lafiya da aka tabbatar da COVID-19, haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata, da haɓaka wadatar injina na gaggawa da ɗakunan gado.
Akwai wasu dabaru da dama game da abin da ya faru da wanda ya fara samun cutar (wanda ake kira ciwon mara lafiya).
Ana iya gano cutar coronavirus a ranar 1 ga Disamba, 2019, lokacin da aka fara gano cutar a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu.
Yawancin su suna da alaƙa da kasuwar siyar da abincin teku ta Hunan, inda ake sayar da dabbobi masu rai, kuma wata ka'idar ita ce, kwayar cutar ta fito ne daga dabba, ko kuma a wasu kalmomin, yana da asalin kwayar cutar daga dabba zuwa mutum. An gano fashewar cutar nimoniya ba tare da sanadin ba a ranar 26 ga Disamba, kuma an kula da shi ta hanyar Dr. Zhang Jixian a asibitin lardin Hubei, wanda ya sanar da CDC na Wuhan Jan Han a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wasu likitoci a babban asibitin Wuhan sun sanar da abokan aikinsu cewa suna da wani sabon kwayar cutar coronavirus kamar SARS.
Likitoci takwas, ciki har da Li Wenliang, sun fuskanci gargadi daga 'yan sanda saboda yada jita-jita na karya, yayin da wata, Ai Fen, ta fuskanci tsauraran shawarwari daga shugabanninta saboda ta kara yawan fargaba.
Hukumar kiwon lafiya ta Wuhan ta fitar da wata sanarwa ga jama'a a ranar 31 ga Disamba, inda ta sanar da WHO.
Hukumomin kiwon lafiya na Wuhan sun fara gudanar da bincike a farkon watan Janairu bayan samun isassun rahotanni game da cutar nimoniya. A farkon lokacin kamuwa da cutar, yawan masu kamuwa da cutar ya ninka sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan kasar Sin saboda Wuhan babban cibiyar sufuri ne da kuma babbar hanyar jirgin kasa, tare da yawan tafiye-tafiye don bikin Sabuwar Shekarar China.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin kamuwa da cutar 140, ciki har da biyu a Beijing da daya a Shaanxang.
Bayanai na hukuma sun nuna cewa mutane 6,174 sun kamu da cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin manyan ƙasashe masu cutar a duniya. A ranar 9 ga Afrilu, 2020, an ba da rahoton cewa akwai mutane miliyan 1.61 da aka tabbatar a duk duniya, tare da mutuwar 97,000 da kuma warkarwa sama da 364,000.
A yanzu haka, akwai wasu kasashe da yankuna 200 da ke fama da cutar.
A Turai, cutar ta shafi ƙasashe da yawa a yankin Schengen, waɗanda ke iyakance motsi da sanya takunkumi a kan iyakoki.
Matakan matakin ƙasa sun haɗa da matakan hana zirga-zirga (wanda kuma aka sani da umarnin zama a gida, umarnin zama a cikin rufi, ko kulle-kulle) da kuma dokar hana fita. Kamar yadda yake a ranar 2 ga Afrilu, kusan mutane miliyan 300, kusan kashi 90% na Amurka, sama da miliyan 50 a Philippines, sama da miliyan 59 a Afirka ta Kudu, da mutane biliyan 1.3 a Indiya suna cikin kulle-kulle.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna fuskantar wasu nau'ikan kulle-kulle, wanda ya karu zuwa biliyan 2.6 (kashi uku na yawan mutanen duniya) a cikin kwanaki biyu masu zuwa.
An fara gano mutum na farko da ke da cutar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019, kuma rahotanni da ba a tabbatar da su ba sun ce farkon barkewar cutar ya faru ne a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ta gano tarin marasa lafiya da cutar nimoniya a ranar 26 ga Disamba, kuma ta sanar da CDC na Wuhan Jainghan a ranar 27 ga Disamba, daidai da ganowar.
A ranar 27 ga Disamba, 2019, gwajin farko na kwayoyin halitta na samfurin mai haƙuri ya gano kasancewar coronavirus mai kama da SARS.
Hukumar kula da lafiya ta Wuhan ta fitar da gargadi ga jama'a a ranar 31 ga Disamba.
A ranar ne WHO ta sanar da hakan.
A daidai lokacin da ake wannan gargadi, 'yan sanda sun gargadi likitoci a Wuhan game da yada jita-jita game da cutar.
Hukumar Lafiya ta Kasa ta kasar Sin a farkonta ta ce babu tabbataccen tabbaci game da yaduwar cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban kamfen na yaki da yaduwar cutar da babban sakataren jam'iyyar kwaminis ta kasar Sin, Shi Jingping ya kira "yaƙin mutane".
An dakatar da zirga-zirgar shiga da fita daga Wuhan a ranar 23 ga Janairu, a matsayin wani yanki na keɓewa na ɗan lokaci wanda aka bayyana a matsayin mafi girma a tarihin ɗan adam. An faɗaɗa zuwa birane 15 a lardin Hubei, yana shafar mutane miliyan 57.
An haramta amfani da motocin jama'a a cikin birnin.
An soke bikin Sabuwar Shekarar Sin a wurare da dama (wanda aka shirya yi a ranar 25 ga Janairu).
Hukumomi sun kuma sanar da cewa ana gina asibitin wucin gadi a Huoshenshan, wanda za a kammala a cikin kwanaki 10.
A lokacin da ake samun karin marasa lafiya, an gina wani asibiti, asibitin Leishenshan.
Baya ga sabbin asibitocin da aka gina, an kara wasu gine-gine 14 zuwa asibitoci na wucin gadi, kamar Cibiyar Taro da Wasanni a Wuhan.A ranar 26 ga Janairu, gwamnati ta aiwatar da ƙarin matakan, gami da ba da sanarwar kiwon lafiya ga matafiya da tsawaita hutun bikin bazara don magance yaduwar COVID-19.
A lokacin da ake zanga-zangar, an rufe makarantu da jami'o'i a fadin kasar.
A wasu wurare a Hong Kong da Macao, musamman makarantu da jami'o'i, an tsara wasu ayyuka da kuma wasu.
A wasu yankuna na kasar Sin, an fara amfani da na'urorin sarrafawa ta nesa.
A lokacin da ake zanga-zangar, an kafa dokar hana fita daga jihar da kuma shiga cikinta.
A cikin watan Agusta, an yi wani sabon mataki na sake fasalin hanyoyin sufuri na jama'a a duk faɗin ƙasar Sin, tare da rufe gidajen tarihi na ɗan lokaci.
Ana aiwatar da iyakancewar motsi a birane da yawa, kuma kusan mutane miliyan 760 (kimanin rabin yawan jama'a) suna fuskantar wasu nau'ikan ƙuntatawa na fita waje.Yar cutar ta kai matakin yaduwa a duniya a watan Maris, kuma hukumomin China sun aiwatar da tsauraran matakai don hana cutar daga shigowa cikin ƙasar daga wasu ƙasashe.
A ranar 23 ga watan Maris, bayan kwana biyar da a ka kafa dokar, an samu mutum daya da ya kamu da cutar a kasar Sin ta hanyar wani matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ce an dakatar da yaduwar cutar a kasar kuma an samu nasarar sarrafa yanayin.
A ranar 26 ga watan Maris, 2020, Ma'aikatar Harkokin Wajen kasar Sin ta sanar da cewa ta dakatar da masu daukan biza ko izinin zama daga ranar 28 ga watan Maris, ba tare da bayyana ainihin lokacin da wannan manufar za ta kare ba.
A cewarsa, idan mutum ya je kasar Sin, dole ne ya nemi biza a ofisoshin jakadancin kasar da kuma ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta yi kira ga ma'aikata da masana'antu da su sake bude kasuwanni da masana'antu a ranar 30 ga watan Maris, tare da bayar da tallafin kudi don karfafa ayyukan. Gwamnatin tsakiya ta bukaci shugabannin iyalai su bi dokar hana taruwa ta yanar gizo don hana sake yaduwar cutar COVID-19, amma Majalisar Jiha ta sanar da yin minti uku na zaman lafiya da makoki a duk fadin kasar a ranar 4 ga Afrilu da karfe 10:00 na ranar bikin.
A ranar 20 ga Janairun 2020, Koriya ta Kudu ta tabbatar da cewa akwai cutar COVID-19 da ta bazu daga China.
Hukumar kiwon lafiya ta kasar ta ba da rahoton karuwar adadin wadanda aka tabbatar da cutar a ranar 20 ga watan Fabrairu, yawancinsu sun kamu ne daga taron da aka yi a garin Daegu na wani sabon addini da ake kira Shin Chung-ji Church of Jesus Christ.
A lokacin da ake zargin cewa shi ne ya haddasa cutar, limaman Shincheonji da ke Wuhan sun ziyarci birnin Daegu na Koriya ta Kudu.
A ranar 22 ga watan Fabrairu, 1,261 ko 13% na masu bin coci 9,336 sun nuna alamun cutar. Koriya ta Kudu ta sanar da matakin gargadi mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an tabbatar da sama da mutane 2,000 da suka kamu da cutar a Koriya, kuma an kai 3,150 a ranar 29 ga Fabrairu.
Kungiyar ta Koriya ta Kudu ta sanya dukkan sansanonin soji a keɓe bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Koriya ta Kudu ta gabatar da abin da aka kwatanta da mafi girma da mafi kyawun tsarin tattara mutane a duniya don gwada mutane don cutar da ke dauke da cutar da kuma keɓewa, da bin diddigin waɗanda suka taɓa hulɗa da su da kuma keɓewa.
Hanyoyin gwaji sun haɗa da bayar da rahoton bayyanar cututtuka na tilas daga balaguron ƙasa da ƙasa da dawowa ta hanyar aikace-aikacen hannu, da kuma yin gwajin kwayar cutar a kan hanya tare da sakamakon gwajin a rana mai zuwa, yana ƙara ƙarfin gwajin zuwa 20,000 kowace rana.
A halin yanzu, ana ganin cewa an samu nasarar magance cutar ba tare da sanya dokar hana fita a cikin biranen Koriya ta Kudu ba.
A cikin wata sanarwa da aka fitar a ranar Talata, wasu daga cikin 'yan kasar sun yi kira ga gwamnatin kasar da ta yi watsi da zargin da ake yi wa Moon da kuma goyon bayansa.
A ranar 23 ga watan Maris, Koriya ta Kudu ta samu mafi karancin adadin masu dauke da cutar a rana guda cikin makonni hudu.
A ranar 29 ga watan Maris, an sanar da cewa duk sabbin masu shigowa daga kasashen waje za su shiga killacewa na makonni biyu daga ranar 1 ga Afrilu.
A ranar 1 ga Afrilu, wata jarida ta ruwaito cewa Koriya ta Kudu ta karbi buƙatun taimako na gwaji daga ƙasashe daban-daban 121.
An bayar da rahoton farkon cutar SARS-CoV-2 a Iran a ranar 19 ga Fabrairu a garin Kwan, kuma a cewar ma'aikatar lafiya da ilimin likitanci, mutane biyu sun mutu a wannan ranar.
A cikin shirye-shiryen da gwamnati ta sanar na farko na hana zirga-zirga da sauran al'adu, wasanni, da kuma ayyukan ibada na Juma'a, da rufe jami'o'i da cibiyoyin ilimi da makarantu.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020, babu wani shiri na killace yankunan da cutar ta bulla, amma mutane ne kawai za a killace.
A watan Maris, an sanar da shirin takaita zirga-zirgar jiragen sama tsakanin biranen, duk da yawan zirga-zirgar jiragen sama tsakanin biranen kafin bikin Sabuwar Shekarar Farisa.
An bude masallatai na Shi'a a Qom, Iran, don masu aikin hajji har zuwa ranar 16 ga Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A yayin da ake zargin cewa an boye adadin masu dauke da cutar a Iran, sama da kasashe 10 sun gano cewa an danganta cututtukan da ke faruwa a cikin kasashensu zuwa Iran kafin ranar 28 ga watan Fabrairu, wanda ke nuna cewa cutar ta fi muni fiye da adadin masu dauke da cutar 388 da gwamnatin Iran ta bayyana a ranar.
A ranar 3 ga watan Maris, an rufe majalisar dokokin Iran bayan da aka ba da rahoton cewa 23 daga cikin wakilai 290 sun gwada tabbatacce ga cutar.
A ranar 12 ga watan Maris, kungiyar kare hakkin dan adam ta bukaci hukumomin kurkuku na Iran da su saki masu kare hakkin dan adam da ake tsare da su saboda rashin jituwa cikin lumana, da kuma sakin dukkan fursunonin da ke tsare da su.
An bayyana cewa akwai haɗarin kamuwa da cutar a cikin cibiyoyin da ba su da isasshen kiwon lafiya, kamar cibiyoyin tsare mutane.
A ranar 15 ga watan Maris, gwamnatin Iran ta ce an samu mutuwar mutane 100 a rana daya, wanda shi ne mafi yawan adadin wadanda suka mutu a kasar tun lokacin da cutar ta fara bulla.
A ranar 17 ga watan Maris, an kashe akalla mutane 12 a matsayin 'yanci na Iran, ko kuma tsoffin 'yan siyasa da jami'an gwamnati.
A ranar 23 ga watan Maris, Iran ta samu sabbin mutane 50 da ke kamuwa da cutar coronavirus a kowace awa da kuma mutuwar mutum daya a kowace minti 10.
A cewar jami'an WHO, adadin masu kamuwa da cutar a Iran ya ninka na wadanda aka ruwaito sau biyar.
A cewarsa, "A cikin wannan shekarar, asarar kudi da aka samu a Iran ta fi yawa a cikin asusun banki na Amurka.
Babban kwamishinan kare hakkin bil adama na Majalisar Dinkin Duniya ya bukaci sassauta takunkumi kan kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da cutar a Italiya lokacin da matafiya biyu 'yan China suka gwada ingancin SARS-CoV-2 a Roma a ranar 31 ga Janairu.
A sakamakon karuwar cututtukan, gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama zuwa da kuma daga China kuma ta ayyana dokar ta baci.
An fara gano barkewar cutar COVID-19 da ba a haɗa ta ba a ranar 21 ga Fabrairu daga mutane 16 da aka tabbatar a Lombardy. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da umarnin doka don hana yaduwar cutar, gami da keɓe mutane sama da 50,000 daga ƙananan garuruwa 11 a cikin tsarin yanki a arewacin Italiya.
A cikin wata sanarwa da ya fitar a ranar Talata, Firaministan kasar, Giuseppe Conte ya ce, "Babu damar shiga ko fita daga wuraren da cutar ta bulla".
"An dakatar da ayyukan kasuwanci da kuma wasannin motsa jiki a yankunan da aka ambata". "A ranar 4 ga Maris, adadin mutuwar a Italiya ya kai 100, kuma gwamnatin Italiya ta ba da umarnin rufe makarantu da jami'o'i a duk faɗin ƙasar".
A ranar 9 ga watan Maris, an dakatar da dukkan wasannin wasanni na akalla wata guda, duk da cewa an umurci dukkan manyan wasannin wasanni, ciki har da wasan kwallon kafa na Serie A, da a buga su a cikin gida har zuwa watan Afrilu.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin kasuwancin, ban da manyan kantunan abinci da kantunan magani. A ranar 6 ga Maris, Kwalejin Anesthesiology, Anesthesiology da Emergency Nursing and Rehabilitation (SIAARTI) ta Italiya ta buga shawarwarin ɗabi'ar likita game da kula da marasa lafiya masu mahimmanci, wanda ya kamata a yi amfani da shi.
A ranar 19 ga Maris, Italiya ta kai adadin mutane 3,405 da suka mutu sakamakon kamuwa da cutar, ta wuce China a matsayin ƙasa mafi yawan masu cutar coronavirus a duniya.
A ranar 22 ga watan Maris, an bayar da rahoton cewa an aika da jiragen sama tara na soji da ke dauke da kayayyakin kiwon lafiya daga Rasha zuwa Italiya.
A ranar 5 ga watan Afrilu, Italiya ta samu mutum 128,948 da suka kamu da cutar, mutane 15,887 da suka mutu, da kuma mutane 21,815 da suka warke, mafi yawansu a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan tsofaffi a Italiya da rashin iya gwada duk waɗanda ke da kwayar cutar a kan lokaci sun haifar da karuwar yawan mace-mace.
Lokacin da cutar ta fara bulla, Burtaniya ta kasance ɗaya daga cikin ƙasashe masu jin daɗi da aka shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta tilasta wa 'yan ƙasa yin amfani da kowane nau'i na nisantar zamantakewa ko keɓewa ba.
Sakamakon haka, gwamnati ta fuskanci mummunan zargi saboda rashin kulawa sosai game da matsalar da ke fuskantar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar hana duk wata tafiya da duk wani nau'i na zamantakewa, yana ba da shawarar yin aiki daga gida idan ya yiwu kuma kauce wa shaguna, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar cewa ta yi alkawarin rufe duk shagunan da ke buɗe don nishaɗi, kamar mashaya da wuraren wasanni, da wuri-wuri, da kuma biyan ma'aikata har zuwa £ 2,500 a wata da kashi 80% na albashin su don hana rashin aikin yi a lokacin annobar. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar cewa za a bi ƙa'idodin ƙa'idodin ƙaurawar zamantakewar da aka ƙara tsaurara, ƙuntatawa taron mutane sama da mutane biyu da ƙuntatawa kan tafiya da fita waje, kamar yadda ya kamata a kiyaye.
A wani bangare kuma, 'yan sanda sun yi amfani da takunkumin da aka sanya musu na tara mutane da kuma tara mutane.
A ranar Litinin, 'yan sanda sun ce an rufe yawancin wuraren kasuwanci, sai dai wadanda ake ganin suna bukatar ci gaba da budewa, ciki har da manyan kantuna, kantunan magani, bankuna, shagunan kayan masarufi, shagunan mai da kuma gidajen gyaran motoci.
A ranar 20 ga Janairu, an tabbatar da farkon sanannen cutar COVID-19 a cikin Pacific Northwest, Washington, ga wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga Janairu, an kafa Kwamitin Kula da Cutar Kwayar cutar Corona na Fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya da kuma takaita shigowar masu yawon bude ido daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Gwamnatin Amurka, babban jami'in kula da lafiyar jama'a, ta sanar da cewa ta samar da nata na'urar gwajin.
Duk da haka, saboda jinkirin da Amurka ta yi wajen fara gwajin cutar, sanin yanayin cutar a lokacin ya zama da wahala.
Gwamnatin tarayya ta ba da izinin gwajin a watan Fabrairu, amma gwajin bai yi tasiri ba saboda kayan gwaji da aka samar a watan Fabrairu. Ƙungiyoyin da ba na gwamnati ba (masana kimiyya, makarantu, jami'o'i) sun ba da izinin gwajin har zuwa ƙarshen Fabrairu, kuma ana buƙatar jama'a su cika ƙa'idodin gwajin har zuwa farkon Maris (wanda kuma ya buƙaci amincewar likita).
A ranar 27 ga watan Fabrairu, a cewar Washington Post, kasa da gwaji 4,000 ne kawai aka yi a Amurka.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa an kammala gwajin fiye da 14,000.
A ranar 22 ga watan Maris, kamfanin dillancin labarai na AP ya ruwaito cewa mutane da yawa da ke da alamun cutar sun jira na sa'o'i ko kwanaki don gwaji bisa umarnin likitoci. Bayan mutuwar farko a Amurka, Gwamna Jay Inslee ya ayyana dokar ta baci a jihar Washington a ranar 29 ga Fabrairu.
An soke makarantu a yankin Seattle a ranar 3 ga Maris, kuma an rufe makarantu a duk faɗin ƙasar a tsakiyar watan Maris. Wata ƙungiyar masana cututtukan cututtuka a Kwalejin Sarauta ta Landan ta ba da shawara ga Amurka a ranar 6 ga Maris, 2020 game da yiwuwar tasirin sabon coronavirus a kan ƙasa.
A wannan ranar, Shugaba Trump ya rattaba hannu kan Dokar Shirye-shiryen Coronavirus da Amsawa, wanda ke ba da dala biliyan 8.3 don tallafawa ayyukan gaggawa ga hukumomin tarayya don magance cutar.
A cikin watan Agusta, kamfanoni da yawa sun sanya takunkumin hana ma'aikata tafiya, soke tarurruka da kuma karfafa ma'aikata su yi aiki daga gida.
An soke wasannin motsa jiki da kuma kakar wasa. Trump ya sanar a ranar 11 ga Maris cewa ya dakatar da tafiye-tafiye zuwa yawancin Turai, ban da Burtaniya, na tsawon kwanaki 30 daga ranar 13 ga Maris.
A ranar da ta gabata, ya fadada takunkumin zuwa Birtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci a kasa, wanda hakan ya ba da damar amfani da kudaden tarayya wajen magance bala'i.
Tun daga ranar 15 ga Maris, an rufe ko rage lokutan aiki a yawancin kasuwancin Amurka don rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da barkewar cutar a jihohi 50 da gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da mutane 10,700 da ke fama da cutar coronavirus, wanda ya fi adadin masu cutar a Koriya ta Kudu.
Gwamnan jihar ya ce a ranar 25 ga Maris cewa yin keɓewa yana da alama yana aiki, saboda an gano cewa adadin adadin masu kamuwa da cutar ya ragu daga 2.0 zuwa 4.7 a cikin kwanaki.
A ranar 28 ga Maris, New York City ta sami mutane 32,308 da suka kamu da cutar, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton cewa ta sami mafi yawan kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya. A ranar 8 ga Afrilu, Amurka tana da mutane 400,335 da suka kamu da cutar da kuma mutuwar 12,841.
A ranar 30 ga watan Maris, rahotanni a kafafen yada labarai sun ce, shugaban Amurka Trump ya yanke shawarar tsawaita dokar nisantar jama'a har zuwa ranar 30 ga watan Afrilu.
A wannan rana, an ajiye jirgin ruwan asibiti na Amurka mai gadaje 1,000 USNS Comfort a birnin New York.
A ranar 3 ga watan Afrilu, Amurka ta kai adadin mutuwar mutum 884 a cikin sa'o'i 24 da suka gabata sakamakon cutar coronavirus.
A ranar 3 ga watan Afrilu, New York ta kai adadin masu kamuwa da cutar sama da 100,000. An zargi Fadar White House da yin la'akari da haɗarin, da kuma yin sanarwa ga jami'an kiwon lafiya da masana kimiyya game da cutar, da kuma umarci ofishin Mataimakin Shugaban Amurka Mike Pence da su haɗa kai da haɗin kai wajen buga labarai.
A cikin wata sanarwa da ya fitar a ranar Talata, shugaban kasar ya bayyana cewa, a halin yanzu, akwai wasu bangarori biyu da ke nuna rashin amincewarsu da yadda Trump ya magance annobar.
Wasu jami'an Amurka da kafofin yada labarai sun soki dogaro da kasar Sin kan shigo da kayayyakin gaggawa, ciki har da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da tsarin zirga-zirgar jiragen sama don yin taswira da kuma hango yanayin yaduwar cutar, kuma an buga binciken a cikin mujallar Travel Medicine a tsakiyar Janairu 2020.
A cewar rahoton Hukumar Kula da Sufurin Jiragen Sama ta Duniya na 2018, Bangkok, Hong Kong, Tokyo da Taipei sun fi samun yawan fasinjoji daga Wuhan.
A cikin rahoton, Dubai, Sydney, da Melbourne sune manyan wuraren da mutane ke zuwa daga Wuhan.
A yayin da biranen Australiya ke cikin matsanancin bukatar keɓewa, an sanar da su su shirya keɓewa a wurare 20, mafi mahimmanci a tsibirin Bali. Ostiraliya ta ba da sanarwar shirin gaggawa na sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ko da yake babu wasu bayanai game da COVID-19, Ostiraliya ta ce za ta ƙara ƙarfafa kula da kan iyakoki da kuma sadarwa don magance cutar.
A ranar 21 ga watan Maris, an ayyana dokar ta baci ta lafiyar dan adam a Australia.
A lokacin da ake gudanar da aikin killace jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da ma'aikatan diflomasiyyarsu daga yankin, da farko ta jiragen sama masu haya zuwa kasashensu, tare da izinin hukumomin kasar Sin.
Kasashen Canada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand ne suka fara fitar da 'yan kasarsu zuwa wani wuri mai aminci.
A ranar Litinin, Pakistan ta ce ba za ta mayar da 'yan kasarta da ke kasar Sin ba.
A ranar 7 ga watan Fabrairu, gwamnatin Brazil ta samu nasarar kwashe 'yan Poland hudu, da wani dan kasar Sin, da wani dan kasar Indiya, da kuma wasu 'yan Brazil 34 ko kuma danginsu.
A ranar Litinin, 'yan kasar Sin da Poland da kuma Indiya sun sauka daga jirgin inda jirgin ya tsaya kafin ya koma Brazil.
An killace 'yan kasar Brazil da suka ziyarci birnin Wuhan a wani sansanin soji da ke kusa da birnin Brasilia.
A rana guda, an sanya 'yan Kanada 215 (mutanen 176 a cikin jirgin farko da gwamnatin Amurka ta yi haya, da 39 a cikin jirgin na biyu) a keɓewa na mako biyu daga Wuhan zuwa CFB Trenton.
A ranar 11 ga watan Fabrairu, wani jirgin sama da ke dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australia sun tura 'yan kasar 277 zuwa wani cibiyar tsare mutane a tsibirin Kirsimeti a ranar 3 da 4 ga watan Fabrairu, inda suka zauna har tsawon kwanaki 14.
Jirgin ceto na New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma an killace fasinjojin (ciki har da wasu 'yan asalin Australiya da wasu daga cikin kasashen Pacific) a sansanin sojan ruwa na Wamparoora a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama dauke da fasinjoji 129 na Kanada daga jirgin ruwa mai suna Diamond Pricess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris, jirgin saman South African Airlines wanda gwamnatin Afirka ta Kudu ta yi hayar sa ya dawo da' yan Afirka ta Kudu 112.
An gudanar da gwajin likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da aka gwada kuma suka tabbatar da cewa ba su da cutar sun koma kasar.
A matsayin kariya, an killace dukkan 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, shugabannin jirgin sama, ma'aikatan otal,' yan sanda da sojoji, waɗanda suka halarci aikin jin kai na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa, kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun ba da taimako ga kasar Sin.
Wasu daliban kasar Sin da ke halartar jami'o'in Amurka sun hada kai a duk fadin Chicago don taimakawa wuraren da cutar ta addabi, inda suka ce sun samu nasarar isar da abin rufe fuska N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta agaji ta hadin gwiwa tare da kungiyar FedEx, tare da wasu kayan kariya na sirri, gami da safar hannu da riguna, sun kai 200,000 ta gaggawa zuwa asibitin jihar Wuhan a ranar 30 ga Janairu.
"A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da cewa sun ba da gudummawar dala miliyan 100 ga WHO don samar da alluran rigakafi da magunguna don kare ""masu rauni a Afirka da Kudancin Asiya""".
A ranar 6 ga watan Fabrairu, gwamnatin China ta ba da gudummawar wasu masks 200,000 ga Philippines, bayan da Sanata Richard Gordon ya bayar da rahoton cewa an aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar Red Cross ta Singapore ta sanar da cewa za ta tura kayayyakin tallafi da suka kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan 1 ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta aika da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta ba da sanarwar ba da gudummawar mundaye na likita miliyan 18 ga China, Jamus ta ba da gudummawar kayayyakin kiwon lafiya iri-iri, gami da kayayyaki 10,000 na Heisman, Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita ga China, kuma ta yi alkawarin ƙarin dala miliyan 100 na taimakon kuɗi ga ƙasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da masana zuwa Italiya don magance yaduwar cutar coronavirus.
Wani dan kasuwa mai suna Jamma ya aika da kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6 da riguna 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya ya aika wa Panama kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Kasashen Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwaji na kasar Sin.
Alal misali, a Spain, an kwace kayan gwaji na coronavirus na kasar Sin 58,000 tare da daidaito na 30%, yayin da a Netherlands an kwace abin rufe fuska 600,000 da ke da lahani na kasar Sin.
A watan Agusta, wata kungiyar masu zanga-zanga ta kasar Sin ta ce, an kwace wasu masks guda 100,000 da ba su dace da amfani ba a kasar Belgium.
A wani bangare kuma, kasashen Latin Amurka da Afirka sun karbi kayan agaji daga China. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani shiri na ba da agaji na gaggawa ga kasashe masu tasowa.
Hukumar lafiya ta duniya ta shawarci hukumomin kasar Sin da su yi kokarin magance cutar.
"WHO ta lura da bambanci mai mahimmanci tsakanin hukumomin kasar Sin, wadanda ake zargi da yin asirin da ya jinkirta ayyukan rigakafi da sarrafa cututtuka a lokacin barkewar cutar SARS ta 2002-2004, da kuma gwamnatin tsakiya, wacce ke "samar da sabuntawa na yau da kullun kafin hutun hutun Sabuwar Shekarar China don kauce wa fargaba a lokacin rikicin na yanzu".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da hukumomin gwamnati suka yanke na aiwatar da dokar hana zirga-zirga a Wuhan, wakilin WHO, Gordon Gallia, ya ce "ba lallai ba ne shawarar da WHO ta bayar ba". Ya kuma ce "Wannan alama ce mai matukar muhimmanci ta ƙudurin da aka yanke na sarrafa annobar a cikin mafi yawan wuraren da aka tattara", yana mai cewa "ba a taɓa yin hakan ba a tarihin ɗan adam".
"Darakta Janar na WHO, Tedros Edhanom, ya ce sanarwar PHEIC ""ta kasance mai matukar muhimmanci saboda yiwuwar barkewar cutar a duniya, musamman a kasashe masu karamin karfi da masu matsakaitan kudade da ba su da tsarin kiwon lafiya mai karfi".
A kan takunkumin tafiye-tafiye, Tedros ya ce: "Babu wani dalili da zai sa a dauki matakan da za su tsoma baki ba tare da bukatar hakan ba a tafiye-tafiye da cinikayya na kasa da kasa, kuma WHO ba ta karfafa takunkumin kasuwanci da tafiye-tafiye".
A ranar 5 ga watan Fabrairu, WHO ta nemi al'umma ta duniya don ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabarun ƙasashe masu ƙarancin kuɗi. Ko da kuwa an yi wannan buƙatar, yana da mahimmanci a tallafawa ƙasashe waɗanda ba su da tsarin gano waɗanda ke da kwayar cutar.
Tedros ya fitar da wata sanarwa, wanda a cikinta ya ce: "Muna da ƙarfi kamar yadda mafi rauni na sarkarmu yake", kuma ya bukaci al'ummar duniya su "sa hannun jari a yau, ko kuma za a biya diyya mai yawa a wani lokaci". A wani taron manema labarai a ranar 11 ga Fabrairu, WHO ta sanya wa cutar sunan COVID-19.
"A wannan rana, Sakatare Janar na Majalisar Dinkin Duniya António Guterres, Tedros ya ce sun amince da su ba da "damar dukkan tsarin Majalisar Dinkin Duniya" don taimakawa a cikin aikin mayar da martani".
An kafa rukunin kula da rikice-rikice na Majalisar Dinkin Duniya, wanda ke ba da damar daidaita amsar Majalisar Dinkin Duniya. Kasashe membobin WHO sun ba su damar mayar da hankali kan amsar kiwon lafiya yayin da sauran hukumomin ke kawo ƙwarewarsu don ɗaukar tasirin zamantakewa, tattalin arziki da ci gaba da ya faru sakamakon yaduwar cutar.
A ranar 14 ga Fabrairu, an kafa wata ƙungiya mai aiki tare da China karkashin jagorancin WHO, tare da ƙwararrun masana na duniya da na WHO don taimakawa China a cikin gida a kan yanayin ƙasa da gudanar da bita da nazarin tsananin cutar da yiwuwar yaduwar cutar a manyan cibiyoyin matakin ƙasa da kuma bita da taro da kuma gudanar da gwajin filin don nazarin tasirin ayyukan mayar da martani a lardin da ƙananan hukumomi, gami da birane da yankuna.
Dangane da karuwar yaduwar cutar a Iran, WHO ta tura tawagar hadin gwiwa zuwa Iran don tantance halin da ake ciki. Jami'an WHO sun ce a ranar 28 ga Fabrairu, kimantawar barazanar coronavirus a matakin yaduwar duniya ya nuna cewa matakin haɗarin na iya tashi daga matakin 7 zuwa 7 mai girma, wanda shine matakin mafi girma na faɗakarwa da kimanta haɗari.
A cikin wata sanarwa da ya fitar a ranar Talata, Myrin, darektan shirin gaggawa na lafiya na WHO, ya yi gargadin cewa: "Wannan abu ne da ya kamata kowace gwamnati a duniya ta yi amfani da shi: farka".
"Cutar ta riga ta fara yaduwa kuma kuna buƙatar kasancewa cikin shiri", in ji shi. "Maganar da ta dace za ta taimaka wa duniya ta guji "mafi munin yanayin".
Ryan ya kara da cewa, "Abubuwan da muke da su yanzu ba su da tabbaci sosai da za su sa jami'an kiwon lafiya su ayyana cutar a matsayin annoba ta duniya, amma yin hakan zai nuna cewa mun yarda da cewa dukkan mutane a duniya za su kamu da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana cutar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO na da matukar damuwa game da ci gaba da kamuwa da cuta da kuma matakan tsanani da kuma rashin karɓar cutar. WHO ta fuskanci babban zargi saboda rashin magance cutar yadda ya kamata, gami da jinkirin ayyana dokar ta baci ta kiwon lafiya da kuma jinkirin ayyana cutar a matsayin annoba.
Wannan ya biyo bayan wasu kalamai da suka shafi batun rashin amincewa da tsarin mulki da kuma rashin amincewa da tsarin mulki.
A ranar 26 ga Maris, 2020, masana da yawa na Majalisar Dinkin Duniya kan kare hakkin dan adam sun yi kira ga girmama haƙƙin ɗan adam na kowane mutum a lokacin annobar COVID-19.
Kungiyar masana ta ce kowa na da hakkin ya amfana daga maganin ceto rai kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa rashin samun kudi ko rashin inshorar lafiya bai kamata ya zama hujja ba don nuna bambanci ga wasu kungiyoyi.
Masana sun jaddada cewa kowane mutum yana da 'yancin samun lafiya, gami da nakasassu da mutane, membobin kungiyoyin 'yan tsiraru, tsofaffi, 'yan gudun hijirar gidaje, marasa gida, wadanda ke rayuwa cikin mawuyacin hali, wadanda aka tsare, amma har da' yan gudun hijira da sauran kungiyoyin da ba a tantance su ba wadanda ke bukatar tallafin gwamnati.
Ƙungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar jama'a na rikicin COVID-19.
Ƙungiyar Tattalin Arziki da Ci Gaban ta samar da wani dandamali don samar da cikakken bayani a kan lokaci da kuma ra'ayoyi da shawarwari game da manufofin mayar da martani a ƙasashe a duniya.
Daga tsara manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da ƙuntatawa na balaguro, cibiyar dijital ta ƙunshi tsarin sa ido kan manufofin ƙasa don taimakawa ƙasashe su lura da juna da kuma daidaita haɗin gwiwar duniya don fuskantar ƙalubalen coronavirus.
A ranar Talata, Shugaba Buhari ya bayyana cewa, kasar Sin ta yi watsi da dokar hana fita da kuma hana fita ta hanyar yin amfani da makamai masu linzami.
An kori wasu gwamnonin jam'iyyar kwaminis ta kasar Sin (CPC) a lardin saboda yadda suka bi da killacewa a tsakiyar kasar Sin, wata alama ce ta rashin jin dadin yadda tsarin siyasa ke amsawa ga barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne domin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Shi Jing-fen daga fushin jama'a kan yaduwar cutar coronavirus.
Wasu jami'an kasar Sin (misali Zhao Lijian) sun yi watsi da yarda da cewa cutar coronavirus ta samo asali ne daga Wuhan, suna mai da hankali kan cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Trump ta Amurka ta kira coronavirus da suna "Covid-19" ko "Covid-19" kuma ta ce, "Cinema ta rufe bayanan da ke haifar da cutar zuwa wata annoba ta duniya". Wasu masu sukar sun yi la'akari da wannan a matsayin nuna bambancin launin fata da kuma nuna rashin nasarar gwamnatin da ke jagorantar ta wajen magance cutar.
A cikin wata sanarwa da ta fitar a ranar Talata, Daily Mail ta ambaci dabarun sadarwa na gwamnatin Amurka da ke bayyana cewa an fara shi ne a Majalisar Tsaro ta kasa.
"An umarce mu da mu yada wannan sakon ta duk wata hanya da za mu iya amfani da ita, gami da taron manema labarai da shirye-shiryen talabijin". "A cewar majiyoyi kamar Politico, Foreign Policy da Bloomberg, kokarin da China ke yi na ba da taimako ga kasashen da ke fama da cutar wani bangare ne na kokarin yada labaran duniya".
"Joshua Borel, kwamishinan harkokin wajen Tarayyar Turai, ya yi gargadin cewa akwai 'yan tawaye' a kokarin da ake yi na samun tasiri a fagen siyasa da kuma burin siyasa".
A cewarsa, kasar Sin tana kokarin samar da yanayi mai kyau da Amurka ta ke so ta zama amintacciyar abokiyar zamanta.
A wannan lokaci, kasar Sin ta ci gaba da ba da tallafi ga Venezuela da Iran, tare da neman a dage takunkumin da Amurka ta kakaba wa Syria, Venezuela da Iran.
An dakatar da kyautar masks 100,000 da Jack Ma ya bayar ga Cuba a ranar 3 ga Afrilu saboda takunkumin da Amurka ta sanya.
A cikin wata sanarwa da aka wallafa a shafinta na Twitter, an zargi jami'an Amurka da amfani da kudaden da aka ba wasu kasashe don amfanin kansu.
A cikin watan Agusta, an gabatar da wata sanarwa game da abin da ya faru a cikin kasar Czech Republic da Italiya da wasu ƙasashe kamar Jamus, Austria da Switzerland.
A wani labarin da ya gabata, wata majiya ta BBC ta ce: "Muna da wasu 'yan'uwa da ke zaune a yankin da ke fama da matsalar rashin lafiya.
A farkon watan Maris, gwamnatin Italiya ta soki kasashen Turai saboda gazawar nuna hadin kai a lokacin da cutar coronavirus ta shafa kasar.
A cewar jakadan Italiya a EU Maurizio Massari, kasar Sin ce kadai ta dauki matakin da ya dace.
"Wannan ba alama ce mai kyau ba ga hadin kan Turai".
A ranar 22 ga watan Maris, bayan tattaunawa ta wayar tarho da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya a tura sojojin Rasha zuwa Italiya da ma'aikatan jinya, motocin kashe kwayoyin cuta da sauran kayan aikin likita.
A wata sanarwa da aka wallafa a jaridar La Stampa ta Italiya, an ambaci wata sanarwa daga wani babban jami'in siyasa da ba a bayyana sunansa ba cewa kashi 80 cikin dari na tallafin da Rasha ke bayarwa ba shi da amfani kuma kadan ne kawai ke amfani da Italiya.
Majiyar ta zargi Rasha da yin leken asiri na siyasa da diflomasiyya.
Gwamnan Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton kafofin watsa labarai kuma sun ce sun gode.
Rasha ta aika da jirgin sama mai jigilar kayayyaki zuwa Amurka don kawo taimakon likita.
A lokacin da yake ba da tallafi ga abokan aikinsa na Amurka, Putin ya yi imanin cewa masana'antun magunguna na Amurka za su iya ba da taimako a lokacin da ake buƙata yayin da samar da kayan aikin likita da kayan aiki ke ci gaba.
"Dangane da wannan, za a yi amfani da shi a matsayin wani nau'i na NATO ""Defender 2020"" wanda aka shirya a Jamus, Poland da kuma Baltic, wanda shine mafi girma daga cikin ayyukan soja na rana tun ƙarshen Cold War".
"A lokacin rikicin kiwon lafiyar jama'a, ba sojoji daga Amurka da Turai ba ne kawai ke cikin hatsari, amma har da rayukan jama'ar kasashen da suke aiki", in ji sakataren kungiyar kare makaman nukiliya, Kate Hudson, game da atisayen Defender 2020. Gwamnatin Iran ta yi fama da cutar sosai, inda kusan 'yan majalisa biyu da manyan shugabannin siyasa 15 na yanzu ko na baya suka kamu da cutar.
Shugaban Iran Hassan Rouhani ya aika da wasikar jama'a ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020. A cikin wasikar, ya bayyana cewa kasarsa na gwagwarmaya don magance yaduwar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka da aka sanya wa Iran. Cutar ta haifar da Amurka da sauran kasashe masu arziki da yawa don karɓar manufofin zamantakewa, gami da kula da lafiya ga kowa, kula da yara ga kowa, izinin iyali tare da albashi, da ƙarin kudade don lafiyar jama'a.
Masu bincike kan harkokin siyasa na ganin cewa hakan zai iya lalata damar da Trump ke da ita na lashe zaben shugaban kasa a shekarar 2020.
Koriya ta Kudu ta soki Japan saboda rashin nuna gaskiya da kuma rashin himma a kokarin da ta yi lokacin da ta ce duk wanda ya zo daga Koriya ta Kudu zai kasance a killace shi na tsawon makonni biyu a wuraren da gwamnati ta tsara.
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, shugaban kasar Moon Jae-In ya bayyana cewa, "Kamar yadda aka saba, ba a taba samun wani abu mai kama da wannan ba a kasar.
Sun ce, 'yan kasar Koriya sun sanya hannu kan wannan takardar domin zargin Moon da rashin kula da cutar da gwamnatin ta yi, ko kuma su yaba masa kan yadda ya kula da cutar.
Wasu masu sharhi sun nuna fargabar cewa hakan zai iya sa gwamnatoci su kara karfafa ikon su.
A Hungary, majalisar dokokin kasar ta amince da bada mulki mara iyaka ga Firaminista Viktor Orbán, dakatar da zabe da majalisa, da hukunta wadanda suka yada labaran karya game da cutar da kuma yadda gwamnati ke magance annobar.
A duk duniya, karuwar amfani da kayan aiki don magance kamuwa da cutar coronavirus ya haifar da wasu lokuta na katsewar samar da kayayyaki saboda katsewar amfani da kayan da ba a buƙata, cinikin firgici, da dakatar da masana'antu da samar da kayayyaki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma katsewar samarwa.
A wasu wurare, mun ga yadda ake samun karancin kayayyaki, inda ake ta samun damuwa da kuma yawan sayayya, inda ake sayen kayan abinci, takarda na bayan gida da kwalaben ruwa daga manyan kantunan sayar da kayayyaki.
A cikin wata sanarwa da aka fitar a watan Agusta, kamfanin dillancin labarai na kasar Sin ya ce, "Babu wani abu da ya faru a kasar nan da ya shafi yadda ake gudanar da harkokin kasuwanci.
A cewar Darakta Janar na WHO, Tedros Adhanom, bukatar kayan aikin kare kai daga ruwa ya karu sau 100.
Wannan bukatar ta sa farashin ya karu sau 20 fiye da yadda ya saba, kuma hakan ya jinkirta samar da kayayyakin kiwon lafiya na wata hudu zuwa shida.
WHO ta kuma yi gargadin cewa hakan zai haifar da karancin kayan kariya na mutum a duniya, wanda zai sanya ma'aikatan lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen kayayyaki na Australiya da ke sayarwa zuwa China da ake kira daigo (wanda ke nufin mutum daga wajen China yana sayayya ga wani a cikin China).
Wannan motsi ya haifar da karancin madarar jarirai a wasu manyan kantunan da gwamnatin Australiya ta dakatar daga baya. An sami karancin abinci a yankuna biyu, musamman a arewacin Italiya da Wuhan, sakamakon karuwar cutar COVID-19, sakamakon karuwar bukatar kayayyakin abinci.
A cikin wani sabon labarin da aka wallafa a shafinsa na Twitter, ya ce: "A cikin shekaru biyar da suka gabata, kasar Sin ta haramta cin abinci da kuma sayar da kayayyaki masu muhimmanci.
A cewar wakilan masana'antar, farashin kayayyaki na iya tashi, duk da cewa ba a samu raguwa mai yawa ba a bangaren samar da kayayyakin gona a arewacin Italiya.
A birnin Wuhan, jami'an gwamnatin kasar Sin sun saki wasu 'yan gudun hijira domin tabbatar da cewa jama'a na samun isasshen abinci.
A Italiya, akwai irin wannan dokar da ta tanadi bukatun masu samar da abinci don adana kayan aiki a irin wannan gaggawa.
A ranar 16 ga Maris, wata kafa ta yada labarai ta ruwaito cewa tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020, inda yawan tallace-tallace ya fadi da kashi 20.5%, sakamakon matakan da gwamnati ta dauka don rage yaduwar kwayar cutar.
Babban yankin China babban cibiyar tattalin arziki da masana'antu ne, kuma ana ganin yana daga cikin manyan barazanar da ke kawo rikice-rikice ga tattalin arzikin duniya yayin barkewar cutar.
Agatha Damarez, na Sashen Kula da Tattalin Arziki, ya yi hasashen cewa kasuwannin za su ci gaba da zama marasa tabbas har sai an samu cikakken hoto game da sakamakon.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin koma bayan tattalin arziki kan ci gaban duniya a lokacin annobar ta yanzu zai iya zama mafi muni fiye da lokacin barkewar cutar SARS ta 2002-2004.
Wani kwararre a Jami'ar Washington a St. Louis ya kiyasta cewa tasirin da ke tattare da sarkar samar da kayayyaki ta duniya ya kai dala biliyan 300 da zai iya wucewa na tsawon shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur ta OPEC ta ce farashin man fetur ya yi kasala a shekarar 2019 sakamakon karancin bukatar da kasar Sin ke yi.
Kasuwancin hannun jari na duniya ya fadi a ranar 24 ga Fabrairu, saboda karuwar yawan masu kamuwa da cutar COVID-19 a wajen China.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da kamuwa da cutar coronavirus, alamun kasuwancin Amurka, gami da NASDAQ-100, S&amp;P 500 da Dow Jones Industrial Average sun faɗi, wanda ya zama mafi girman koma baya tun 2008. Dow ya faɗi 1,191, mafi girma a cikin rana ɗaya tun bayan rikicin 2007-08.
A karshen mako, dukkan alamun sun fadi da sama da kashi 10.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya amince da kimanta bashin kasar Sin, amma ya ci gaba da kasancewa mai nuna rashin amincewa.
Kasuwar hannayen jari ta sake faduwa a ranar 16 ga Maris a cikin mafi girman koma baya a tarihinta saboda tsoron cutar coronavirus.
A cewarsa, "Muna da tabbacin cewa za mu iya samun ci gaba a cikin tattalin arzikinmu.
Wani masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da kuma kasashen da suka dauki matakan gaggawa a kan lokaci.
A cikin shekarar 2008, an samu karuwar masu amfani da fasahar zamani a duniya.
Wannan shi ne daya daga cikin bangarorin da suka fi fama da matsalar saboda takunkumin tafiye-tafiye, rufe wuraren taruwar jama'a da wuraren yawon bude ido da kuma shawarwarin gwamnatoci game da duk wani tafiya a duniya.
Sakamakon haka, yawancin kamfanonin jiragen sama, ciki har da British Airways, China Eastern Airlines da kuma Quantum Airlines sun soke zirga-zirgar su saboda karancin fasinjoji, kuma kamfanin jirgin sama na Flybe na Burtaniya ya fadi.
A halin yanzu, an samu karuwar masu amfani da jirgin ruwa a fadin duniya.
An rufe tashoshin jirgin kasa da kuma tashar jirgin sama da dama a garin.
Cutar ta barke ne a daidai lokacin da ake babban lokacin yawon bude ido na Chunyun, wanda ke da alaƙa da hutun Sabuwar Shekarar China.
Kamfanoni masu zaman kansu sun rufe shagunan su da wuraren jan hankalin masu yawon bude ido kamar Hong Kong Disneyland da Shanghai Disneyland, kuma gwamnatocin kasa da na cikin gida sun soke manyan bukukuwa da dama, gami da bikin sabuwar shekara na shekara-shekara.
An rufe yawancin bukukuwan Sabuwar Shekara ta Sin da wuraren yawon bude ido a Beijing don kauce wa taron jama'a, ciki har da Birnin da aka haramta da kuma wuraren ibada na gargajiya.
Hukumomi a larduna 24 daga cikin 31 da birane da yankuna na karamar hukuma sun tsawaita hutun Sabuwar Shekara zuwa ranar 10 ga Fabrairu, kuma sun umarci yawancin wuraren kasuwanci da kada su sake buɗewa kafin wannan ranar.
A cikin wannan yanki, an samu kashi 80 cikin dari na GDP da kashi 90 cikin dari na fitarwa.
A Hong Kong, an sanar da matakin gaggawa na rigakafin cutar, rufe makarantu da soke bukukuwan bikin Sabuwar Shekara har zuwa watan Maris. Rage lokutan buɗewa da rufe shaguna na ɗan lokaci ya shafi rawar da 'yan kasuwa ke takawa a duniya.
A Turai da Latin Amurka, yawan masu zuwa kantin sayar da kayayyaki ya ragu da kashi 40 cikin dari.
Masu sayar da kayayyaki a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50 zuwa 60 cikin dari.
Bugu da ƙari, yawan masu tafiya zuwa cibiyoyin cin kasuwa ya ragu da kashi 43 cikin dari a watan Maris, daga 33 zuwa 43 a watan Fabrairu.
Masu cibiyoyin kasuwanci a duk duniya suna amfani da wasu hanyoyin da suka dace, kamar ƙara tsabtace gidaje, sanya na'urorin zafin jiki da kuma duba yawan zafin jiki na masu siye, da kuma soke abubuwan da suka faru. Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka ta kiyasta cewa yawan mutanen da ke cikin matsanancin talauci a Latin Amurka zai iya tashi daga miliyan 14 zuwa miliyan 22 bayan barkewar cutar.
A watan Janairu da Fabrairun 2020, mutane kusan miliyan biyar sun rasa ayyukansu a China yayin da cutar ta yi ta bulla a Wuhan.
A watan Maris na shekarar 2020, sama da 'yan Amurka 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
The Federal Reserve Bank of Saint Louis ta kiyasta cewa cutar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka, kuma rashin aikin yi na iya kaiwa kashi 32%. Kullewa a Indiya ya bar ma'aikata sama da miliyan goma na Indiya (ma'aikata masu aiki na yau da kullun). Binciken da Jami'ar Angus Reid ta yi ya gano cewa kashi 44% na gidajen Kanada ma ba su da aiki.
A watan Maris, ma'aikata miliyan hudu a Faransa sun samu alawus din rashin aikin yi na wucin gadi, kuma ma'aikata miliyan daya a Birtaniya sun samu tallafin bashi. Kimanin kamfanoni miliyan biyar a Jamus sun tura ma'aikatansu zuwa ga tsarin aikin wucin gadi na gwamnati da ake kira Kurzarbeit.
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, ya ce: "A cikin wannan shekara, mutane da yawa sun yi aiki a cikin gidajen abinci.
Cutar ta yi mummunan tasiri ga fannonin fasaha da al'adun gargajiya, tare da tasirin ayyukan kungiyar da ma'aikata da masu zaman kansu a duk duniya.
Kungiyoyin da ke cikin bangaren fasaha da al'adu sun ci gaba da kokarin cimma burinsu na samar da damar al'adu ga jama'a, tabbatar da lafiyar ma'aikatansu da jama'a a kowane lokaci, da kuma tallafawa masu fasaha a duk lokacin da zasu iya (wanda gwamnati ke tallafawa).
A watan Maris na 2020, jami'o'i, gidajen tarihi, dakunan karatu, wuraren shakatawa da sauran wuraren al'adu a duk duniya sun rufe har abada, tare da sokewa ko dakatar da baje kolin su, bukukuwa da wasanni.
A sakamakon haka, an yi ƙoƙari sosai don samar da sabis na madadin ta hanyar dandamali na dijital. Wani sabon abu kuma mai saurin haɓaka saboda cutar shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewar jama'a kamar kide kide da wake-wake da nunin fage, taron fasaha da nunin salon.
A cikin watan Agusta, Vatican ta sanar da cewa ta soke halartar mako na tashin Yesu daga matattu a Roma, wanda aka yi a karshen makon Asabar na azumi, don tunawa da wahalar Almasihu.
A wasu wurare, ana gaya wa Kiristoci tsofaffi su zauna a gida maimakon su halarci ibadarsu ta ranar Lahadi. Wasu suna zuwa coci da mota don su yi ibada, wasu kuma suna yin addu'o'i a kan rediyo ko kuma a talabijin.
An rufe majami'un Roman Katolika da wuraren ibada da wuraren ibada na Kirista, an soke sauran ayyukan addini, kuma an haramta taruwa a majami'u, masallatai, majami'u, majami'u da kuma gidajen ibada.
A ranar Juma'a, ma'aikatar lafiya ta Iran ta haramta yin sallar Juma'a a yankunan da cutar ta shafa, sannan ta rufe masallatai. Saudiyya ta hana masu bautar da kasashen waje shiga kasar, tare da hana 'yan kasarsu shiga wuraren ibada a Makka da Madina.
Wannan annoba ta haifar da dakatarwa mafi girma a kalandar wasanni na duniya tun bayan yakin duniya na biyu.
An soke ko dakatar da yawancin manyan wasannin wasanni, gami da gasar zakarun Turai ta 2019-20, Premier League ta 2019-20, UEFA Euro 2020, kakar NBA ta 2019-20 da kakar NHL ta 2019-20.
Shirye-shiryen wasannin Olympics na bazara na 2020 da aka shirya fara a ƙarshen Yuli an dakatar da su saboda cutar. Kwamitin Olympics na Duniya ya ba da sanarwar ranar 24 ga Maris cewa za a iya shirya don yin su a wata rana bayan 2020 ba daga baya ba fiye da bazara ta 2021.
Wannan lamarin ya sa yawancin masu caca suka koma caca ta yanar gizo, kuma a cewar shafukan caca ta yanar gizo, sun sami sabon rajista sosai. Har ila yau, masana'antar nishaɗi ma ta sami tasiri, kuma yawancin ƙungiyoyi sun dakatar ko soke yawon shakatawa.
A lokacin da ake gudanar da zanga-zangar, an yi zanga-zangar ne a kan wani babban gidan wasan kwaikwayo da ke birnin New York.
Wasu masu fasaha sun nemi hanyoyin da za su ci gaba da aiki da kuma raba ayyukansu a kan Intanet maimakon tsarin wasan kwaikwayo na gargajiya, kamar ƙirƙirar raye-raye na raye-raye ko abubuwan da suka shafi yanar gizo inda masu fasaha ke yin aiki, rarraba su kuma aika ayyukansu ga masu sauraro.
A cikin wannan rikici, mutane da yawa sun fi son raha da kuma jan hankali, kuma yawancin abubuwan da ke tattare da cutar coronavirus sun bayyana a yanar gizo.
Tun bayan barkewar cutar COVID-19, an sami raguwar rashin sanin yakamata, karuwar tsoron baki da kuma nuna wariyar launin fata a cikin ƙasashen Turai, Amurka da sauran ƙasashe da ke da asalin Gabashin Asiya da kuma yankunan da cutar ta shafa.
Wannan mummunan yanayi na tsoro, shakka da ƙiyayya ya zama ruwan dare gama gari a ƙasashe da yawa, musamman a Turai, Gabashin Asiya da Arewacin Amurka da Asiya Pacific.
Rahotanni sun nuna cewa tun daga watan Fabrairu (wanda har yanzu shine mafi yawan lokuta a kasar Sin), akwai wasu ra'ayoyin wariyar launin fata da aka bayyana a cikin kungiyoyi daban-daban a duniya, cewa Sinawa sun cancanci cutar ko kuma suna fuskantar hukunci.
A wasu kasashen Afirka ma, an samu karuwar nuna adawa da kasar Sin.
A cikin wata sanarwa da aka fitar a watan Janairun, 'yan jarida sun ce, "Mutanen da ke zaune a Wuhan da Hubei sun yi fama da nuna bambanci a matsayin masu neman mafaka a kasarsu".
A cikin watan Agusta, an samu karin mutane da yawa da ke fama da cutar a China.
Rashin tabbas da tsoro ya tashi a cikin mutane a Italiya, ƙasa ta farko da ta fara fuskantar mummunan yaduwar COVID-19 a Turai, bayan ci gaban yaduwar cutar zuwa sabbin ƙasashe da ba a kamu da cutar ba. 'Yan ƙasa daga wasu ƙasashe, gami da Malaysia, New Zealand, Singapore da Koriya ta Kudu, sun fara sanya hannu kan buƙatun hana shiga Sinawa a ƙoƙarin dakatar da yaduwar cutar zuwa ƙasashensu.
A Japan, amfani da hashtag #ChineseDontComeToJapan ya zama ruwan dare gama gari.
Wasu 'yan Asiya, ciki har da Sinawa a Burtaniya da Amurka sun ba da rahoton karuwar nuna bambanci da nuna wariya da kuma cin zarafi.
Masu sukar kasar Sin sun ce wannan kalma ta nuna kyamar kasar Sin da kuma wariyar launin fata ne saboda shugaban Amurka Donald Trump ya kira cutar coronavirus da sunan "Covid-19".
A cikin watan Nuwamba, 'yan tawaye sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da kuma kasashen waje da ke gudun hijira daga Wuhan zuwa Novosibirsk.
Dalibai da ke karatu a manyan biranen Indiya daga arewa maso gabashin Indiya da ke da iyaka da China sun ce cutar coronavirus ta kawo cikas.
A wani shafinsa na Twitter, Dilys Ghosh, shugaban jam'iyyar Bharatiya Janata a jihar West Bengal, ya ce "Allah ne ya rama wa Sinawa saboda sun lalata muhalli".
A lokacin da ake fama da annobar, tsoron da ake nunawa ga mutanen da ba Sinawa ba da ke zaune a kasar Sin da kuma nuna wariyar launin fata sun haifar da zanga-zangar kashe-kashe, inda aka bayyana 'yan kasashen waje a matsayin wuraren zubar da shara da kuma yin amfani da su.
Yawancin jaridu da ke da biyan kuɗi na kowane wata sun cire aikace-aikacen da ke ba da damar karanta duk ko wasu labaran cutar coronavirus.
A cikin wata sanarwa da aka wallafa a watan Janairun, masana kimiyya sun ce, "Muna da wasu abubuwa da yawa da za mu iya yi don mu magance cutar.
Wasu masana kimiyya sun zaɓi raba sakamakon su akan sabobin shirye-shiryen buga littattafai a bioRxiv.
Cutar cututtuka mai yawa - cuta mai saurin kamuwa da cuta ta hanyar cutar da ke faruwa. Sau da yawa yana da banbanci a cikin girmansa ko hanyar yaduwarsa.
A cikin wannan labarin, za mu tattauna game da yadda za a magance cututtuka a duniya.
Ƙari ga haka, a wasu wurare a duniya, mutane suna mutuwa don cututtuka.
Kasuwancin dabbobi da kuma cututtuka da dabbobi suke kawowa ga mutane - Ƙalubalen Lafiya da ke tattare da sayar da dabbobi
Gwaje-gwajen dakin gwaje-gwaje na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma SARS-CoV-2 sun haɗa da hanyoyin gano cutar da kuma gano ƙwayoyin cuta da aka samar don amsawa ga kamuwa da cuta.
RT-PCR, wanda ke ganowa da kuma gwada RNA na coronavirus, ya tabbatar da kasancewar cutar a cikin marasa lafiya.
An tsara wannan gwajin musamman don gano RNA na SARS-CoV-2.
A cikin watan Agusta, cutar ta kamu da cutar a cikin kasar Sin.
Ana iya amfani da ganowar ƙwayoyin cuta (plasma) don duka ganewar asali da kuma ganowa a cikin al'umma.
Gwaje-gwajen rigakafi suna nuna yawan mutanen da suka kamu da cutar, gami da waɗanda ke da alamun rashin lafiya da ba za a iya ba da rahoto ba ko waɗanda ba su da alamun cutar.
Sakamakon wannan gwajin zai iya tantance ainihin mutuwar cutar da kuma matakan samun rigakafi a cikin al'umma.
A watan Maris na 2020, babu wata ƙasa da ta iya ba da tabbataccen bayani game da yaduwar cutar a tsakanin jama'arsu saboda ƙuntatawa a cikin gwaji.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma yawan gwaje-gwajen da aka yi ya bambanta sosai a ƙasashe da yawa.
Wannan bambancin yana da alama yana da tasiri sosai a kan yawan mutuwar marasa lafiya da aka gano, wanda aka kiyasta a wasu ƙasashe.
Ta amfani da real-time polymerase chain reverse transcription chemistry (rRT-PCR), gwajin zai iya gwadawa akan samfurori na numfashi da aka rufe ta hanyoyi daban-daban, ciki har da samfurin ƙuƙwalwar hanci ko samfurin leɓen ruwa.
A cikin 'yan sa'o'i kadan, sakamakon zai iya zuwa cikin kwanaki biyu.
Gwajin RT-PCR da aka yi da ƙwayoyin cuta na makogwaro yana da tabbaci ne kawai a farkon makon cutar.
Daga nan, kwayar cutar ta ɓace a cikin makogwaro yayin da take ci gaba da ninkawa a cikin huhu.
A mako na biyu, masu kamuwa da cutar da aka gwada za su iya amfani da kayan samfurin ta hanyar bututun da aka sha daga cikin zurfin numfashi ko kuma tari (sneeze).
A watan Janairun 2020, an gudanar da gwajin PCR na farko ta amfani da maganin sake juyawa na sarkar polymerase (rRT-PCR) a cikin lokaci na ainihi a Charité a Berlin, wanda ya zama tushen kayan gwaji 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
UnitNet kuma ya ƙaddamar da gwaji a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya ƙaddamar da saitin bincike na PCR-based SARS-CoV-2 a ranar 28 ga Janairu, 2020.
A cikin China, BGI Group ita ce kamfani na farko da ta sami amincewar gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta Sin don kayan gwajin SARS-CoV-2 na PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) sun rarraba takaddun ganowa na RT-PCR na ainihin lokacin 2019-novel coronavirus (2019-nCoV) zuwa dakunan gwaje-gwaje na kiwon lafiyar jama'a ta hanyar tushen amsawa na duniya.
Sakamakon ba ya rufe duka sakamakon gwajin da aka yi a cikin tsofaffin kayan gwaji, ɗaya daga cikin gwaje-gwaje uku na kwayoyin halitta da aka yi da sinadarai da gwajin kwalban kwalba a CDC a Atlanta.
An ba da izinin gwaje-gwaje na jihohi da na gida don fara gwaji, ba tare da yanke shawarar ko za a iya karɓar gwaje-gwaje tare da waɗannan abubuwa biyu ba har zuwa 28 ga Fabrairu 2020.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa. Dakunan gwaje-gwaje na kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa gwajin RT-PCR na COVID-19 yana samuwa a duk ƙasar.
Quest Diagnostics ta yi hakan don samar da gwajin COVID-19 a duk ƙasar a ranar 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar. Tarin samfuran nama da ayyukan aiki dole ne su kasance daidai da takamaiman buƙatun CDC.
Cibiyar Nazarin Kwayoyin cuta da Kimiyyar Kimiyyar Halitta (VECTOR) ce ta haɓaka gwajin COVID-19 a Rasha.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta haɓaka gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwaji guda ɗaya wanda za a iya yin sa'o'i 3.5 a cikin adadi mai yawa, wanda zai ba da damar yin gwaje-gwaje 4,128 a cikin awanni 24 a kan inji ɗaya.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga Abbott Laboratories don gwada tsarin m2000 na Abbott. A baya, FDA ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
Cepheid ya kuma sami izinin amfani da gaggawa (EUA) daga FDA don gwaji na minti 45 a ranar 21 ga Maris, 2020.
Hukumar ta FDA ta amince da gwajin da ke amfani da fasahar fadada isomalt nucleic acid maimakon PCR.
Wannan ba ya buƙatar haɗuwa da yanayin zafin jiki mai canzawa, amma wannan hanyar tana ba da sakamako mai kyau a cikin minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu, akwai kimanin 18,000 na irin wannan na'urar a Amurka, kuma Abbott yana fatan haɓaka samarwa don yin gwaje-gwaje 50,000 a rana. Taiwan tana haɓaka gwajin da ke amfani da ƙwayoyin cuta na monoclonal wanda ke haɗa ƙwayoyin nucleic acid (N protein) na sabon coronavirus, wanda ake tsammanin zai ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin mura mai sauri.
Wani bita na harshen Maris 2020 ya nuna cewa hotunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Abubuwan da aka saba gani a CT sun hada da ganowa da yawa na gilashin ƙasa da ke da yawa a bangarorin biyu tare da rarrabawa a baya, ba tare da daidaituwa a gefen gefen ba.
A cewar wani mai bincike, cutar ta ci gaba da zama sanadiyyar rashin lafiyar da ke tattare da cutar.
Ko da yake wani bincike ya kwatanta PCR da CT a Wuhan, asalin cutar ta duniya, yana da ƙarancin daidaito, bayyanar ta na da yawa tare da sauran cututtukan huhu da ci gaban cutar, kuma CT tana da ƙwarewa sosai fiye da PCR.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don gwajin COVID-19 ko a matsayin gwajin farko don gano cutar. A watan Maris na 2020, CDC ta ba da shawarar PCR azaman gwajin farko.
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta shine samar da ƙwayoyin cuta, gami da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta, nazarin rigakafi, da kuma tantance mutane a cikin mutane 7 da suka wuce daga farkon bayyanar cututtuka. Ana iya yin gwaje-gwaje a cibiyoyin bincike na cibiyar sadarwa (CLT) ko wuraren gwaji na kulawa (PoCT).
Ko da yake tsarin sarrafa kansa mai ƙarfi a yawancin dakunan gwaje-gwaje na likita zai iya yin waɗannan gwaje-gwajen, ingancinsu ya dogara da yawan sakamakon kowane tsarin.
Ana iya amfani da samfuran ƙwayoyin halitta don nazarin amsar tsarin garkuwar jiki, amma ana amfani da su a cikin samfurin jini a cikin sassan jiki don CLT.
Ana samun samfurin jini guda ɗaya don PoCT ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin cirewa kafin a yi gwajin.A ranar 26 ga Maris, 2020, FDA ta gano sunayen ƙungiyoyi 29 da suka sanar da hukumar kuma yanzu za su iya rarraba gwajin rigakafin su.
A ƙarshen Maris 2020, Cibiyar Nazarin Magunguna ta Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin ƙungiyar Turai don na'urorin gwajin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan jini.
Wannan gwajin yana da sauri fiye da gwajin RNA na PCR na yau da kullun saboda yana iya gwada ɗaruruwan samfurori a cikin awanni.
Yawancin lokaci ana iya gano ƙwayoyin cuta a cikin kwanaki 14 bayan kamuwa da cuta. A farkon watan Afrilu, Burtaniya ta gano cewa kayan gwajin ƙwayoyin cuta da ta saya ba sa aiki yadda ya kamata.
A cikin Hong Kong, an kafa tsarin da ke sa marasa lafiya da ake zargi su zauna a gida.  Ma'aikatar gaggawa za ta ba da mai haƙuri bututun gilashin da aka yi amfani da shi don yin amfani da shi.  Suna yayyafa yau da kullun a ciki kuma za a dawo da sakamakon ba da daɗewa ba.
Cibiyoyin gwajin motoci suna ba Koriya ta Kudu damar samun gwaji mafi sauri da kuma mafi girma fiye da kowace ƙasa. A Jamus, Kungiyar Likitocin Kula da Lafiya ta Kasa ta ce a ranar 2 ga Maris za su iya yin gwajin fam 12,000 a rana a cikin keɓewa, sama da gwaje-gwaje 10,700 a makon da ya gabata.
A lokacin da likita ya rubuta gwajin, kamfanin inshora yana ɗaukar farashin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwaje-gwaje 160,000 a mako.
A ranar 19 ga watan Maris, an fara gwajin motar a birane da dama.
A ranar 26 ga Maris, 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda sakamakon cutar ne kawai aka bayyana.
Binciken farko na dakin gwaje-gwaje ya nuna alamun SARS-CoV-2 33,491 (6.9%) da kuma jimlar samfuran 483,295 a cikin makon kalandar 12/2020, gami da makon 12/2020. Masu bincike a asibitocin Technion da Rambam a Isra'ila sun gano hanyar da za su iya gwada samfuran daga marasa lafiya 64 a lokaci guda.
Wani samfurin da aka tsara cikin kwanaki biyar, wanda mai kula da BGI, Wang Jian ya tsara, ya nuna cewa idan ba a yi amfani da wannan ƙarfin gwajin ba, ƙwayoyin cuta a Hubei na iya ƙaruwa da kashi 47 cikin ɗari, kuma farashin kula da keɓewar keɓaɓɓu na iya ninka sau biyu.
Nan da nan, dakin gwaje-gwaje na Wuhan da asibitocin Shenzhen, Tianjin, Beijing, da Shanghai Huayan sun bi sahun a birane 12 a duk faɗin ƙasar Sin.
A ranar 4 ga Maris, 2020, gwajin yau da kullun yana da gwaje-gwaje 50,000 a rana. Buɗe tushen, da yawa an tsara su da kyau, kuma na'urar da Origami Assays ta samar tana amfani da gwaje-gwaje 93 kawai don gwada samfuran ƙwayoyin cuta na marasa lafiya 1,122 don COVID-19 a rana ɗaya.
A watan Maris, ƙarancin kayan gwaji da ƙarancin kayan aiki ya haifar da ƙarancin gwaji a cikin EU, UK da Amurka.
Wannan ya sa wasu marubuta suka gano hanyoyin shirya samfurin wanda ya hada da dumama samfurin na tsawon mintuna 5 a zafin jiki 98 °C (208 °F) don samar da kwayoyin halittar RNA don ƙarin gwaji.A ranar 31 ga Maris, Hadaddiyar Daular Larabawa (UAE) ta ba da sanarwar cewa yanzu tana gwada ƙarin mutane don cutar coronavirus fiye da kowace ƙasa a cikin jama'arta, kuma tana kan hanyar isa ga mafi yawan jama'arta.
Wannan ya hada da yin amfani da hanyar wucewa da kuma sayen maganin cutar a kan mutane da yawa ta hanyar rukuni na 42 da BGI (Huo-Yan bincike na gaggawa a cikin dakunan gwaje-gwaje a kasar Sin).
An gina dakin gwaje-gwaje na kwanaki 14 kuma yana gudanar da gwaje-gwaje na RT-PCR dubun dubatan a kowace rana, wanda shine dakin gwaje-gwaje na farko a duniya da ke aiki a wannan sikelin a wajen China.
An gano hanyoyin gwaji daban-daban na asibiti da ke nufin abubuwa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta samar da kayan haɗin Jamusanci don kayan aikinta ga ƙasashe masu ƙarancin kuɗi ba tare da buƙatar albarkatu don samar da kansu ba.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka sun jinkirta samun gwaji a Amurka kuma ba a samu ba har zuwa 28 ga Janairu. A farkon barkewar cutar, China da Amurka suna da damuwa game da amincin kayan gwaji, kuma waɗannan ƙasashe da Ostiraliya ba su samar da isasshen kayan gwaji da gwaje-gwaje da ƙwararrun likitocin kiwon lafiya suka ba da shawarar ba har sai an biya buƙatun.
A wani bangare kuma, masana sun ce samun gwajin da ake samu a Koriya ta Kudu zai taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina wasu manyan dakunan gwaje-gwaje a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara hanzarta shirye-shiryen gwaji a matsayin hanya mafi kyau don rage yaduwar cutar COVID-19. Babban bukatar gwaji saboda yaduwar kwayar cutar ya haifar da ɗaruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, wanda ke haifar da katsewa da kayan aiki da magunguna.
A watan Maris na 2020, kasar Sin ta ba da rahoton matsalar daidaito a cikin kayan gwajin ta.
A Amurka, kayan gwajin da CDC ta samar sun ƙunshi "kurakurai" da yawa. Gwamnati ta cire shingen da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co., Ltd. na China, amma ta gano cewa sakamakon bai dace ba.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin ingancin samfurin ko kuma rashin amfani da kayan aikin gwaji.
Ma'aikatar ta ce za ta sake kwashe kayan bincike da ke samar da sakamakon da ba daidai ba kuma za ta maye gurbin su da kayan bincike da kamfanin Shenzhen Bioeasy na fasahar kere kere ya bayar. Kashi 80 cikin dari na kayan bincike na kasar Sin da Jamhuriyar Czech ta saya sun samar da sakamakon da ba daidai ba. Slovakia ta sayi kayan bincike miliyan 1.2 daga kasar Sin kuma an gano cewa ba su samar da sakamako daidai ba.
A watan Afrilu na shekarar 2020, Birtaniya ta sayi kayan gwaji miliyan 3.5 daga China, amma a farkon watan Afrilu na 2020, ta bayyana cewa ba za a iya amfani da su ba.
Gwaje-gwaje da ke kewaye da kewaye da masu cutar da kuma gano duk wanda ya taɓa saduwa da masu cutar SARS-CoV-2 sun ba da sakamako mai kyau.
Masu bincike da ke aiki a birnin Vo na Italiya, wanda ya zama farkon mutuwar COVID-19 a Italiya, sun keɓe kusan mazauna 3,400 na birnin na kwanaki 10, suna gwada kowa sau biyu.
Kimanin rabin mutanen da aka gwada sun nuna babu wata alama, kuma duk wadanda aka gano suna cikin keɓewa.
Wannan ya sa ya yiwu a kawar da sabbin cututtuka ta hanyar hana tafiye-tafiye.
Ta hanyar bin diddigin lamba, gwaji, da keɓewa, cutar coronavirus ta 2020 a Singapore ta bayyana cewa tana yaduwa a hankali fiye da sauran ƙasashe masu tasowa, ba tare da buƙatar ƙuntata gidajen abinci da wuraren sayar da kayayyaki ba.
An soke wasu abubuwan da aka yi a ranar 28 ga watan Maris, kuma an umarci mazauna birnin su zauna a gidajensu, amma an sake bude makarantu a ranar 23 ga watan Maris, bayan kammala hutun makaranta.
Wasu kasashe da dama sun aiwatar da tsauraran matakan kula da hulɗa, ƙuntatawa na balaguro na cikin gida, da keɓewa yayin gudanar da annobar, amma ba su aiwatar da takunkumi ba: misali Iceland da Koriya ta Kudu.
Wani bincike ya gano cewa ƙasashe da ke yin gwaji sosai suna da ƙananan mace-mace idan aka kwatanta da yawan mutuwar, watakila saboda sun fi iya gano alamun rashin lafiya ko babu su.
WHO ta ba da shawarar cewa ƙasashe marasa gwajin gwaji da dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙwarewa kawai a kan COVID-19 su aika da samfuran farko guda biyar da aka gano da kuma samfuran farko guda goma marasa COVID-19 zuwa ɗayan dakunan gwaje-gwaje 16 da WHO ta ba da shawarar don tabbatar da gwaji.
A cikin labaran 16 na Index, bakwai suna cikin Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka, ɗaya a Ostiraliya.
A cikin teburin da ke ƙasa, kashi  na masu cutar da gwajin da aka yi sun shafi manufofin gwajin ƙasar.
Idan aka kwatanta da ƙasashe da ke gwada duk 'yan ƙasa ko da sun nuna alamun cutar, ƙasar da ke gwada waɗanda ke asibiti kawai za ta sami kashi mafi girma na gwajin, kodayake dukansu daidai ne a wasu fannoni.
Wanke hannu, wanda aka fi sani da tsabtace hannu, shine aikin wanke hannuwan mutum don kawar da datti, mai, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
Wanke hannuwanka da sabulu a wasu lokuta masu mahimmanci a cikin rana yana hana kamuwa da cututtuka da yawa kamar zawo da mura, waɗanda ke yaduwa ta hanyar hanyar fitsari-bakin.
Idan mutane ba su wanke hannayensu kafin su taɓa idanunsu, hanci da bakinsu (mucous membranes), zasu iya kamuwa da cututtukan numfashi kamar su sanyi na yau da kullun ko mura.
A wasu lokutan da suka fi muhimmanci a wanke hannuwanka da sabulu da ruwa a rana, sun hada da kafin ka je gidan wanka da bayan ka canza tufafin jaririn ko kuma bayan ka canza diapers, kafin ka ciyar da jaririn, kafin ka shirya abinci ko kuma kafin ka yi amfani da nama, kifi ko naman alade.
Idan babu sabulu da ruwa, zaka iya wanke hannayenka da toka.
Kafin, yayin da, da kuma bayan shirya abinci.
Kafin da kuma bayan kula da wani mai matsalar ji.
Bayan canza diapers ko wanke jariri bayan ya je bayan gida.
Bayan yin sneeze, tari ko sneeze
Ko kuma idan ka taɓa dabba, abincin dabba, ko ƙazamin dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace muhalli da ke tattare da ayyukan likita.
Wanke hannu kafin a ba da magani ko kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu a likitanci shine kawar da ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta masu sa cututtuka) da sinadarai masu haɗari ko masu sa cututtuka a hannu.
Wannan al'ada tana da mahimmanci ga masu sarrafa abinci ko masu aiki a fannin kiwon lafiya, amma yana da mahimmanci ga jama'a gaba ɗaya.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka, hana kamuwa da cuta da ke haifar da zawo, da rage kamuwa da cututtukan numfashi.
A sakamakon haka, yawan haihuwa a gida ya ragu.
Wani bincike da aka yi a 2013 ya nuna cewa inganta al'adar wanke hannu na iya haifar da ɗan ci gaba a cikin ci gaban yara a cikin shekaru biyar.
A cikin ƙasashe masu tasowa, yawancin mutuwar yara suna da alaƙa da cututtukan numfashi da na ciki, waɗanda za a iya rage su ta hanyar sauya halayen sauƙaƙe kamar sabulu da wanke hannu.
Wannan aikin mai sauki zai iya rage mutuwar kusan kashi 50 cikin dari.
Matakan da ke inganta wanke hannu na iya rage yawan cutar zazzabi da kashi ɗaya bisa uku, wanda ya yi daidai da samar da ruwa mai tsafta a yankunan da ke da ƙarancin kuɗi.
48% na raguwa a lokutan zawo na iya kasancewa tare da sabulu da wanke hannu. Sabulu da wanke hannu sune hanya mafi inganci da rahusa don hana zawo da cututtukan cututtukan numfashi (ARI) kamar yadda ake yi a gidaje, makarantu, da al'ummomi a duniya.
Babban cutar sankarar bargo, ARI, ita ce babbar hanyar mutuwar yara 'yan kasa da shekaru biyar, inda kusan yara miliyan 1.8 ke mutuwa a kowace shekara.
A kowace shekara, kusan yara miliyan 3.5 ke mutuwa sakamakon ciwon sanyin jiki da ciwon huhu.
UNICEF ta ce, yin wanke hannu da sabulu kafin cin abinci da bayan bayan bayan gida zai ceci rayuka fiye da allurar rigakafi ko magani, kuma zai rage mutuwar cututtukan hanji da kusan kashi ɗaya cikin huɗu, da kuma mutuwar cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana amfani da wanke hannu tare da sauran hanyoyin wanke ruwa a matsayin wani ɓangare na shirye-shiryen ruwa, najasa da tsabtace muhalli (WASH).
Wanke hannu yana hana cututtukan da ke tattare da taɓawa ta jiki.
Wani sakamako mai illa na wanke hannu shine cewa yawan wanke hannu yana haifar da lalacewar fata ta hanyar bushewar fata.
Wani binciken Danish na 2012 ya gano cewa wanke hannu da yawa na iya haifar da ɓarna na fata wanda aka fi sani da itching, haushi ko ciwon hannu a cikin ma'aikatan kiwon lafiya.
Wanke hannu da yawa wani abu ne da ake kira OCD.
Akwai lokuta biyar masu mahimmanci a rana don wanke hannaye da sabulu don rage yaduwar cututtukan daga bayan gida zuwa baki: bayan amfani da bayan gida (yin wanka da hawan igiya), bayan wanke jaririn (canza tufafi), kafin ciyar da jariri, kafin cin abinci da kuma shirya abinci ko kuma kafin aiki da nama, kifi ko kaji.
Sauran lokutan da ya kamata a yi amfani da maganin wanke hannu don hana kamuwa da cuta sun haɗa da kafin da bayan warkar da rauni ko rauni, bayan hancin, tari ko hancin hanci, bayan taɓa ƙazamar dabba ko dabba, da kuma bayan sarrafa shara.
A yawancin ƙasashe, sabulu da wanke hannu ba su da yawa.
A cikin 2015, binciken wanke hannu a cikin ƙasashe 54 ya nuna cewa kusan kashi 38.7% na gidaje suna yin wanke hannu da sabulu. Binciken na 2014 ya nuna cewa Saudi Arabia tana da mafi girma tare da kashi 97%, Amurka tana da matsakaici tare da kashi 77%, kuma China tana da mafi ƙasƙanci tare da kashi 23%.
A cikin shirin kula da lafiya na musamman da Ma'aikatar Ilimi ta aiwatar a Philippines, wani misali ne na babban aiki na inganta lafiyar yara da ilimi.
A cikin wannan shirin, an yi amfani da maganin shafawa na yau da kullum, wanda ya hada da wanke hannayenka da sabulu sau biyu a shekara.
An kuma samu nasarar aiwatar da shi a Indonesia.
A cikin wannan yanayin, ana iya amfani da sabulu mai tsabta a cikin ruwa ko kuma a cikin wanki don kawar da ƙwayoyin cuta daga fata.
Babban aikin sabulu da sabulu foda shine rage shingen narkewa da haɓaka narkewa.
Man fetur da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa, saboda haka wankewa da ruwa kawai ba zai iya tsabtace fata ba.
A cikin wannan labarin, an bayyana cewa, a cikin shekaru da yawa, mutane da yawa sun yi watsi da ruwa.
Saboda yanayin sake amfani da shi, sabulu mai wuya yana riƙe da ƙwayoyin cuta da aka samu daga amfani da shi.
Wasu nazarin da suka yi nazarin kamuwa da kwayar cuta daga sabulu mai dauke da cuta sun kammala cewa kamuwa da cuta ba zai yiwu ba idan an kawar da kwayoyin cuta ta hanyar sabulu.
Cibiyar Kula da Cututtuka ta Amurka ta bada shawarar cewa a kara amfani da sabulu da ba a amfani da shi wajen wanke hannu.
A cikin wata sanarwa da aka fitar a watan Agusta, an bayyana cewa, an yi amfani da sabulu mai kashe kwayoyin cuta a cikin wasu wuraren da ake amfani da su a kasar.
A yau, babu wata hujja da ta nuna cewa ana amfani da maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta da aka zaba don cutar da ke haifar da maganin rigakafi.
Amma sabulu masu kashe kwayoyin cuta sun hada da wasu magungunan kashe kwayoyin cuta kamar trichloroquine, wanda ke dauke da wasu nau'ikan kwayoyin cuta masu jurewa.
Saboda haka, sabulu da ke kashe ƙwayoyin cuta ba zai iya yin tasiri kamar yadda aka ce ba, ko da ba a zaɓi juriya ga maganin rigakafi ba.
Baya ga kayan shafawa da kayan kare fata, yawancin girke-girke na zamani suna amfani da acid (acetic acid, ascorbic acid, lactic acid) a matsayin masu daidaita pH, benzoic acid mai kashe kwayoyin cuta, da sauran kayan shafawa na fata (wanda zai iya haɗawa da man shafawa, bitamin, foda, da man kayan lambu). A cikin cikakken bincike na Jami'ar Kiwon Lafiyar Jama'a ta Oregon, wani bincike ya nuna cewa sabulu mai amfani da kwayoyin cuta kamar su sabulu na kashe kwayoyin cuta yana da tasiri mai tasiri wajen hana cututtuka da kuma kawar da cututtuka.
Mai wanke hannu mai kyau ba ya zafi sosai don kashe kwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 ° C).
Amma ruwan sabulu mai dumi ya fi ruwan sabulu mai sanyi amfani wajen kawar da ƙazanta da ƙwayoyin cuta.
A wani labarin da aka wallafa a shafin yanar gizonmu na Twitter, wani mutum mai suna John F. Kennedy ya ce: "A lokacin da nake aiki a matsayin mai kula da gidaje, ina ganin cewa ba na son in yi amfani da ruwa mai zafi a kan hannu na.
Sanitizer na hannu ko sanitizer na hannu sanitizer ne na hannu wanda ba ya amfani da ruwa.
A ƙarshen shekarun 1990s da farkon karni na 21, masu tsabtace hannu na alkali (wanda aka fi sani da alkoki na alkoki, maganin shafawa, ko wanke hannu) sun zama sananne.
Yawancin su suna amfani da isopropane alcohol ko ethanol a matsayin gel ta amfani da carbomer (polymer acrylic acid) a matsayin mai sanyaya, ko kuma a matsayin ruwa mai laushi kamar glycine ko kumfa don sauƙaƙe amfani da kuma rage tasirin bushewar alcohol.
Bugu da ƙari, ƙara hydrogen peroxide mai rauni yana ƙara haɓaka aikin antibacterial. Ruwan wanke hannu wanda ke da akalla 60 zuwa 95% na alcohol yana da tasiri wajen kashe ƙwayoyin cuta.
Magungunan tsabtace jiki na barasa suna kashe kwayoyin cuta, kwayoyin cuta masu yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, syphilis, RSV, rhinovirus, syphilis, mura, da hepatitis) da fungi.
Sanitizer na alcohol mai dauke da kashi 70% na barasa yana kashe kwayoyin cuta a hannu 99.97% (rage 3.5 l ko rage 35 decibels) bayan 30 seconds bayan shafawa, kuma yana kashe kwayoyin cuta a hannu daga 99.99% zuwa 99.999% (rage 4 zuwa 5 l) bayan minti daya bayan shafawa. Sanitizers na hannu suna da tasiri ga yawancin kwayoyin cuta kuma basu da tasiri ga wasu ƙwayoyin cuta.
Don cutar da ke haifar da cututtukan hanji da cututtukan hanji, mafi yawan su ne norovirus ko Norovirus, maganin wanke hannu na barasa ba shi da tasiri sosai. Don kiyaye hannayen biyu cikin danshi ko tsabtace su, ana iya amfani da maganin wanke hannu ko shafawa tare da maganin wanke hannu mai yalwa da giya.
Ana shafawa a gaban hannu da bayan hannu da kuma tsakanin yatsunsu da kuma saman yatsunsu na kimanin 30 seconds har sai ruwa, kumfa ko jam sun bushe.
A cikin wannan yanayin, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma, a cikin takalma.
Ana amfani da wannan magani don ƙarin amfani da shi saboda sauƙin amfani da kuma saurin kashe ƙwayoyin cuta. Ko da yake, idan akwai, wankewa da sabulu da ruwa bai kamata ya maye gurbin wankewa ba.
Idan ba a ƙara kayan shafawa da / ko masu tsabtace fata ba, yawan amfani da maganin wanke hannu na barasa na iya haifar da bushewar fata.
Ƙarin kayan shafawa da / ko wasu kayan shafawa na fata a cikin samfurin magani na iya rage ko kawar da tasirin bushewar fata na mura.
A cikin gwaji na asibiti, maganin wanke hannu na barasa wanda ke dauke da kayan shafawa na fata yana haifar da ƙwanƙwasawa da bushewar fata fiye da sabulu ko kayan shafawa na antibacterial.
Rashin lafiyar jiki na jiki, ƙarancin fata, bayyanar cututtuka na ƙwayar cuta, ko kuma rashin amsawa ga barasa ko kuma damuwa da kayan shafawa na barasa.
Abin sha'awa shi ne, akwai ƙananan cututtukan fata da ke haifar da rashin jin daɗi idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da tasiri, masu tsabtace hannu ba tare da ruwa ba ba sa kawar da kwayoyin halitta, amma suna kashe hannuwan hannu.
Wannan saboda sanannun kayan wanke hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan saboda sun ci gaba da kasancewa a hannu.
Ingancin maganin wanke hannu mara shan barasa ya dogara da yawancin sinadarai da tsarin hadawa, kuma a tarihi ya kasance ƙasa da tasirin maganin wanke hannu da maganin wanke hannu.
A cikin 'yan kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna daidaito da kuma aikin antibacterial mai haɗuwa idan aka yi amfani da su, ba kamar alkaloids ba, wanda zai iya haifar da raguwa a cikin tasiri saboda yawan halayen fata na gaba bayan sake amfani.
A cikin wasu yankunan da ke da karancin kudi, mutane da yawa ba za su iya sayen sabulu ba, saboda haka suna amfani da toka ko ƙasa a madadin.
Gishiri ko ƙasa suna da amfani fiye da ruwa, amma ba su da amfani kamar sabulu.
Abin damuwa shi ne, idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta, za su iya ƙara yaduwar cutar maimakon rage cutar.
Kamar sabulu, toka tana kashe kwayoyin cuta domin idan ta zo cikin ruwa, tana samar da ruwa mai laushi.
A lokacin da ba a samun sabulu, WHO ta ba da shawarar yin amfani da toka da yashi maimakon sabulu.
Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar yin wanke hannu da kyau ta haɗa da waɗannan matakan:
Ka yi amfani da ruwan zafi ko ruwan sanyi don ka yi wanka.
Saboda haka, idan babu bambancin zafin jiki, ana ba da shawarar amfani da ruwa mai gudana kawai saboda wanke hannu na tsaye na iya zama mai ƙazanta.
Ku shafa hannayenku da sabulu da ke tsakanin hannayenku da kuma ƙarƙashin ƙusoshinku har sai kun cire kumfa.
A cewar wani bincike, sabulu yana kawar da kwayoyin cuta daga fata, kuma idan mutane suka wanke hannayensu da sabulu maimakon ruwa, hakan na nuna cewa suna bukatar su wanke hannayensu sosai.
Ka shafa kuma ka wanke na akalla dakika 20.
Fitar da fata yana sa a yi taɓawa don kawar da ƙwayoyin cuta a fata, amma yin hakan na dogon lokaci zai iya sa a kawar da ƙwayoyin cuta.
Ka wanke wanka da ruwa mai gudana.
Wanke hannu a cikin wanki na iya sake gurbata hannayenku.
Ka goge shi da tawul mai tsabta ko kuma ka bar shi ya bushe a iska.
Hannun da ke cikin ruwa da kuma hannayen da ke cikin ruwa suna da saukin kamuwa da ƙwayoyin cuta. Mafi yawan lokuta, wurare da ke cikin hannu, wuyan hannu, tsakanin yatsunsu, da kuma ƙarƙashin kusoshi.
A cikin wannan labarin, an bayyana cewa, a cikin 'yan shekarun da suka gabata, an yi amfani da takalma na takalma don yin ado da takalma.
Don kiyaye hannayenku bushe, ana ba da shawarar sau da yawa shafawa da ke sanya fata ta bushe. Drying fata na iya haifar da lalacewar fata, wanda hakan ke kara hadarin kamuwa da cuta.
"Misali: zubar da ruwa daga busassun kwalba tare da ramuka masu girman da suka dace da kuma / ko amfani da toka idan ya cancanta a ƙasashe masu tasowa, yana ba da zaɓuɓɓuka masu tsada don yin wanke hannu a wurare inda ba a samun ruwan famfo da / ko sabulu. Akwai mafita mai tanadi na ruwa a cikin yanayin da akwai iyakantaccen samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa) kamar 'tap tap' da sauran zaɓuɓɓuka masu arha. "
A cikin wannan aikin, ana amfani da igiya don jan ruwa mai kyau kuma a cikin ƙafafun kafa ana zuba ruwa mai yawa a kan sabulu da hannu.
Ko da yake bushewa hannu mai inganci wani muhimmin bangare ne na tsabtace hannu, har yanzu ana muhawara game da mafi ingancin bushewa a wuraren wanka na jama'a.
Yawancin bincike sun nuna cewa takardar tawul tana da tsabta fiye da na'urar busar hannu ta lantarki da ake samu a dakunan wanka da yawa.
A shekara ta 2008, wani bincike da aka yi da aka ba da kuɗin European Tissue Symposium, wani kamfanin samar da takarda, da Jami'ar Westminster, London, ya yi don kwatanta matakan tsabtace takarda, bushewar hannu da na'urorin bushewa na zamani.
Bayan wanke hannu da bushewa da iska, yawan kwayoyin cuta a yatsunsu ya karu da kashi 194 cikin dari kuma a wuyan hannu ya karu da kashi 254 cikin dari.
A matsakaici, bushewar busassun iska ya kara yawan kwayoyin cuta a yatsunsu da kashi 42% da kuma hannayen hannu da kashi 15%.
Bayan wanke hannuwanku da kuma goge su da tawul ɗin takarda, jimlar adadin kwayoyin cuta ya ragu da kashi 76 cikin ɗari a kan yatsunsu da kashi 77 cikin ɗari a kan dabino. Masana kimiyya sun gudanar da gwaje-gwaje don tabbatar da ko kowane irin bushewa yana da yiwuwar yaduwa ga sauran masu amfani da bayan gida da kuma yanayin bayan gida.
Wannan na'urar bushewa ta hannu tana da karfin iska mai saurin gudu na 180 m/s (650 km/h, 400 mph) kuma tana iya busa hannayen da kuma kwayoyin halitta daga cikin na'urar zuwa sauran masu amfani da bayan gida da kuma kewaye da bayan gida har zuwa mita 2.
A cikin wannan yanayin, ana iya amfani da na'urar bushewa ta hannu mai zafi don yada kwayoyin cuta a cikin nisan mita 0.25 daga na'urar bushewa.
A cikin binciken da TÜV Produkt und Umwelt ta gudanar a shekara ta 2005, an kimanta hanyoyi daban-daban na bushewa hannu.
Bayan an bushe hannayenmu, mun ga waɗannan canje-canje a cikin adadin kwayoyin:
Akwai masu kera na'urorin bushe hannu da yawa, kuma ana iya kwatanta bushe hannu da na'urorin bushe hannu da takarda.
Sanitizer na wanke hannu yana da amfani sosai a lokacin tafiya inda babu sabulu da ruwa.
Aƙalla kashi 60 cikin ɗari na maganin wanke hannu da ke ɗauke da barasa.
Wanke hannu ya zama al'ada a cikin likitanci tun lokacin da likitan Hungary Ignaz Semmelweis ya gano tasirin wanke hannu don hana cututtuka a cikin asibiti (a cikin 1846).
A halin yanzu, akwai wasu na'urorin lantarki da ke ba da amsa don faɗakar da ma'aikatan asibiti idan sun manta da wanke hannayensu.
Wani bincike ya gano cewa amfani da su na rage yawan kamuwa da cutar.
Wanke hannu na likita yana nufin shafa kowane ɓangaren hannayenka da sabulu da ruwa mai laushi na akalla dakika 15 ko amfani da gel a kan fata.
Ya kamata a shafa hannaye da yatsunsu.
Idan akwai lalacewar da ke ƙarƙashin kusoshi, ana iya amfani da goga don cire su.
A cikin wannan yanayin, yana da muhimmanci a cire ruwa daga hannayenka kuma a goge shi da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul don rufe ruwa (kuma buɗe kofar fita idan ya cancanta).
Wannan yana hana sake kamuwa da cutar daga waɗannan fuskokin zuwa hannayenku.
"Manufar wanke hannu a cikin ma'aikatar kiwon lafiya ita ce kawar da ƙwayoyin cuta masu cutarwa ("ƙwayoyin cuta") da hana su yaduwa".
Ko da yake rashin wanke hannu ya kasance matakin da ba a yarda da shi a yawancin wuraren kiwon lafiya ba, jaridar New England Medical Journal ta rubuta cewa likitoci da ma'aikatan jinya da yawa sun manta da wanke hannayensu kafin su taɓa marasa lafiya, wanda ke haifar da kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran ayyuka masu sauki na iya rage yawan kamuwa da cutar sankarar bargo da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta rarraba takarda da ke nuna yadda ake wanke hannu da kuma shafa hannu a bangarorin kiwon lafiya.
Har ila yau, akwai wasu ka'idojin tsabtace hannu na kungiyar a shafin yanar gizon don jama'a su yi sharhi.
Wannan shi ne abin da Whitby et al.
Idan ana bukatar bin doka, injunan sayar da kayayyaki na iya auna da kuma tabbatar da tsabtace hannu.
"Kungiyar Lafiya ta Duniya ta bayyana" lokatai biyar "don wanke hannu:
Bayan haɗuwa da jini ko ruwa na ciki
Kafin aikin da ba shi da ƙwayoyin cuta, da kuma
Bayan kula da mai haƙuri. Baya ga sabulu, ƙarin sinadarai masu kashe kwayoyin cuta (sabo mai dauke da magunguna ko sabulu mai hana ƙwayoyin cuta) ana ba da ƙarin aikin kashe ƙwayoyin cuta ga maganin wanke hannu.
Irin wannan kashewa yana da mahimmanci a yanayin da kwayoyin cuta masu amfani da maganin rigakafi suka fi yawa ko kafin aikin tiyata. Don yin aikin tiyata, ana buƙatar bututun ruwa mai rufewa wanda ba ya taɓa hannun mutum yayin wanke hannunsa, wankewa da chlorine ko iodine, tawul mai tsabta don wankewa da bushewa, da kuma goga mai tsabta don shafawa, da kuma ƙarin kayan aikin tsabtace tsabta don tsabtace ƙarƙashin kusoshi.
Ya kamata a cire duk kayan kwalliya.
Wannan aikin yana buƙatar wanke hannu da yatsun hannu har zuwa gwiwoyi, yawanci na minti 2-6.
Ba ma bukatar dogon lokaci na tsagewa (minti 10)
Idan ka wanke hannuwanka, kada ka bar ruwa ya sake gudana a kan yatsunsu.
Bayan ka gama wanke hannuwanka, ka bushe hannayenka da mayafi mai tsabta kuma ka saka tufafin tiyata.
Don rage yaduwar kwayoyin cuta, ya kamata a wanke hannu kafin da kuma bayan kula da marasa lafiya da maganin wanke hannu.
An gano cewa mafi kyawun fa'idar wanke hannu don kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututut
Wankewa da sabulu mai tsabta yana da kashi uku cikin ɗari na kamuwa da cututtukan ƙwayoyin cuta a cikin abinci, idan aka kwatanta da wankewa da sabulu mai ƙwayoyin cuta. Goge hannu da sabulu mai ƙwayoyin cuta yana rage yawan ƙwayoyin cuta da kashi 26% idan aka kwatanta da wanke hannu da sabulu mai ƙwayoyin cuta na matsakaici na 30 seconds.
Wanke hannu da sabulu da ruwa ya fi inganci fiye da masu tsabtace hannu na barasa don rage yawan kwayar cutar H1N1 influenza A da ke haifar da cutar kwayar cuta (Clostridium difficile) daga hannaye. Ayyuka don inganta tsabtace hannu a wuraren kiwon lafiya na iya haɗawa da ilimantar da ma'aikata game da wanke hannu, haɓaka wadatar kayan tsabtace hannu na barasa, da kuma faɗakar da ma'aikata ta hanyar rubutu da magana.
A wasu wurare, akwai wasu hanyoyin da za a iya amfani da su don magance matsalar rashin lafiya.
A kasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai sauki da kuma muhimmanci wajen inganta lafiya da abinci mai gina jiki.
Amma rashin isasshen ruwa, sabulu ko na'urar wanke hannu a gidaje, makarantu da wuraren aiki na iya zama wata matsala ga al'adar wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, akwai wasu hanyoyin da ba su da tsada don gina wanka, amma wanka a kusa da gidajen wanka na jama'a ko na masu zaman kansu ba su da yawa.
Amma, rashin wanke hannu yana da nasaba da al'ada fiye da rashin sabulu ko ruwa.
Taron gayyata da kuma ba da shawara game da wanke hannu da sabulu na iya tasiri kan yanke shawara, da fadakar da mutane game da fa'idodin wanke hannu, da kuma haifar da canjin halaye na dogon lokaci ga mutane da yawa.
Wannan ya nuna cewa akwai wasu abubuwa da yawa da za a iya yi a wannan duniyar.
Binciken da aka yi na nazarin nazarin 70 ya gano cewa hanyoyin ayyukan al'umma a cikin ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi (LMICs) suna da tasiri wajen haɓaka al'adun wanke hannu, yayin da kamfen ɗin tallan kafofin watsa labarun ba su da tasiri sosai. Misali na inganta al'adun wanke hannu a makarantu shine tsarin taurari uku na UNICEF wanda ke ƙarfafa ɗalibai suyi amfani da hanyoyi masu sauƙi da araha don sa hannuwan su wanke da sabulu, a tsakanin sauran abubuwan da za a yi don tsabtace kansu.
Idan aka cika mafi ƙarancin ƙa'idodi, makarantu na iya canzawa daga tauraro ɗaya zuwa mafi yawan taurari uku.
Ginin wuraren wanke hannu na iya zama wani bangare na motsi na inganta wanke hannu da nufin rage cututtuka da mutuwar yara.
Ranar Tattoo ta Duniya misali ne na kamfen na wayar da kan jama'a da ke ƙoƙarin cimma canjin halaye. A sakamakon annobar coronavirus ta 2019-20, UNICEF ta ba da shawarar amfani da emojis na tatto.
Wasu nazarin sun yi la'akari da rage yawan farashin wanke hannu a kasashe masu tasowa ta hanyar kawar da DALY.
Amma wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi rahusa idan aka kwatanta da sauran hanyoyin wankewa da ruwa.
Maganin wanke hannu don lafiyar ɗan adam, musamman ga mutane a cikin yanayi mai rauni kamar jarirai ko sojoji da aka ji rauni a asibiti, shine farkon wanda likitan Hungary Ignaz Semmelweis da ke aiki a Vienna, Austria, da kuma Ingilishi Florence Nightingale suka fara ganewa a tsakiyar karni na 19th.
A lokacin, mutane da yawa sun yi imani cewa cututtukan suna haifar da ƙanshin ƙanshi da ake kira miasmas.
A cikin shekarun 1980, barkewar cututtukan cututtukan abinci da cututtukan cututtukan kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su ƙara ƙarfafa tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar cututtuka.
Cutar mura ta 2009 da COVID-19 a 2020 sun haifar da ƙarin sani a ƙasashe da yawa game da mahimmancin wanke hannu da sabulu don kare kanku daga waɗannan cututtukan.
Alal misali, a Jamus, ana rataye allon tallace-tallace da ke nuna yadda za a wanke hannu a kusa da dakunan wanka na gine-ginen gwamnati da na ofisoshi da kuma wuraren wanke hannu a filayen jirgin sama.
A cikin wata sanarwa da aka wallafa a shafinta na Twitter, ta ce: "Abin da ya sa muke wanke hannuwanmu shi ne don nuna cewa ba ma son mu dauki alhakin wani abu ko kuma mu yi wani abu da ya shafi wani abu".
Wannan kalmar ta samo asali ne daga littafin Matta inda mai ridda Bilatus ya wanke hannunsa don yanke shawarar giciye Ubangijinsa Yesu, amma ya zama sanannen sanarwa a wasu yankunan Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta sosai a ƙoƙarin kawar da hoton da ke nuna cewa ta nuna laifinta game da laifuffukan da ta aikata da kuma laifin da ta sa mijinta ya aikata.
Mutane suna wanke hannayensu sau da yawa fiye da sauran mutane bayan tunawa ko tunanin yin lalata da su, kuma suna daraja kayan wanke hannu.
Bugu da kari, mutanen da suke da irin wannan hankali kuma daga baya aka basu damar wanke hannayensu ba sa yawan shiga wasu ayyukan tsaftacewa kamar aikin sa kai.
Addinai suna ba da shawarar wanke hannu don tsabtace jiki da dalilai na al'ada. Wanke hannu da ruwa kawai ba tare da sabulu ba shine hanyar al'ada ta al'ada da aka yi amfani da ita a cikin addinai da yawa, ciki har da Baha'i, Hindu, Tawila da Na'tila Yadiyyah na Yahudanci, Labaro a cikin Kristanci, da Wadhu a cikin Islama. Addinai suna ba da shawarar wanke hannuwan jiki, musamman bayan wasu ayyuka.
A cikin addinin Hindu, Yahudanci da kuma addinin Islama, an koyar da wanke hannu bayan amfani da bayan gida.
A wasu addinai, kamar Hindu, Buddha, Sikh, Yahudanci da Musulunci, ana wanke hannu kafin da kuma bayan cin abinci.
Gudanar da haɗarin aiki don COVID-19.
Kula da haɗarin aiki don COVID-19 ya haɗa da amfani da matakan aminci da kiwon lafiya na wurin aiki don kula da haɗarin don hana cutar coronavirus 2019 (COVID-19).
Kulawa mai kyau a wurin aiki ya dogara da yanayin aiki da manufofin aiki, gwajin haɗari na tushen haɗari, tsananin cutar a cikin al'umma, da abubuwan da ke haifar da haɗari ga kowane ma'aikaci wanda ke da damar kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA), wuraren aiki da ke da haɗuwa da mutane da yawa da kuma abokan aiki kaɗan suna da ƙananan haɗarin kamuwa da cuta, kuma ana ba da shawarar matakan rigakafin kamuwa da cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan ba su da lafiya, kiyaye ƙa'idodin hanci da tari, da tsaftacewa da kuma tsabtace yanayin aiki a kai a kai.
Ayyukan da ke buƙatar hulɗa sau da yawa ko kusanci da mutanen da ba a sani ba ko waɗanda ake zargi da cutar COVID-19, da kuma waɗanda ke iya kamuwa da cutar ta hanyar yaduwar jama'a ko tafiya ta ƙasa da ƙasa, suma suna cikin haɗarin kamuwa da cuta.
Wannan ya hada da ma'aikata da ke fuskantar jama'a, kamar makarantu, wuraren aiki masu yawan jama'a, da kuma wasu wuraren da ake sayar da kayayyaki da yawa.
Baya ga ayyukan rigakafin kamuwa da cuta na asali, kula da haɗari ga wannan rukunin ya haɗa da yin amfani da matattarar iska mai inganci, kayan kariya na hancin, da kayan kariya na mutum idan kuna hulɗa da mutumin da ke da COVID-19.
Ma'aikatan kiwon lafiya ko masu aikin asibiti waɗanda ke fuskantar haɗarin haɗari tare da mutanen da aka sani ko ake zargi da COVID-19 suna da haɗarin haɗari sosai idan ma'aikata ne waɗanda ke tattara ko sarrafa samfuran nama daga mutanen da aka sani ko ake zargi da COVID-19 ko kuma masu aiki da ƙwayoyin iska.
Kula da haɗari da suka dace ga waɗannan ma'aikata sun haɗa da sarrafa aikin injiniya, kamar ɗakunan da ke da iska mai kyau da iska mai kyau da kuma kayan aikin kare kai wanda ya dace da burin aikin.
Cutar COVID-19 tana da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin rashin aikin yi saboda rashin lafiya, kula da wasu, ko kuma tsoron yiwuwar kamuwa da cutar.
A cikin wannan yanayin, ana iya samun sauye-sauye a cikin tsarin kasuwanci da kuma yadda ake samun kaya (misali: cin kasuwa a lokacin da ba a cikin taron jama'a, ko kuma tsarin isar da kaya zuwa gida ko sabis na sayen kaya).
A ƙarshe, ana iya dakatar da jigilar kayayyaki daga yankunan da ke da mummunan kamuwa da COVID-19. Shirye-shiryen rigakafin cututtukan cututtuka da shirye-shiryen magance su na iya zama jagora don ayyukan rigakafi.
Ayyukan suna magance ma'aunin tushen haɗari, gami da haɗarin da ke tattare da wurare daban-daban da burin kasuwanci, haɗarin da ke tasowa daga tsarin gida da al'umma, da kuma abubuwan haɗarin kowane ma'aikaci kamar tsufa ko yanayin rashin lafiya mai tsanani.
A cikin wannan labarin, an bayyana cewa, a cikin shekaru shida da suka gabata, an yi wa mutane fiye da dubu biyu da ke fama da cutar a cikin yankunan da ke kusa da su.
Shirye-shiryen shirye-shirye da shirye-shiryen amsawa ga cutar ya kamata su bi shawarwari na kasa ko na gida.
Manufofin da aka tsara don amsawa ga cutar sun haɗa da rage kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke cikin haɗarin haɗari ga abubuwan da ke faruwa na kiwon lafiya, kiyaye ayyukan kasuwanci da rage tasirin tasirin tasirin tasirin hanyoyin samar da su ga sauran kamfanoni.
A cikin al'ummomin da ake aiki, tsananin cutar yana shafar yadda ake amsawa.
Matsayi na kula da haɗari tsari ne da aka yi amfani da shi a cikin lafiyar da lafiyar wurin aiki don rarraba matakan kula da haɗari bisa ga inganci.
Idan ba za a iya kawar da haɗarin COVID-19 ba, iko mafi inganci shine sarrafa injiniya, sannan sarrafawa, kuma a ƙarshe, kayan kariya na mutum.
Wannan tsari na aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikaci ba, kuma yana iya zama mafita mafi tsada don aiwatarwa.
Gudanar da gudanarwa yana da canji a cikin manufofin aiki ko hanyoyin da ma'aikaci ko mai aiki ke buƙatar yin aiki.
Kayan kariya na mutum (PPE) ba su da tasiri kamar sarrafa injiniya da sarrafawa, amma suna taimakawa wajen kare wasu abubuwan da ke tattare da su.
Dukkanin nau'ikan PPE dole ne a zaɓa bisa haɗarin ma'aikaci a wurin aiki, sanya su daidai (misali, inhalers), saka su daidai, bincika su akai-akai, kula da su, musanya su kamar yadda ya cancanta, cire su da kyau, tsabtace su, kuma adana su ko zubar da su ba tare da yin amfani da su ba.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da mafi ƙarancin haɗarin aiki ga jama'a da sauran abokan aiki.
Ayyukan rigakafin cututtukan cututtuka na asali da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannuwanku akai-akai da kuma a hankali, ƙarfafa ma'aikata su zauna a gida idan rana ta yi mummunan aiki, rufe tari da hancin, bayar da kayan aiki da kuma kiyaye kayan sharar gida, shirya don sadarwa mai nisa ko raba wuraren aiki idan ya cancanta, hana ma'aikata amfani da wasu shirye-shirye da kayan aiki, da ci gaba da kiyaye tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace
Gano da kuma ware mutanen da ke cikin haɗari da wuri yana da mahimmanci don kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) suna ba da shawarar ma'aikata da ke da alamun rashin lafiyar numfashi na kwatsam su zauna a gida har tsawon sa'o'i 24 ba tare da zazzabi, zazzabi, ko wasu alamun cutar ba, ba tare da shan maganin mura ko magungunan da ke canza alamun cutar ba, kuma su ba da damar sauƙaƙe manufofin hutu na rashin lafiya, don ma'aikata su iya kula da dangin da ke rashin lafiya a gida kuma su sanar da ma'aikata manufofin.
A cewar OSHA, aiki tare da mutane masu cutar COVID-19 ko kuma waɗanda ake zargi da kamuwa da cutar ko kuma waɗanda ba a san su ba a cikin nisan mita shida (1.8) ko kuma kusanci da su yana cikin matsakaicin haɗarin kamuwa da cutar. Koyaya, mai yiwuwa mutumin ya sami SARS-CoV-2 saboda kwanan nan ya yi tafiya zuwa wani yanki inda cutar ta COVID-19 ke yaduwa ko kuma saboda akwai yaduwar cutar a cikin yankin da ke kewaye da kasuwancin da mai cutar ke aiki.
Waɗannan sun haɗa da ma'aikata waɗanda ke da haɗuwa da jama'a gaba ɗaya, kamar makarantu, yanayin aiki mai cunkoson jama'a, da wasu wuraren sayar da kayayyaki masu tsada. Hakanan, sarrafawa na injiniya don ƙungiyoyin haɗari masu haɗari sun haɗa da sanya kayan aikin laser masu inganci sosai, haɓaka ƙarar iska, sanya shinge na zahiri kamar masu toshe filastik masu tsalle-tsalle da sanya rigunan motsa jiki don sabis na abokin ciniki, rarraba kayan aiki na yau da kullun, ɗaukar kayan aiki na yau da kullun, ɗaukar kayan aiki na gaggawa, da kuma ƙarin shirye-shirye don ƙungiyoyin haɗari.
A cikin wannan rukuni na masu haɗari, ma'aikata ba sa bukatar yin amfani da na'urar numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da nisantar da mara lafiya daga wasu a nesa da ƙafa 6, sanya ma'aikacin jirgin sama don kula da mara lafiya, da ba da abin rufe fuska ga mara lafiya lokacin da yake tari ko hancinsa, ko sanya takardar takarda a kan hanci da bakinsa.
Masu aikin jirgin sama ya kamata su sa safar hannu na likita na yau da kullun lokacin da suke hulɗa da fuskoki masu haɗari ko ruwan jiki, ko kuma suna kula da fasinjoji marasa lafiya. Idan za su iya, ma'aikatan jirgin sama ya kamata su sa ƙarin kayan kariya na mutum idan sun lura da alamun zazzabi ko tari mai ɗumi ko wahalar numfashi a cikin fasinjojin da ke rashin lafiya.
A zubar da safofin hannu da sauran kayan da aka yi amfani da su a cikin jakar kariya ta kwayar halitta, sannan a tsabtace da kuma bincika fuskokin da suka taɓa su. Ana aiwatar da matakan kula da haɗari, gami da jinkirta tafiya lokacin rashin lafiya, da keɓe kai, da sanar da cibiyar kiwon lafiya ta jirgin ruwa nan da nan idan zazzabi da sauran alamun cutar suka bayyana yayin tafiya.
A cikin keɓewar, mafi kyawun yanayin kula da lafiya shine a cikin ɗaki. CDC ta ba da shawarar rufe makarantu da wuraren kula da yara na ɗan lokaci don tsabtace ko kashe ƙwayoyin cuta idan wani mai cutar ya taɓa shiga harabar makarantar, ko yana yaduwa a cikin al'umma ko a'a.
Lokacin da akwai ƙananan zuwa matsakaiciyar yaduwar jama'a, ana iya aiwatar da dabarun nisantar da jama'a kamar tafiye-tafiye, tarurruka, da sauran manyan tarurruka kamar yin motsa jiki ko darussan waƙa, ko cin abinci a cikin kofi, ƙara sarari tsakanin teburin, jinkirta jadawalin don hana rikicewar lokacin isowa da tashi, iyakance baƙi marasa mahimmanci, da amfani da wuraren ofisoshin kiwon lafiya na musamman don yara masu alamun mura.
A lokacin da akwai yawan kamuwa da cutar a cikin al'ummomin asali, ana iya yin la'akari da fadada lokacin makaranta tare da dabarun nisantar zamantakewa. CDC ta ƙaddara cewa akwai ƙananan haɗarin lafiya na mutum ga jami'in tilasta yin aiki wanda ke gudanar da ayyukan yau da kullun.
Ana ba da shawarar cewa jami'an tilasta yin doka waɗanda ke fuskantar haɗuwa da tabbataccen ko wanda ake zargi da kamuwa da COVID-19 su bi irin wannan jagororin kamar masu aikin gaggawa, gami da amfani da kayan kariya na mutum.
Idan akwai wata matsala a lokacin haɗari, ma'aikata su tsabtace da kuma kashe ƙwayoyin cuta tare da tsabtace gida ko kuma tsabtace tufafi kafin sake amfani da bel ɗin su da kayan aiki, sannan su bi ƙa'idodin da aka tsara don shigarwa da zubar da PPE da kuma shigarwa da cire tufafi.
OSHA ta sanya wasu ma'aikatan kiwon lafiya da masu aikin tiyata a cikin manyan ko manyan haɗarin haɗari.
Ayyukan da ke da haɗari sun haɗa da samar da kiwon lafiya, samarwa, dakin gwaje-gwaje, da ma'aikatan jigilar kayayyaki na likita waɗanda ke fuskantar haɗari tare da waɗanda aka sani ko ake zargi da COVID 19.
Idan ma'aikata suka tattara ko kuma suka yi aiki da wasu mutane da aka sani ko ake zargi da cutar COVID-19 kuma suka sanya ƙananan ƙwayoyin cuta a kansu, haɗarin yana da girma sosai.
A wasu lokuta, ana iya yin amfani da kwayoyin halitta don yin amfani da su a cikin iska, kamar su, yin amfani da su a cikin iska, yin amfani da su don rage tari, yin amfani da su don yin amfani da su a cikin iska, yin amfani da su don yin amfani da su a cikin iska, yin amfani da su don yin amfani da su a cikin iska, da kuma yin amfani da su don yin amfani da su a cikin iska.
Ayyukan asibiti masu haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin marasa lafiya waɗanda aka sani ko ake zargin suna da COVID-19 a lokacin mutuwarsu. Suna da haɗari sosai idan sun yi binciken kirji. Bugu da ƙari, suna yin ƙarin aikin injiniya don sarrafa waɗannan rukunin haɗari, gami da ayyukan da ke haifar da ƙwayoyin iska, gami da keɓaɓɓun ɗakuna don marasa lafiya da aka sani ko ake zargin suna da COVID-19.
Wannan tsarin na musamman na iska mai iska mai iska yana da kyau ga wasu wuraren kiwon lafiya da kuma wuraren da aka yi amfani da su.
Ana iya sarrafa samfurori na nama tare da matakan kariya na 3 na biosafety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar keɓe marasa lafiya da ke zuwa a wuraren keɓewa dangane da yiwuwar ko rashin kamuwa da COVID-19. OSHA ta ba da shawarar sanya kayan aikin numfashi ga waɗanda ke da cutar SARS-CoV-2 ko waɗanda aka yi zargin sun kamu da cutar, da kuma marasa lafiya da ke aiki a cikin nisan ƙafa 6 ko waɗanda ke yin wasu hanyoyin kamar shigar da iska a cikin iska.
A cikin Amurka, ana buƙatar yin amfani da N95 mai tace fuska mai numfashi ko mafi kyau a cikin mahallin cikakken shirin kariya na numfashi wanda ya haɗa da gwajin motsa jiki, horo da gwajin likita.
Sauran abin rufe fuska tare da kayan aiki na numfashi na iya ba da ƙarin kariya kuma ya sa ma'aikaci ya sami kwanciyar hankali. COVID-19 cuta ce ta hanyar numfashi maimakon yaduwa ta hanyar ruwa na jiki, don haka WHO ba ta ba da shawarar rufewa gaba ɗaya ba.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa ma'aikatan da ke yin gwajin a wuraren shiga su yi amfani da abin rufe fuska na tiyata kawai.
WHO ta ba da shawarar cewa duk wanda ya ɗauki samfurin ƙwayoyin numfashi daga marasa lafiya na COVID-19, masu kula da marasa lafiya, ko masu jigilar kaya, ya sa abin rufe fuska na tiyata, tabarau na iyo ko abin rufe fuska, riguna da safar hannu ba tare da samar da ƙananan abubuwa masu iska ba.
Idan kuna yin aikin da ke haifar da ƙananan ƙwayoyin iska, za ku iya maye gurbin abin rufe fuska na N95 ko FFP2 na numfashi maimakon abin rufe fuska na tiyata.
Saboda karancin kayan PPE a duniya, WHO ta ba da shawarar rage yawan bukatun PPE ta hanyar amfani da fasahar sadarwa ta zamani don samar da kiwon lafiya (telemedicine), amfani da shinge na zahiri kamar windows, barin masu shiga cikin ɗaki don kula da kai tsaye ga marasa lafiya na COVID-19, amfani da PPE kawai don ayyukan da suka dace, ba tare da cire na'urar numfashi ɗaya ba yayin kula da mutane da yawa tare da cutar guda, ƙarfafa amfani da kayan aikin PPE don ci gaba da sa ido da daidaitawa da kuma amfani da abin rufe fuska ga waɗanda ba su da alamun cutar.
Daga: Katherine Maher, Shugabar Gidauniyar Wikimedia
Ko: Dukan ma'aikatan Gidauniyar Wikimedia
Labari: [Covid-19] Rage matsaloli da shirya don nan gaba
Ranar aikawa: 14 ga Maris, 2020 00:24 UTC
Ba tare da lasisi ba. CC0.
A wannan watan, mutane suna neman matsayin su na musamman.
Yaduwar COVID-19 ya nuna yadda muke da alaƙa da juna da kuma alhakin juna a duk duniya.
Ko da yake ba mu da al'ada ga waɗannan ƙalubalen, mun san cewa mafi kyawun amsarmu ta dogara ne akan jinƙai, haɗin kai a duk duniya, da kuma tsarin al'umma wanda ke cikin zuciyar wannan ƙungiyar.
A cikin imel, kira da sakonnin rubutu, halin jaruntaka da kulawa da na gani tsakanin dukkan abokan aikina ya nuna cewa su mutane ne masu daraja da suka yi sa'ar yin aiki tare.
Ba zan iya yin farin ciki da alfahari da ku ba.
A makon da ya gabata, wani ya ce ya yaba musu kan aikin da suke yi.
Suna tunatar da duniya yadda wannan ke nufin canza Wikipedia a yanzu da kuma yadda wannan alama ce mai ƙarfi ga wannan muhimmiyar hanya don ci gaba da kasancewa akan layi kuma kowa ya samu.
Ko kun farka a wurin aiki, ko abokan aikinku sun ba ku, ko kuma al'ummarku ta kasance cikin aminci, aikinku ya sa hakan ya yiwu.
A yau, duniya tana bukatar bayanan da Wikipedia ke bayarwa fiye da kowane lokaci.
Wannan lokaci ne wanda ba kawai abin da muke yi ba amma yadda muke yi zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, za mu yi wasu canje-canje masu mahimmanci a yadda za mu yi aiki tare, daga mako mai zuwa.
(Matta 28:19, 20) Idan muka yi hakan, za mu kasance da tabbaci cewa Jehobah yana ƙaunarmu.
Kamar yadda Robyn ta ambata a baya, ƙungiyar C-team ta tattauna game da tsarin su da jadawalin su na kwanaki da watanni masu zuwa a daren jiya.
A cikin wannan jawabin, sun yi la'akari da kansu a matsayin amsa mai dacewa ga abin da muke fuskanta da kuma hanya mafi kyau don kiyaye dorewar ƙungiyar a wannan lokacin.
A cikin wannan labarin, na ga cewa wasu daga cikin manyan kamfanonin da ke da alaka da kasuwancin su sun yi watsi da wannan tsari na rashin daidaito.
Idan kana bukatar sake kira, yana da kyau.
A cikin wannan labarin, an yi magana game da yadda za a yi amfani da wannan hanyar don magance matsalar rashin tsaro.
A cewarsa, "Muna fatan za mu yi aiki na tsawon sa'o'i hudu a rana ko kuma awa 20 a mako har sai an sanar da wani abu".
(Matta 28:19, 20) Idan ka yi aiki fiye da lokacin da aka saba, za ka iya samun aiki a wurin.
A wannan duniyar da ba a san lokacin da za a yi hakan ba, muna son mu taimaka maka ka biya dukan bukatunka, ko dai wajen kula da ƙaunatattunka, sayen kayayyaki, ko kuma zuwa asibiti.
Ba wai kawai ku bata lokacinku ba.
Kada ku yi aiki idan kuna rashin lafiya.
A cikin wata sanarwa da ya fitar a ranar Talata, ya ce:
Ranar rashin lafiya ko PTO ba a buƙata: Kawai ka gaya wa manajanka kuma ka taimaka wa ƙungiyarka ta sake tsara kalandarku da jadawalin don rufe manyan wuraren aiki.
(Idan ka gwada tabbatacce ga COVID-19, don Allah sanar da Bryan a cikin T&C Ops, T&C na iya taimaka maka ka sami kulawa ta dace daga tallafi da gudanarwa.)
Ma'aikata na sa'a za su sami cikakken albashi.
Kamar yadda muka fada, mun sake tabbatar da cewa muna girmama aikinmu na dindindin ga 'yan kwangilarmu da abokan aikinmu na sa'a.
A karkashin yanayi na yau da kullun, kowa zai sami albashi bisa ga yawan lokutan aikinsa.
A cikin wasikar, an rubuta cewa ba za ka iya zuwa aiki ba saboda ba ka da lafiya.
Idan kana son aiki, muna tallafa maka.
Mutane da yawa suna amfani da aikinsu wajen kawar da damuwarsu a cikin duniyar da ke kewaye da su.
A cikin wannan labarin, mun ga cewa akwai wasu abubuwa da yawa da za mu iya yi, musamman ma a wannan lokacin.
A wannan karon, ku kula da kanku.
Muna rokon ka ka tuntubi manajan ka, domin mu san abin da ake bukata kuma mu yi shawarwari daidai.
(Matta 6:33) A wasu lokatai, muna iya yin wasu ayyuka da muke gani suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
(Daga cikin wasu sassan) SRE, HR Ops, Trust da tsaro da kuma kungiyoyin tara kudade suna yin muhimman ayyuka don samar da karin tallafi da suke bukata.
A cikin wannan shirin, muna aiki tare da dukkan sassanmu don gano manufofinmu na yanzu da kuma mayar da hankali kan abin da ke da mahimmanci ga burinmu na kasuwanci.
Akwai aiki da yawa da za ku yi, amma za ku mai da hankali kan ayyukan da suka fi muhimmanci.
Saurin tafiya yanzu ba zai cutar da ku ba a nan gaba.
Ba mu da shirin yin tafiya sau biyu don samun sauki bayan mun shawo kan cutar.
Ba za ku bukaci karin lokaci ba don ku cika takamaiman lokacin da ba za ku iya ba yanzu.
A cewarsa, "Muna da tabbacin cewa za mu cimma burinmu na ganin an cimma wannan buri a duk lokacin da muke da shi.
(Shirye-shiryen shekara-shekara) Me game da APP?
A cewarsa, "Muna fatan za mu daidaita lokacin da za mu fitar da shirinmu na shekara-shekara na 2020-2021 don daidaita sabon yanayin rayuwarmu da tsammanin aikin yau da kullun".
Manufar su ita ce su ba da shawarar tsawaita shirin su na 2019-2020 wanda zai ba ma'aikata ƙarin lokaci don tsara kasafin kuɗi don ba da fifiko ga mahimman ayyuka, kula da kansu da kuma kula da ƙaunatattun su, don ba wa waɗanda suke so ko suke son yin gajerun jadawalin aiki damar yin hakan a cikin makonni masu zuwa.
Wannan fadada jadawalin ya rage yawan aikin da ake yi a yanzu da kuma matsin lamba a kan kungiyar baki daya.
A mako mai zuwa, za mu gabatar da shawarwarinmu ga kwamitin, kuma da zarar an amince da su, za mu sanar da wakilai da tawagarmu game da abubuwan da suka faru a mataki na gaba.
Na gode wa ƙungiyar APP don jagorantar wannan.
"Na yi farin ciki sosai da na sami wannan aikin.
A makon da ya gabata, mun gano cewa ɗaya daga cikin abokan aikinmu a San Francisco na iya kamuwa da cutar COVID-19.
A cikin abubuwan da za a lura da su, mun yi hayar ƙungiyar kawar da cutar don kashe ƙwayoyin cuta a kan dukkan tebur da kujeru a ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafin cutar a asibiti don kashe ƙwayoyin cuta ba kawai a kowane farfajiyar ba amma har da dakunan zama da kuma matakan hawa zuwa benen su.
Ginin ya kafa tsarin kula da kansa game da amfani da kayan da ke ba da kariya ga masu haya.
A lokacin da suka yanke shawarar komawa, ofishin ya shirya su sosai kuma sun ji daɗi.
Ofishinmu na DC yana cikin WeWork, inda muke raba hanyoyin COVID-19 tare da kanmu da duk ma'aikatanmu na DC.
A makon da ya gabata, mun canza ofishinmu na DC zuwa cikakken aiki na nesa, daidai da jagororin da aka raba daga San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, muna kuma neman haya a Brooklyn.
A halin yanzu dai ana ci gaba da tattaunawar, amma ana iya samun jinkiri.
Wasu daga cikin abokan aikina suna aiki daga nesa a karon farko.
Abokan aikin su na nesa sun san cewa za su daidaita wannan kuma suna so su ba ku wasu shawarwari.
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, ya ce: "Muna bukatar mu rage tsawon taron zuwa awa ɗaya ko biyu".
Idan kuna buƙatar ayyuka na dogon lokaci, ku yi la'akari da yadda za ku tattara su cikin makonni.
Ka bayyana taron a sarari, ka tsara shi, kuma ka sanar da abin da za ka karanta a gaba.
Ka sa bidiyon ya kasance a cikin asalinsa don taimaka wa shirye-shirye kamar Google Docs da Zoom don haɓaka haɗin kai da sadarwa kai tsaye.
Ka yi shiri don kowane taro ya kasance mai sauƙi da kuma daɗi. Ka sa wani ya lura da tattaunawar don yin tambayoyi da kuma rubuta jerin abubuwan da za a tattauna da kuma wani ya taimaka ko kuma ya yi rubutu.
Idan kana bukatar lasifikan kai mai kyau, aika imel zuwa goyon bayan fasaha.
Ku kashe kuɗin da kuke kashewa a kan jinya don ku biya kuɗin ruwan hakori.
Ka shiga layin Slack na #remoties don tattaunawa da abokan aikinka game da ayyukan da aka raba.
Ƙungiyar HR ta yi nazari kan jagororin samar da kayan aiki na yanar gizo don tallafawa ci gaban ayyukan da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata, mun nemi duk kungiyoyin al'umma da ke karbar kudade su dakatar da taron jama'a kamar taron editocin da Wikimedia ke tallafawa har sai WHO ta ayyana cewa annobar ta kare.
Muna sanar da su cewa mun fahimci cewa bukatar da muke yi na soke su da sauran takunkumi ba zai ba su damar kammala ayyukan da suka amince da su ba kuma kada a hukunta kowa don jinkirta ko canza manufofin.
A mako mai zuwa, za mu ci gaba da bin ƙarin jagororin kan Wikimedia da sauran taron yanki da na al'ada.
Ko da yake akwai wasu abubuwan da ke faruwa a tsakanin al'ummomin duniya da ke baƙin ciki a lokacin da aka daina aiki, mutane suna jin dadi idan sun kasance a fili kuma suna mai da hankali ga al'ummomin su, Wikimedia da sauransu.
A gaba, CRT na aiki kan gina shafin Meta-Wiki don al'umma su iya lura da tasirin da kuma ayyukan su.
Bari mu tattauna game da al'amuran da suka shafi COVID-19.
Muna aika gayyata zuwa kalandarku don taron ma'aikata na ranar Alhamis mai zuwa 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin gyare-gyare, amsa tambayoyinku, da kuma ba da lokaci don sadarwa tare da juna.
Za mu fuskanci wannan tare kuma muna shirye mu taimaka a duk hanyar da za mu iya.
A halin yanzu, zaku iya ci gaba da bincika bayanan daga wannan imel ɗin kuma ku sami duk sauran bayanan da ba a sani ba game da COVID-19 a cikin Wiki na Office.
CRT za ta ci gaba da samar da bayanai na yau da kullum a kan waɗannan shafuka kuma za ta tabbatar da cewa duk bayanan suna cikin wuri guda.
Muna kuma ci gaba da kasancewa cikin hulɗa tare da ma'aikatanmu da ke zaune a ƙasashen da ke fama da cutar a kwanan nan.
Idan kana da tambayoyi game da tafiya, abubuwan da suka faru, babban aiki ko ƙalubalen inshora, ko kuma duk wani taimako da kake buƙata, kada ka yi jinkirin sanar da CRT kuma ka taimaka.
Muna shirye mu taimaka da sadarwa idan an buƙata.
Idan kana da wasu batutuwa masu sirri ko masu sirri, don Allah aika imel zuwa Bryan Juan: Daraktan Harkokin Ma'aikata na Kasuwancinmu na Duniya.
Ba za mu iya ganin kowanne daga cikin wadannan canje-canje a matsayin aikinmu ko aikinmu ba.
A maimakon haka, a yanzu suna bukatar a gane su, kuma su yarda da aikinsu da kuma hakkokinsu a hanyar da ba su taba yi ba a baya.
Waɗannan su ne matakan da muka yi imani da su, kuma waɗannan abubuwa suna buƙatar tallafawa juna, amma kawai za mu iya ci gaba da aiki, don ba da taimakon da suke buƙata ta hanyar ayyukanmu, kuma don ci gaba da ba da sabis ɗin da suke dogara da shi a duniya.
A lokacin da suka shirya, ayyukansu za su dawo gare su.
Yanzu lokaci ya yi da za mu tallafa wa juna da kuma samar da sarari don muhimman ayyuka a makonni da watanni masu zuwa.
Don wannan ya yi nasara, muna bukatar ku duka ku kula da kanku da iyalanku domin ku kasance mafi kyau a gare ku lokacin da bukatunku suka taso.
Yanzu fa, ina roƙonku, ku wanke hannuwanku, kada ku taɓa fuskarku.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S) da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn a, Ryan M, da Toby N).
b'Angiotensin-converting enzyme2 (ACE2) wani enzyme ne wanda ke ɗaure da ƙwayoyin cuta (ƙwayoyin cuta na ƙwayoyin cuta) a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana da amfani sosai wajen maganin cututtukan zuciya da jijiyoyin jini saboda yana hana aikin Angiotensin Converting Enzyme (ACE) wanda ke da alaƙa da shi ta hanyar rage adadin Angiotensin-II da haɓaka adadin Ang (1-7). ACE2 kuma yana aiki azaman ƙofar cikin ƙwayoyin cuta ga wasu coronavirus.
A cikin mutane, an fi kiran wannan enzyme hACE2.
Angiotensin-converting enzyme 2 wani nau'i ne na sinadarin da ke dauke da metallolenzymes wanda ke cikin endothelial da sauran ƙwayoyin halitta.
Kwayar ACE2 tana da yanki na N-terminal peptidase M2 da kuma yankin jigilar amino acid na C-terminal collectrin.
ACE2 shine furotin membrane mai wucewa guda ɗaya na nau'in I wanda ke aiki tare da yankin aiki na enzyme a saman ƙwayoyin cuta a cikin huhu da sauran kyallen takarda.
Ana cire yankin waje na ACE2 daga yankin da ke cikin membrane ta hanyar wani enzyme da ake kira sheddase, kuma furotin mai narkewa ya shiga cikin jini kuma a ƙarshe an fitar da shi a fitsari.
ACE2 yana cikin yawancin sassan jiki - ACE2 yana da mahimmanci a cikin membrane na ƙwayoyin cutar cutar cutar ta II, ƙwayoyin anthrax na hanji, ƙwayoyin membrane na arteries da arteries, da ƙwayoyin tsoka mai laushi a yawancin sassan jiki.
Ana kuma gano bayanin ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwa, wani ɓangare na ƙwaƙwalwar ƙwaƙwalwa, da kuma hormone da ake buƙata a jiki, tsarin juyayi, da kuma hypothalamus, wani ɓangare na kwakwalwa wanda ke daidaita hormones, da kuma kwakwalwa.
Babban aikin ACE2 shine aiki a matsayin mai hana ACE.
ACE yana ɗaure hormone na angiotensin I zuwa angiotensin II, wanda ke haifar da jijiyoyin jini.
A sakamakon haka, ACE2 ya rabu da carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) wanda aka narkar da shi cikin ruwa a cikin angiotensin (1-7) mai narkewa, (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya yin amfani da wasu magungunan ƙwayar cuta, ciki har da [des-Arg9]-bradiquinine, aspirin, neurotonin, dinophene A, da ghrelin.
ACE2 kuma yana daidaita motsi na membrane na mai jigilar amino acid mai tsaka tsaki SLC6A19, wanda kuma ya danganci cutar Hartnup.
ACE2, furotin mai ƙwanƙwasa membrane, shine rukunin da aka ɗauka a matsayin babbar hanyar shiga cikin ƙwayoyin cuta don wasu coronaviruses, gami da HCoV-NL63, SARS-CoV (wanda ke haifar da SARS) da SARS-CoV-2 (wanda ke haifar da COVID-19).
Musamman, haɗuwa da SARS-CoV da SARS-CoV2 S1 mai ƙwanƙwasa a cikin yankin enzyme na ACE2 a saman ƙwayoyin halitta yana haifar da ƙwayoyin cuta da ƙwayoyin cuta don shiga da kuma matsawa cikin ɗakunan endocytes a cikin ƙwayoyin.
Wannan aikin shiga yana buƙatar shirya S-protein ta hanyar TMPRSS2 mai karɓar mai karɓar, wanda ake nazarin shi a matsayin maganin furotin. Saboda haka, wasu masu bincike sun ba da shawarar cewa rage yawan ACE2 a cikin sel na iya taimakawa wajen yaƙi da kamuwa da cuta.
Duk da haka, ƙungiyoyi da kungiyoyi masu ba da shawara sun ba da shawarar ci gaba da amfani da maganin ACE mai hanawa da ARB.
Wani bincike da aka yi a ranar 11 ga Yuli, 2012, wanda ya haɗa da nazarin da aka tsara da kuma bayanan kididdiga, ya gano cewa masu hana ACE suna da alaƙa da raguwa mai yawa na cutar huhu da kashi 34% idan aka kwatanta da nazarin kwatancen.
"Bugu da ƙari, "" an gano cewa maganin ACE inhibitors yana rage haɗarin ciwon huhu, musamman a cikin marasa lafiya da ke fama da bugun jini da cututtukan zuciya da ke haifar da haɗarin ciwon huhu. "
Ko da yake sakamakon bai da tabbaci sosai game da duk cututtukan cututtukan huhu, amfani da masu hana ACE na iya rage mutuwar da ke tattare da cutar huhu.
An gano cewa, maganin cutar da ake kira human-related ACE2 (rhACE2) wanda aka tsara shi ne sabon magani don cutar da ke da mummunar cutar huhu, wanda ke haifar da haɓakar lipopolysaccharide wanda ke ƙarfafa tsarin garkuwar jiki, yana inganta haɓakar jini da kuma oxygenation a cikin fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen
Bayan mako guda na aiki na 24 na magani, lokacin da rabin kashi na rhACE2 a jikin mutum ya kasance kusan awanni 10 kuma lokacin fara aiki na magani minti 30.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai yiwuwa ga mutanen da ba su da ƙarfin hali ga masu hana tsarin renin-angiotensin (RAS antibodies) ko kuma cututtukan da ke haifar da hawan jini na angiotensin II. An gwada rhACE2 mai haɗuwa a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
"B'COVID-19 apps sune aikace-aikacen software na wayar hannu waɗanda aka tsara don aiwatar da bin diddigin haɗuwa, ma'ana: gano waɗanda ke da cutar da waɗanda suka taɓa kamuwa da cutar (""" haɗuwa"") don amsa cutar coronavirus ta 2019-20".
A wasu yankuna da yankunan da ke da iko, an samar da aikace-aikace da yawa ko kuma an ba da shawarar su tare da tallafin gwamnati.
A cikin wannan labarin, an yi amfani da wasu daga cikin hanyoyin da aka tsara don ƙirƙirar aikace-aikacen sa ido na taɓawa.
A cikin wata sanarwa da aka fitar a ranar Talata, wasu daga cikin masu amfani da manhajar sun ce, "Babu wata matsala da ke tattare da wannan batu.
Wasu hanyoyin da ba sa tsangwama sun hada da amfani da igiyoyin Bluetooth don yin rikodin nesa da mai amfani da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun ba da sanarwar hadin gwiwa cewa za su haɗa ayyukan da za su ba da damar yin amfani da waɗannan ƙa'idodin na Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar ta samar da wata manhaja da za ta iya amfani da 'yan kasar don gano idan sun taɓa saduwa da mutanen da ke da cutar COVID-19 ta hanyar amfani da Alipay.
A halin yanzu, ana amfani da shi a birane sama da 200 a kasar Sin.
An kirkiro wannan manhajar ne daga wata kungiyar kwararrun IT ta yankin kuma an samar da ita kyauta kuma za a ba da ita ga gwamnati. A Arewacin Macedonia, an fara amfani da StopKorona!, aikace-aikacen Bluetooth don bin diddigin hulɗa da waɗanda suka kamu da cutar da kuma taimaka wa hukumomin kiwon lafiya su amsa da sauri.
Aikin ya fito ne daga ma'aikatar sadarwa da fasaha da ma'aikatar lafiya.
Tun daga ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran tabbaci daga Google Play Store da Apple App Store.
"Gwamnati ta sanar a ranar 12 ga Afrilu cewa ci gaban aikace-aikacen sa ido kan taɓawa yana kan kammala shi kuma zai fara aiki a cikin 'yan makonni. Ana shirin yin irin wannan aikace-aikacen a Ireland da Faransa ("Covid"). "
Australia da New Zealand suna la'akari da haɓaka aikace-aikace bisa ƙa'idar TraceTogether ta Singapore da yarjejeniyar BlueTrace. Rasha tana da niyyar ƙaddamar da aikace-aikacen geofencing wanda aka tsara don tabbatar da cewa marasa lafiya da ke fama da COVID-19 da ke zaune a Moscow ba za su bar gida ba.
Ross Anderson, farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli na zahiri da ke faruwa tare da tsarin tushen aikace-aikace, gami da rashin inganci da kuskuren tabbatarwa idan ƙananan adadin jama'a ke amfani da aikace-aikacen.
Don magance damuwa game da yaduwar "Covid-19 mai ɓatarwa ko mai haɗari", Apple ya iyakance nau'ikan ƙungiyoyi da za su iya ƙara aikace-aikacen da ke da alaƙa da cutar coronavirus a cikin Shagon sa na App, kuma ƙungiyoyi masu izini ne kawai za su iya ƙarawa.
Google da Amazon sun aiwatar da irin wannan ƙuntatawa.
Masu fafutukar kare sirrin bayanai sun nuna damuwarsu game da tasirin tasirin sa ido kan mutane ta hanyar amfani da aikace-aikacen coronavirus, musamman idan za a iya kawar da tsarin sa ido da aka kirkira don lura da cutar coronavirus bayan barkewar cutar.
A ranar Litinin, 'yan sanda sun yi kira ga masu zanga-zangar da su yi watsi da wannan dokar.
Kungiyoyi sun bayyana sharudda takwas ga ayyukan gwamnati.
Wannan ya nuna cewa, idan aka yi amfani da wannan hanyar, za a iya samun 'yancin yin amfani da ita a cikin gida.
A cikin dokar, an ce a dakatar da masu zaman kansu a cikin gida bayan an kammala wani lokaci.
Za a iyakance amfani da bayanan don dalilai na COVID-19.
Dole ne a tabbatar da tsaro da rashin suna, kuma a bayyana cewa an tabbatar da shi.
A cewarsa, "Shirye-shiryen da aka yi a cikin wannan yanki na da matukar muhimmanci ga 'yancin kai, kuma hakan ya sa ya zama wajibi a yi amfani da su wajen kare 'yancin kai.
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, ya ce: "Muna da wasu mutane da muke son mu sanar da su.
Dole ne 'yan ƙasa su sami dokokin kariya daga azabtarwa da kuma haƙƙin amsawa ga azabtarwa.
"Za a buƙaci" sa hannu mai ma'ana "na duk "'yan wasa masu dacewa ", gami da ƙwararrun likitocin kiwon lafiya da ƙungiyoyi masu zaman kansu.
A cikin shirin da aka gabatar, Google da Apple suna son magance matsalar sa ido ta hanyar cire tsarin bin sawu daga tsarin aiki na na'urorin su.
Wasu ƙasashe sun yi amfani da hanyar bin hanyar sadarwa maimakon aikace-aikace don kawar da buƙatar saukar da aikace-aikace da kuma ikon kauce wa sa ido.
A Isra'ila, an tabbatar da bin hanyar sadarwa.
A cikin wannan labarin, an bayyana cewa, "Muna da wasu hanyoyin da za mu iya amfani da su don samun damar yin amfani da bayanan wuri.
Duk da haka, ba duk tsarin da ke da cibiyoyin sadarwa ba ne ke buƙatar samun bayanan wuri na mutum. An ƙirƙiri wasu tsarin da ke riƙe da bayanan sirri wanda ke amfani da cibiyoyin sadarwa kawai don sadarwa (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da wata hanyar da ba ta amfani da manhaja ba don gano mutanen da ke da cutar.
Maimakon amfani da wata manhaja, tsarin yana tattara bayanai, gami da bayanan da aka bi ta hanyoyi daban-daban, gami da na'urar hannu da bayanan biyan kuɗi ta katin kuɗi, ya haɗa su kuma ya aika da faɗakarwa ta saƙon rubutu ga masu yuwuwar kamuwa da cutar.
Bugu da ƙari, yin amfani da wannan bayanin don faɗakar da waɗanda ke da yiwuwar haɗuwa da mai cutar, gwamnati ta ba da damar samun bayanan wuri ga jama'a, kuma an sami canje-canje da yawa a cikin dokar tsaro na bayanai tun bayan barkewar cutar MERS a ƙasar don ba da izinin yin hakan.
A wasu kasashe, kamar Jamus, ana tunanin amfani da tsarin tsare sirri na tsakiya.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Bayanin tuntuɓar da ke kare tsaro na bayanan sirri ra'ayi ne wanda aka tabbatar da shi ta hanyar takaddun bincike da yawa da aka yi aƙalla tun daga 2013. A ranar 7 ga Afrilu, 2020, ƙungiyoyi da yawa na masana suna aiki kan hanyoyin da suka dace don kare lafiyar bayanan sirri, kamar amfani da fasahar Bluetooth mai amfani da wutar lantarki (BLE) don yin rikodin hulɗar mai amfani da wasu wayoyin hannu.
Koyaya, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi duka hanyoyin sarrafawa da ragewa, kuma ba hanya ɗaya ba. Hanyoyin da aka ragewa sun haɗa da bin diddigin tuntuɓar da ke kare tsaron bayanan sirri na cibiyar sadarwa (DP-PPT/DP-3T), lambobin tuntuɓar wucin gadi (TCN, fka Lambobin Abun Haɗuwa, CEN), mahimman hanyoyin tsaro da tsarin sirri don bin diddigin sadarwa ta hannu (PACT), da sauransu.
A cikin waɗannan hanyoyin, za a iya tabbatar da bayanan sirri a cikin na'urar kuma ba za a taɓa samun damar fita daga na'urar ba.
Wata ƙungiya a MIT Media Lab tana aiwatar da SafePaths, wani dandamali wanda ke ba da damar amfani da hanyoyin da aka keɓance lokacin tattara bayanai na wuri ko kewayawa don bin diddigin yaduwar COVID-19.
Ya dogara ne akan bayanan da aka buga a cikin wata takarda a cikin Maris 2020 mai taken "Apps Gone Rogue - Tsare Sirrin Keɓaɓɓen Bayanai a Tsakanin Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
SafeTrace yana amfani da ingantattun fasahohin kayan aiki don bawa masu amfani damar raba mahimman bayanai da bayanan kiwon lafiya tare da sauran masu amfani da jami'ai ba tare da yin sulhu kan sirrin bayanan ba.
An kafa haɗin gwiwar TCN na Duniya a ranar 5 ga Afrilu, 2020, ƙungiyoyi waɗanda ke haɗuwa da kusan irin wannan hanyar da kuma kusan irin wannan hanyoyin tare da manufar rage bambancin da ke taka muhimmiyar rawa wajen samun karbuwa da haɓaka aikace-aikacen sa ido da faɗakarwa tare a duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta samar da yarjejeniyar BlueTrace da aka yi amfani da ita a cikin aikace-aikacen gwamnati na hukuma kyauta.
A ranar 10 ga Afrilu, 2020, kamfanonin Google da Apple, waɗanda ke sarrafa dandamali na Android da iOS, sun ba da sanarwar wata hanyar bin diddigin taɓawa. Sun yi iƙirarin cewa wannan hanyar ta dogara ne da haɗin fasahar Bluetooth mai ƙarancin makamashi da kuma ɓoye-karanta / karantawa don kare bayanan sirri.
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, an bayyana cewa, "Muna da wasu manyan fasahohi da muke amfani da su a cikin wannan tsarin.
A cewar Apple da Google, shirin zai fara aiki a matakai uku:
Gabatar da kayan aiki don samar da aikace-aikacen bin diddigin cutar coronavirus na hukuma da ke kare bayanan sirri na gwamnatoci.
Don haɗa wannan aikin kai tsaye cikin iOS da Android, Google da Apple suna shirin fara sakin tsarin ta hanyar sabunta tsarin aiki, sannan su cire tsarin ta hanyar da ta dace don magance matsalolin sa ido na yau da kullun.
b'Sake amfani da magani (wanda aka fi sani da sake yin amfani da shi, sake fasalinsa, sake yin amfani da shi, ko kuma sake fasalin maganin cutar) shine sake amfani da magani wanda aka amince da shi don magance wata cuta ko yanayin kiwon lafiya daban da wanda aka fara amfani da shi.
Wannan shine dalilin binciken kimiyya na yanzu don samar da ingantattun magungunan COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma allurar plasma daga mai warkewa. SARS-CoV-2 yana da sunadarai 66 masu warkewa, kowannensu yana da wurare da yawa na haɗin kwayoyin.
Nazarin waɗannan rukunin tsoma baki yana ba da gudummawa ga aikin da ya dace don haɓaka ingantaccen maganin rigakafi don magance ƙwayoyin COVID-19.
Muhimman sunadarai masu mahimmanci na SARS-CoV-2 sune sunadarai kamar papillins, RNA-dogara RNA polymers, helicases, S-protein da ADP ribophosphate.
Hussein AA, et al. don ba da shawara game da ƙirar binciken asibiti, a cikin binciken sa na farko, sun yi nazarin da kuma nazarin yawancin mahaɗan da ke gano mafi kyawun hanyar da za a iya daidaita su da magunguna da aka amince da su don haɓaka haɓakar maganin SARS-CoV-2 mai yuwuwa.
Chloroquine magani ne na rigakafin zazzabin cizon sauro da ake amfani da shi don magance wasu cututtukan da ke hana metabolism.
A ranar 18 ga Maris, WHO ta sanar da cewa Chloroquine da Hydroxychloroquine sun kasance cikin magunguna huɗu da aka yi nazari a matsayin wani ɓangare na gwajin haɗin gwiwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin New York na chlorine da hydrochlorine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydrochlorine sulfate da chlorine phosphate a ƙarƙashin Amfani da Izinin Gaggawa (EUA).
A halin yanzu, ba a amince da maganin ta hanyar hanyoyin gwajin gwaji na FDA ba, amma EUA ta ba da izinin kawai a matsayin gwaji don gaggawa ga marasa lafiya da ke asibiti waɗanda ba za su iya samun gwajin gwaji ba.
Cibiyar Kula da Cututtuka (CDC) ta ce har yanzu ba a tabbatar da yadda za a yi amfani da Hydroxychloroquine ba, ko kuma yawan adadinsa, ko lokacin da za a yi amfani da shi don hana ko kuma magance cutar SARS-CoV-2.
A cewar likitoci, ana amfani da magunguna ne a lokacin da babu wani zabi.
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, jami'an tsaro sun ce, "Muna da wasu mutane da ke da hannu a wannan harin da ake kaiwa a jihar.
A yanzu haka, akwai wasu manyan bincike da ake yi a jami'ar Duke da Oxford.
Makarantar Likita ta NYU Langone tana gudanar da gwaji kan yadda za a iya amfani da hydrochlorothiazines cikin aminci da inganci.
A cikin wata sanarwa da aka fitar a watan Nuwamba, an ce, "An yi gwajin cutar a Wuhan da Shenzhen, inda aka bukaci a tabbatar da ingancin maganin".
A cikin marasa lafiya 35 a Shenzhen, babu cutar a cikin kwanaki huɗu, amma a cikin marasa lafiya 45 da ba su sami cutar ba, tsawon lokacin rashin lafiya ya kai kwanaki 11.
A wani bincike da aka yi a Wuhan, an yi amfani da 240 marasa lafiya da ke fama da cutar tarin fuka, rabin marasa lafiyar sun sami favipiravir (farvipiravir) da sauran kuma umifenovir (umifenova).
Hukumar kula da magunguna ta Italiya ta gargadi jama'a cewa shaidar da ke cikin kayayyakin magani ta takaita kuma har yanzu gwaji ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don adana su, ta kuma yi amfani da sojoji don isar da magunguna zuwa asibitocin jami'a don kula da marasa lafiya na COVID-19.
A cewar wani rahoto daga kasar Sin ta Kudu, Shinzo Abe ya gabatar da tsarin gwamnatin Trump na sayen magunguna, wadanda ba su da tasiri sosai a lokacin annobar da ta fi tsanani, inda cutar ta fi yawa.
Ba shi da lafiya ga mata masu ciki da kuma waɗanda suke ƙoƙarin yin ciki.
Wani binciken da aka yi da maganin rigakafi na maganin rigakafi na maganin rigakafi (lopinavir) /ritonavir na maganin HIV/AIDS (Keltra) ya kammala cewa babu wani fa'ida.
An kirkiro magunguna da za su hana yaduwar cutar HIV ta hanyar ɗaure ta da furotin.
Wata ƙungiyar bincike a Jami'ar Colorado tana ƙoƙarin inganta magunguna don gano mahaɗan da za su iya ɗaure ƙwayoyin cuta na SARS-CoV-2. Akwai ƙin yarda a cikin al'ummomin kimiyya game da tushen da ke jagorantar sake amfani da magungunan da aka tsara don cutar HIV / AIDS.
WHO ta haɗa maganin rigakafin cutar retroviral (lopinavir) / HIV/AIDS (ritonavir) a cikin gwajin haɗin gwiwar ƙasa da ƙasa.
Gilead Sciences ta haɓaka Remdesivir don maganin cutar Ebola da kamuwa da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir na iya amfani da shi don maganin filato-, pneumo-, paramyxo- da coronavirus.
Wani batun da ya shafi maganin kashe ƙwayoyin cuta shine haɓaka rigakafi ta hanyar maye gurbi wanda zai iya haifar da cututtuka masu tsanani da yaduwa.
Wasu daga cikin farkon gwajin da aka ba da shawarar akan maganin cutar na iya zama babbar hanyar hana kwayar halitta. Akwai gwaji da yawa na asibiti a halin yanzu, gami da biyu da asibitocin Jami'ar Cleveland ke gudanarwa, don mutum ɗaya da ke da cutar mai laushi da kuma wanda ke da cutar mai tsanani.
A halin yanzu, akwai gwaji uku na asibiti na maganin cutar sankara na bitamin C ga mutanen da ke fama da cutar COVID-19 da ke asibiti, biyu tare da sarrafawar placebo (China da Kanada) da kuma ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwajin gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) na shirin gudanar da gwajin asibiti na Teijin's Alvax (sislisinone), wani corticosteroid mai shan iska don maganin cutar asma don kula da marasa lafiya da ke nuna alamun kamuwa da cutar coronavirus.
Wani gwaji na Phase II na wani nau'in enzyme mai canza angiotensin 2 zai yi amfani da marasa lafiya 200 masu fama da cutar a asibiti a Denmark, Jamus da Austria don tantance ingancin maganin.
Masu bincike a Jami'ar Zuciya ta Montreal a Kanada suna nazarin rawar Colchicine a rage ciwon huhu da sababbin cututtukan huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Binciken da aka kira COLCORONA ya haɗa da manya 6,000 waɗanda ke fama da cutar COVID-19 kuma suna da alamun rashin lafiya waɗanda ba sa buƙatar asibiti.
Ba a ba da shawarar yin amfani da maganin al'ada ga mata masu ciki ko masu shayarwa ko kuma waɗanda ba su taɓa amfani da maganin hana ɗaukar ciki mai tasiri ba.
A cikin watan Agusta, an yi gwajin maganin hana jini a Italiya.
An yi amfani da maganin mai ƙarancin kwayoyin halitta na Heparin don kula da marasa lafiya kuma ana kiran hukumomin likitancin Italiya da su buga jagororin amfani da shi.
An sanar a Italiya a ranar 14 ga Afrilu na binciken cibiyoyi da yawa game da amfani da enosafarin a cikin rigakafi da maganin cututtuka a cikin marasa lafiya 300.
Saboda SARS-CoV-2 kwayar cuta ce, hankalin kimiyya da za a yi la'akari da shi ya mai da hankali ne kan sake amfani da maganin rigakafin da aka amince da shi wanda aka tsara don ɓarkewar cutar da ta gabata, kamar MERS, SARS, da West Nile virus.
Rivarin: An ba da shawarar Rivarin don maganin COVID-19 a cikin jagororin da aka sake bita na 7 na kasar Sin.
Umifenovir: Jagororin China na 7 da aka sake duba sun ba da shawarar amfani da umifenovir don maganin COVID-19.
Wasu ƙwayoyin cuta da aka ware waɗanda aka sake tsara su na ɗan lokaci don maganin COVID-19:
Tosylzuzumab (mai karɓar maganin anti-IL-6): China ta amince da shi.
Ka kuma duba gwaji a Italiya da China, da Tocilizumab#COVID-19.
allurar rigakafin COVID-19 b'A allurar rigakafi ce da za a iya amfani da ita don cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu wani allurar rigakafi da ta yi nasara a gwajin magani, akwai wasu ƙoƙarin da ake yi don samar da allurar rigakafi.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafi a cikin watanni 18 ba don cutar SARS-CoV-2, cutar da ke haifar da sakamako mai illa.
A watan Afrilu, akwai magunguna biyar da aka yi amfani da su a matsayin rigakafi a cikin gwajin lafiyar mataki na 1.
An gano cutar COVID-19 a watan Disamba na 2019.
Babban barkewar cutar ya bazu a duniya a cikin 2020, wanda ya haifar da saka hannun jari da bincike mai yawa don haɓaka allurar rigakafi.
Yawancin kungiyoyi suna amfani da kayan kwalliya da aka buga don haɓaka yiwuwar allurar rigakafi da za ta iya magance SARS-CoV-2.
A watan Afrilu, CEPI ta sanar da cewa ta ƙaddamar da wani muhimmin shiri na samar da allurar rigakafi tare da saurin aiki, samarwa, amfani da sikelin da kuma samun damar amfani a duk duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa akwai dandamali na fasaha daban-daban guda 10 waɗanda aka gudanar a farkon 2020 don yin bincike da aiwatar da allurar rigakafi mai tasiri da za ta iya yaƙar COVID-19.
Babban manufofin dandamali da suka kai ga matakin I na binciken tsaro sun hada da:
Nucleic acid (DNA da RNA) (mai ɗaukar mataki na I da kuma maganin da aka tsara: Moderna, mRNA-1273)
Adadin da aka bayyana game da kwayar cutar (mai gudanarwa na matakin I da kuma maganin da aka tsara: CanSino Biologics, adenovirus type 5 adenoviruses)
A cikin watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa aƙalla sabbin magunguna 115 suna cikin matakan samarwa na farko, tare da ayyukan da aka amince da su 78 (a cewar Jami'ar Milken 79) da kuma ayyukan 37 waɗanda ba a sanar da su ba tukuna (wanda za a iya ɗauka a cikin shirin ko kuma a cikin ƙirar ƙira) amma ba a bayyana su sosai ga jama'a ba.
A cikin ƙayyade takamaiman magani, gwajin Matakan I-II yana aiki ne akan gwajin farko na aminci da magani wanda ke nuna rashin tasirin kwayoyi da kuma yanayin da ya dace.
A lokacin da ake lura da sakamako masu illa a mafi kyawun sashi, gwaje-gwaje na Mataki na III sun haɗa da ƙarin mahalarta, gami da ƙungiyar sarrafawa, da kuma gwada ingancin allurar rigakafin don hana cutar.
Daga cikin alluran rigakafi 79 da ake samarwa a halin yanzu (wanda aka amince da shi a farkon Afrilu na 2020), 74 ba a gwada su a kan mutane ba tukuna (a cikin gwaji na farko ko bincike).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland a Ostiraliya ta sanar da cewa tana nazarin yiwuwar yin allurar rigakafin kwayar halitta wanda zai iya canza kwayoyin cutar ta hanyar kwayoyin halitta don haifar da amsawar rigakafi.
A Kanada, Cibiyar allurar rigakafi ta kasa da kasa a Jami'ar Saskatchewan (VIDO-InterVac) ta sanar a ranar 24 ga Janairu, 2020, cewa ta fara samar da allurar rigakafin, wanda ke da niyyar fara gwajin mutum a 2021.
An sanar da ayyukan samar da allurar rigakafi a cibiyar kula da rigakafin cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020 da kuma Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, kamfanonin harhada magunguna na Janssen, wanda Hanneke Schuitemaker ke jagoranta, sun sanar da cewa sun fara aiki kan samar da allurar rigakafi.
A cikin watan Agusta, a cikin shekara ta 2015, an ba da shawarar cewa a yi amfani da maganin rigakafi a cikin gida.
A ranar 18 ga Maris, 2020, kamfanin Emergent BioSolutions ya sanar da cewa ya haɗu da kamfanin Vaxart don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, OncoGen Lab a Romania ya buga wata takarda don samar da allurar rigakafi ta amfani da fasaha mai kama da wacce ake amfani da ita don maganin maganin neoantigen na ciwon daji.
A ranar 25 ga watan Maris, shugaban kungiyar ya sanar da cewa sun kammala hada-hadar allurar rigakafin kuma sun fara gwajin.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani reshen kamfanin Generex, ya ba da sanarwar cewa suna ƙaddamar da aikin allurar rigakafi don ƙirƙirar Ii-Key compound, allurar rigakafin COVID-19.
A cewarsa, "Muna da wasu abubuwa da muke son mu yi, amma ba mu da wani abu da za mu iya yi.
A ranar 5 ga watan Maris na 2020, Jami'ar Washington da ke St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula
A ranar 10 ga Maris, 2020, kamfanin Emergent Biosolutions ya sanar da haɗin gwiwa tare da Novavax Inc.
A cikin wannan labarin, an yi magana game da yadda ake yin allurar rigakafi.
Ƙungiyoyin bincike na abokan hulɗa sun ci gaba da sanar da shirye-shirye don gwajin farko da gwaji na farko a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da ƙungiyoyi daban-daban 11 kuma za su ɗauki shekara ɗaya da rabi zuwa shekaru biyu kafin su samar da allurar rigakafi, koda kuwa za su iya yin hakan da sauri.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere kere da ke Quebec City, Quebec, ya ba da sanarwar cewa ya samar da kwayar cutar coronavirus tare da tallafin kuɗi na Jami'o'in Kiwon Lafiya na Kanada.
A yanzu haka, ana gudanar da gwajin gwaji a cikin dakin gwaje-gwaje, tare da shirin gwajin mutum a watan Yuli ko Agusta na 2020.
"A farkon makon nan, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba da CureVac ""babban kuɗi"" don samun damar yin allurar rigakafin COVID-19, wanda gwamnatin Jamus ta yi hamayya da shi".
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka maganin rigakafin mRNA.
Ana sa ran fara amfani da maganin BNT162, wanda aka sanya shi a matsayin rigakafin mRNA wanda ke cikin gwajin rigakafin gwaji, a watan Afrilu 2020.
A Italiya, kamfanin fasahar halittu na Italiya Takis Biotech ya sanar a ranar 17 ga Maris, 2020 cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020, kuma za su iya fara gwajin gwajin mutum na allurar rigakafin su a kaka.
A Faransa, a ranar 19 ga Maris, 2020, Kungiyar kirkirar shirye-shiryen rigakafin cutar (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin rukunin binciken allurar rigakafin COVID-19, wanda ya hada da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh.
Sauran abokan haɗin gwiwar saka hannun jari na CEPI don aiwatar da COVID-19 sun haɗa da Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin wasu sabbin alluran rigakafi guda shida a kan dabbobi.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna aiki kan rigakafin RNA na gida don COVID-19.
An samar da maganin rigakafin a cikin kwanaki 14 bayan karbar cutar daga China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da cewa za ta ba da kuɗin dala miliyan 275 na Kanada don ayyukan bincike 96 don hanyoyin magance COVID-19, gami da haɓaka sabbin alluran rigakafi a kamfanonin Kanada da jami'o'i kamar Medicago da Jami'ar Saskatchewan.
A halin yanzu, gwamnatin Kanada ta sanar da cewa za ta kashe dala miliyan 192 na Kanada don samar da allurar rigakafin COVID-19 tare da shirin gina bankin allurar rigakafin ƙasa wanda zai sami sabbin alluran rigakafi da za a iya amfani da su idan akwai wani sabon barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Kiwon Lafiya ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc na yiwuwar allurar COVID-19 a cikin beraye, inda MNA ta samar da allurar rigakafin SARS-CoV-2 S1 wanda zai iya haifar da rigakafin rigakafin rigakafin cutar mai yiwuwa wanda ya fara bayyana a cikin makonni 2 bayan allurar [a cikin beraye].
A Kanada, Makarantar Magunguna ta Jami'ar Waterloo ta sanar a ranar 16 ga Afrilu, 2020, cewa ta haɓaka sabon allurar rigakafin DNA mai amfani da allurar hanci.
Ana amfani da kwayoyin cuta don tsara DNA don yin kwayar halitta a cikin kwayoyin cuta na mutum don samar da kwayoyin cuta marasa cutarwa waɗanda ke motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta waɗanda zasu iya yaƙar cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatocin Amurka uku, masana'antu, da jami'o'i sun haɗa albarkatu don samun damar amfani da manyan kwamfutoci daga IBM, tare da albarkatun lissafi daga Hewlett Packard Interactive, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira tasirin rashin daidaituwa.
Wannan yana nufin cewa suna iya samun riba fiye da cutar da suke hanawa.
A Australia, wani gwaji na bazuwar ya yi ƙoƙarin shiga ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar cewa alluran rigakafin da ake samarwa ba su da lafiya ko kuma ba su da tasiri.
Binciken farko don kimanta tasirin maganin COVID-19 ta amfani da samfuran dabbobi na musamman na gwaji, kamar beraye masu haɓaka ACE2, da sauran dabbobin dakin gwaje-gwaje, da kuma na dabbobi masu farauta waɗanda ba mutane ba, sun nuna cewa ana buƙatar haɗin gwiwar duniya don samar da matakan hanawa na matakin 3 na biosafety da kuma matakan tsaro na yau da kullun don magance ƙwayoyin cuta masu rai.
An gwada alluran rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekara ta 2020, babu magani ko allurar rigakafi don SARS da aka nuna yana da lafiya da tasiri a cikin mutane.
A cewar wasu takardu da aka buga a 2005 da 2006, ganowa da kuma samar da sabbin alluran rigakafi da magunguna don magance SARS ya kasance babban fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya. Har yanzu babu wani allurar rigakafi da aka amince da ita don yaƙar MERS.
A lokacin barkewar cutar MERS, an yi imanin cewa binciken SARS na yanzu zai iya zama da amfani wajen gano alluran rigakafi da magunguna don kamuwa da cutar MERS-CoV.
A watan Maris na 2020, an kammala gwajin gwaji na farko na mutum na ɗaya daga cikin alluran rigakafin (DNA-based) MERS, yayin da wasu uku ke ci gaba da gwaji, dukansu alluran rigakafin kwayar cutar ne, wato, alluran adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) da MVA-vectored (MVA-MERS-S).
A cikin wata sanarwa da aka wallafa a shafinsa na Twitter, an bayyana cewa, an riga an san cutar da ke bayan COVID-19 kuma akwai riga-kafi.
Takaddun shaida da aka nuna ta hanyar sakonnin kafofin watsa labarun daban-daban suna ambaton tasirin kwayoyin halitta ga wasu nau'ikan coronavirus kamar SARS coronavirus da kuma takaddun shaida na yanzu don alluran rigakafi.
Cutar coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa wacce ke haifar da cutar coronavirus 2 (SARS-CoV-2), wata cuta mai saurin kamuwa da cutar numfashi.
Alamomin da aka fi sani da zazzabi, tari, da kuma numfashi.
Sauran alamun cututtuka sun haɗa da gajiya, ciwon tsoka, amai, ciwon makogwaro, rashin numfashi, da ciwon ciki da ciwon ciki.
Lokacin bayyanar cututtuka yawanci yana cikin kwanaki biyar, amma zai iya zama daga kwana biyu zuwa 14.
Yawancin marasa lafiya suna da alamun bayyanar cututtuka masu sauƙi, amma wasu suna fama da cutar nimoniya da lalacewar gabobin jiki.
A ranar 17 ga Afrilu, 2020, an samu karuwar masu kamuwa da cutar miliyan 2.24 da mutuwar mutane sama da 153,000 a kasashe da yankuna 210.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar tsakanin mutane ta hanyar ƙananan ɗigon ruwa da ke fitowa daga tari, hancin ko magana, galibi a cikin kusanci.
A lokacin da ake numfashi, ƙananan ƙwayoyin da ke cikin iska sukan faɗi a ƙasa ko kuma a saman abubuwa, amma ba sa iya yin nesa sosai.
Mutane da yawa suna iya kamuwa da cutar ta hanyar taɓa idanunsu, hanci, ko bakinsu bayan sun taɓa farfajiyar da ke dauke da cutar.
Kwayar cutar na iya rayuwa a kan abubuwa har tsawon sa'o'i 72.
Ko da yake akwai yiwuwar kamuwa da cuta a farkon bayyanar cututtuka da kuma a cikin matakai na gaba na cutar, lokaci a cikin kwanaki uku na farko bayan bayyanar cututtuka shine mafi mahimmanci. Hanyar ganewa ta yau da kullum ita ce yin amfani da ainihin lokacin juyawa na polymerase chain reaction (rRT-PCR) daga hanci da hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargi da cutar da kuma masu kula da su.
Wasu hukumomi sun bada shawarar a guji amfani da abin rufe fuska, wasu sun bada shawarar amfani da abin rufe fuska, wasu kuma sun bada shawarar amfani da su, amma shawarwarin da aka bayar game da amfani da abin rufe fuska ga jama'a sun bambanta.
A halin yanzu, babu allurar rigakafi ko magani ga COVID-19 ko kwayar cutar ta musamman.
An samu karuwar kamuwa da cutar a yawancin kasashe a dukkan yankuna shida na WHO.
Mutane da ke dauke da kwayar cutar ba za su iya nuna alamun cutar ba ko kuma za su iya nuna alamun cutar kamar zazzabi, tari, gajiya da wahalar numfashi.
Alamomin gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsin lamba, firgita, rashin jin daɗi da ƙazantar fuska ko lebe, kuma ana ba da shawarar neman kulawar likita nan da nan idan waɗannan alamun sun bayyana.
Hakanan ana iya samun alamun cututtukan na sama kamar su hancin iska, hancin jini ko ciwon makogwaro.
A cikin wannan binciken, an gano cewa a cikin mutane fiye da dubu biyu, an gano alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututut
Wasu marasa lafiya a China sun fara nuna damuwa da bugun zuciya.
Wasu daga cikinsu suna fama da ciwon huhu, lalacewar gabobin jiki da mutuwa.
Wannan shine lokacin haifuwa.
Lokacin kamuwa da cutar na COVID-19 yawanci yana tsakanin kwanaki biyar zuwa shida amma zai iya kasancewa daga kwana biyu zuwa 14.
97.5% na masu kamuwa da cutar suna nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa duk masu kamuwa da cutar ba su nuna alamun cutar ba.
Har yanzu ba a san cikakken rawar da marasa alamun ke takawa ba a cikin kamuwa da cutar, amma shaidun farko sun nuna cewa suna iya haifar da yaduwar cutar.
Har yanzu ba a san adadin mutanen da ke kamuwa da cutar ba tare da nuna alamun cutar ba, kuma Cibiyar Kula da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20 cikin dari na duk mutanen da aka tabbatar da cutar ba su nuna alamun cutar ba yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara karawa mutane marasa alamun cutar a jerin sunayen marasa lafiya a ranar 1 ga Afrilu. Daga cikin mutane 166 da suka kamu da cutar a ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
A cikin wannan labarin, an gano cewa cutar ta kamu da cutar a cikin ƙwayar cuta ta hanyar ƙwayar cuta ta ƙwayar cuta.
Yin magana da babbar murya yana haifar da ƙarin ɗigon ruwa fiye da magana ta yau da kullun.
Wani bincike a Singapore ya nuna cewa tari ba tare da kariya ba zai iya sa ruwa ya zube har tsawon mita 4.5.
Ko da yake kwayar cutar ba yawanci kwayoyin halittar iska ba ne, Cibiyar Nazarin Kimiyya ta Kasa ta iya kamuwa da cutar ta kwayoyin halittar iska, kuma ta gano RNA na kwayar cutar a cikin samfuran mai daga injunan iska da aka sanya a cikin hanyoyin da ke waje da ɗakunan jama'a.
Hanyoyin kiwon lafiya kamar su allurar rigakafi da sake farfado da zuciya da huhu (CPR) suna haifar da ƙananan ƙwayoyin cuta na iska da ke yawo cikin iska, wanda ke haifar da kamuwa da cuta ta iska.
Wannan haɗarin yana da ƙarancin haɗari yayin da akwai damuwa game da yiwuwar kamuwa da cutar ta hanyar fitsari. Kwayar cutar tana da haɗari sosai yayin bayyanar cututtuka. Ana iya samun kamuwa da cuta kafin bayyanar cututtuka, amma ba ta da haɗari.
Ko da yake ba a san yadda cutar ke yaduwa ba, Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce mutum ɗaya yana iya cutar da mutane biyu zuwa uku. Kwayar cutar na iya rayuwa a kan fuskoki na awanni da kwanaki.
Musamman, an gano cewa kwayar cutar na iya rayuwa a kan kwali na kwana ɗaya, har zuwa kwana uku a kan filastik (polypropylene) da ƙarfe (AISI 304) da kuma har zuwa awanni huɗu a kan jan ƙarfe 99%.
Koyaya, ya bambanta dangane da zafi da zafin jiki.
Idan aka yi amfani da sabulu da kayan wankewa yadda ya kamata, kayan sabulu suna da tasiri, ba wai kawai suna lalata fatar ƙwayar cutar ba, suna kashe ta, amma suna hana ta zama a kan fata da sauran farfajiya.
Sauran ruwaye, kamar su benzalkonium chloride da collohexidine gluconate (wani maganin rigakafi na tiyata), ba su da tasiri sosai. A cikin binciken Hong Kong, an tattara samfurin leɓen bayan kwana biyu bayan fara asibiti.
A cikin marasa lafiya shida zuwa biyar, samfurin farko ya nuna mafi girman ƙwayar cutar, yayin da na shida ya nuna mafi yawan ƙwayar cutar a gwajin rana ta biyu.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututut
Dukkanin siffofin sabon SARS-CoV-2 suna faruwa a cikin kwayar cutar coronavirus ta halitta.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar fashewar bututun ruwa wanda sabulu na gida ya hana. SARS-CoV-2 yana da kamanceceniya da asalin SARS-CoV.
Cutar ta COVID-19 tana shafar huhu sosai saboda cutar ta shiga cikin ƙwayoyin halitta ta hanyar kwayar cutar ta hanyar kwayar cutar ta 2 (ACE2), wanda aka fi samu a cikin ƙwayoyin cuta na type 2 AVOLAS a cikin huhu.
Kwayar cutar tana amfani da furotin mai ƙarancin ƙwayoyin cuta na musamman da ake kira papilloma don haɗawa da ACE2 da shiga cikin ƙwayoyin mai karɓar.
A Wuhan, kasar Sin, kashi 12 cikin 100 na mutanen da ke dauke da kwayar cutar da aka kwantar a asibiti sun kamu da ciwon zuciya, wanda ya fi yawa a cikin cututtuka masu tsanani.
A cikin ci gaban cutar, akwai ƙarancin cututtukan zuciya da ke haifar da rashin lafiyar jijiyoyin jiki da kuma rashin lafiyar jiki, amma kuma ana iya samun mummunan rauni na zuciya wanda ke da alaƙa da mai karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da yawa a cikin zuciya kuma suna da hannu cikin ayyukan zuciya.
An sami ƙaruwa mai yawa na jini a cikin jijiyoyi (31%) da kuma toshewar jini a cikin jijiyoyi (25%) a cikin marasa lafiya da ke cikin ICU tare da kamuwa da cutar COVID-19, kuma yana iya zama saboda rashin ci gaba.Binciken kirji na waɗanda suka mutu daga COVID-19 ya nuna lalacewar ƙwayar cuta (DAD) da kuma shigar da ƙwayoyin cuta cikin huhu.
Ko da yake SARS-COV-2 yana da canji a cikin ƙwayoyin ƙwayoyin cuta na jiki, wanda ke nuna ACE2 na hanyar numfashi, marasa lafiya da ke fama da cutar COVID-19 mai tsanani suna da alamun cutar da ke haifar da fatar jiki mai launin ja a jiki.
Musamman, ƙwayoyin T da ke ɓoye GM-CSF masu cutarwa suna da alaƙa da tarin IL-6 mai ɓoye ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta da kuma ciwon huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma samu rahotanni na shigar da kwayoyin halittar jini a cikin gwaje-gwaje na cututtukan zuciya.
Hukumar Lafiya ta Duniya ta fitar da wasu hanyoyin gwaji don cutar.
Hanyar da aka saba amfani da ita ita ce ta hanyar gwajin polymerase-transferase-reverse reaction (rRT-PCR).
Ana yin wannan gwajin ne da samfurori na numfashi da aka samo ta hanyar daukar hoto na hanci da makogwaro, amma ana iya amfani da samfurin hanci ko samfurin mucous.
A cikin 'yan sa'o'i kadan, sakamakon zai iya zuwa cikin kwanaki biyu.
Ana iya amfani da gwaje-gwajen jini, amma suna buƙatar a ɗauki samfurin jini a kowane shekara biyu, kuma sakamakon yana da ƙima kaɗan.
Masana kimiyya na kasar Sin sun ware kwayar cutar coronavirus kuma sun bayyana tsarin kwayoyin halittar ta, wanda ya ba dakunan gwaje-gwaje a duniya damar yin gwajin PCR don gano cutar da kansu.
A ranar 4 ga Afrilu, 2020, an gano gwajin rigakafi (wanda ke gwada kasancewar cutar da kuma waɗanda ke da cutar a baya), amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar kasar Sin game da gwajin ya nuna cewa daidaito ya kasance kawai daga 60% zuwa 70%.
Hukumar Kula da Abinci da Magunguna ta Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris, 2020, don amfani da shi a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun ba da shawarar hanyoyin bincike bisa ga alamun asibiti da haɗarin cututtukan cututtuka.
A farkon kamuwa da cutar, ana samun alamun da ba su da haske, kamar ƙananan gilashin gilashi a gefen huhu, tare da yaduwar ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A lokacin da cutar ta kara tsanantawa, za a iya samun ƙarancin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Akwai bayanai kaɗan game da abubuwan da ke haifar da raunin da ake gani a cikin microscope da ilimin lissafi na COVID-19.
Wasu daga cikin manyan binciken cututtuka a cikin binciken cututtuka sune:
A cikin wannan littafin, an kwatanta yadda za a iya ganin abubuwa a cikin jiki da kuma yadda za a iya ganin abubuwa a cikin jiki.
A cikin wannan labarin, an gano cewa cutar ta kamu da cutar ta hanyar cutar sankara da kuma ciwon huhu.
Ƙarƙashin ƙwayoyin cuta: ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu girma da yawa, ƙwayoyin lymph, da kuma ƙwayoyin cuta masu yawa.
Cutar huhu mai tsanani: yaduwar ruwa da kuma lalacewar jijiyoyin jiki (DAD).
DAD shine sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Warkar da ciwon huhu: Tsarin ruwa da kuma ƙwayoyin ƙwayoyin cuta daga hanyoyin aviola
Jini: DIC, amsawar kwayar cuta ta jiki
Matakan kariya don rage yiwuwar kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wuraren taruwa, wanke hannuwanku akai-akai da sabulu da ruwa na aƙalla sakan 20, aiwatar da tsabtace iska mai kyau, da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar rufe baki da hanci da kayan shafa yayin tari ko hancin, kuma idan babu kayan shafa, amfani da kayan aiki na ciki.
Ana ƙarfafa tsabtace hannaye bayan tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a a matsayin wani ɓangare na iyakance kamuwa da cuta daga mutanen da ba su da alamun cutar. Dabarun nisantar jama'a suna da nufin rage haɗuwa da mutane masu cutar da ke cikin jama'a ta hanyar rufe makarantu da wuraren aiki, ƙuntata balaguro, da soke manyan tarurruka.
Jagororin nisantar da mutane sun hada da nisantar mutane aƙalla ƙafa 6 (mita 1.8).
Babu wani magani mai tasiri da aka sani wanda zai iya hana COVID-19. Tun da ba a sa ran samun allurar rigakafi har zuwa farkon 2021 ba, babban ɓangare na gudanar da COVID-19 shine ƙoƙarin rage yawan kamuwa da cutar, wanda ake kira  daidaitawa da lanƙwasawa.
CDC ta kuma ba da shawarar mutane su wanke hannayensu da sabulu da ruwa na aƙalla dakika 20 bayan sun je bayan gida, musamman bayan sun yi wanka ko hannayensu sun yi datti sosai, kafin cin abinci da kuma bayan yin fitsari, bayan tari ko hancin.
Ya kuma ba da shawarar yin amfani da maganin wanke hannu wanda ya ƙunshi aƙalla kashi 60% na barasa, amma kawai idan akwai ruwa da sabulu a cikin wadata. Ga yankunan da ba a samun ruwan wanke hannu na kasuwanci ba, WHO ta ba da wasu dabaru guda biyu waɗanda za a iya samarwa a cikin gida.
A cikin waɗannan ƙirar, aikin antibacterial yana faruwa ne ta hanyar ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da kwayoyin cuta. Ba shine sinadarin da ke aiki ba don kashe kwayoyin cuta.
An haɗa glycerin a matsayin mai kiyaye danshi.
Ana gudanar da mutane ta hanyar hana masu ba da ruwa, samar da iskar oxygen da sauran abubuwan da ke shafar gabobin jiki.
CDC ta ba da shawarar cewa duk wanda ake zargin yana dauke da kwayar cutar ya sanya abin rufe fuska.
A cikin wannan labarin, an yi magana game da yadda ake amfani da ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta.
Don ƙarfafa rigakafin cutar, ya kamata mu riƙa tsabtace jikinmu da kuma yin rayuwa mai kyau da kuma cin abinci mai gina jiki.
Hakanan, magungunan tallafi na iya zama da amfani ga waɗanda ke da alamun bayyanar cututtuka masu sauƙi a farkon lokacin kamuwa da cutar. WHO da Hukumar Kiwon Lafiyar Jama'a ta China sun ba da shawarwari don kula da asibiti don COVID-19.
Likitoci masu kulawa da ciwon huhu da likitocin cutar sankarar bargo a Amurka sun tattara shawarwarin magani daga sassa daban-daban na kiwon lafiya a IBCC, tushen bayanai kyauta.
A watan Afrilun 2020, babu wata magani da ta dace da cutar COVID-19.
Don alamun, wasu likitoci sun ba da shawarar amfani da paracetamol (acetaminophen) a matsayin farkon matakin amfani maimakon ibuprofen.
Musamman a wuraren kula da lafiya, idan ana amfani da hanyoyin da ke haifar da iska mai iska, kamar su kayan taimako na numfashi ko na hannu, ana buƙatar ɗaukar matakan kariya don rage haɗarin yaduwar kwayar cutar.
Ga masu kula da lafiya da ke kula da mutanen da ke da cutar COVID-19, CDC ta ba da shawarar bin ƙa'idodin rigakafi, rigakafin tuntuɓar, da rigakafin ƙwayoyin cuta na iska, da kuma kula da marasa lafiya a cikin keɓewar ƙwayar cuta ta iska (AIIR).
An ba da shawarar: Kayan PPE, mashin numfashi ko abin rufe fuska, abin rufe ido, da safar hannu na likita. Idan akwai, ka fi son yin amfani da na'urar numfashi (maimakon mashin).
Ko da yake an amince da kayan numfashi na N95 don aikace-aikacen masana'antu, FDA ta ba da izinin amfani da abin rufe fuska ta hanyar Dokar Amincewa da Amfani da Gaggawa (EUA).
Ko da yake an tsara su don kare su daga ƙwayoyin ƙura kamar ƙura a cikin iska, babu tabbacin inganci akan takamaiman wakili na halitta don amfani ba tare da alamar ba.
CDC ta ba da shawarar yin amfani da abin rufe fuska da kayan rufe fuska na zamani idan ba za a iya samun su ba.
Yawancin masu kamuwa da COVID-19 ba su da tsanani sosai don haka suna buƙatar injin numfashi ko na'urar kama da su.
Ana nazarin irin wannan taimakon numfashi ga mutanen da ke fama da matsalar numfashi da ke da alaƙa da COVID-19 a halin yanzu don yawancin marasa lafiya a asibiti, kuma wasu shaidu sun nuna cewa ƙaramin bututun hanci mai gudana ko matsin lamba mai matsin lamba biyu na iska zai iya hana shigar da su.
Ba a san ko ɗayan waɗannan abubuwa biyu na haifar da fa'idodi iri ɗaya ga waɗanda ke fama da ciwo mai tsanani ba.
Wasu likitoci sun fi son zama tare da injin injin mai aiki da ƙarfi idan ya yiwu, idan aka kwatanta da bututun hanci mai yawan iska. Wannan hanya tana iyakance yaduwar ƙananan ƙwayoyin da ke yawo cikin iska.
A yawancin ƙasashe masu tasowa, tsarin kiwon lafiya yana da iyakantaccen ikon magance hauhawar yawan marasa lafiya na COVID-19 masu tsanani da ke kwance a asibiti, kuma babu isasshen gadajen asibiti ga kowane mutum.
Wani bincike da aka yi a China ya nuna cewa kashi 5 cikin 100 na yara sun je asibiti, kashi 2.3 cikin 100 na bukatar taimakon na'urar numfashi, kuma kashi 1.4 cikin 100 sun mutu.
A China, kashi 30 cikin dari na mutanen da ke da cutar COVID-19 da ke asibiti suna cikin ci gaba da zuwa ICU.
COVID-19 yana haifar da bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana buƙatar masu numfashi da masu buƙatar PEEP masu ƙarfi waɗanda zasu iya yin yanayin matsin lamba da ake buƙata don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da haɗarin iska tsakanin huhu da kirji.
Wasu tsofaffin inhalers ba su da damar samun PEEP mai yawa.
An fara binciken yiwuwar maganin a watan Janairun 2020, kuma ana gwajin gwaji na asibiti na magunguna da ke kashe yawancin ƙwayoyin cuta.
A cewarsa, "Ramdesivir ya fi dacewa da mutane da yawa.
Ko da yake zai iya ɗaukar har zuwa 2021 kafin a sami sabon magani, yawancin magungunan da aka gwada an riga an amince da su don wasu amfani kuma ana ci gaba da gwaji.
A cikin wasu lokuta, masu cutar za su iya gwada maganin da ke kashe ƙwayoyin cuta.
WHO ta ba da shawarar masu sa kai don shiga cikin gwaje-gwaje don tabbatar da inganci da amincin magunguna masu yuwuwa. FDA ta ba da izini na ɗan lokaci don amfani da plasma na mai shan rana a matsayin magani na gwaji lokacin da rayuwar mutum ke cikin haɗari ko na yanzu.
Ba a kammala nazarin asibiti da ake bukata don nuna cewa yana da lafiya da tasiri a wannan cuta ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar salula don magance cutar.
Masu amfani suna buƙatar shigar da sunayensu da lambar ID.
Wannan app din yana amfani da bayanan sa ido don ganowa game da haɗuwa da haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano yiwuwar cutar, manhajar ba kawai tana ba da shawarar keɓe kai ba, har ma tana sanar da jami'an kiwon lafiya na gida. Ana bin diddigin mutane ta amfani da manyan tsarin nazarin bayanai a wayoyin salula, fasahar gane fuska, bin diddigin wayar hannu da fasahar ƙwaƙwalwar ajiya ta wucin gadi don gano mutanen da ke dauke da cutar da kuma waɗanda suka taɓa saduwa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, hukumomin tsaron Isra'ila sun yi amfani da wayoyin salula na mutane da ake zargi da dauke da cutar coronavirus.
Ana aiwatar da matakan karfafa keɓewa da kare waɗanda ke da yiwuwar haɗuwa da mutanen da ke da cutar.
A watan Maris na 2020, Deutsche Telekom ta raba bayanan wurin da aka tattara tare da cibiyar Robert Koch, wata hukumar gwamnatin tarayya ta Jamus don gudanar da bincike da hana yaduwar kwayar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano masu karya dokar hana fita.
Kwamishinan kiwon lafiya na yankin Italiya, Giulio Gallera, ya ce kamfanonin wayar salula sun sanar da shi cewa kashi 40 cikin dari na mazauna kasar suna tafiya a wasu hanyoyi.
Gwamnatin Jamus ta gudanar da gasar shiga ba tare da izini ba na tsawon sa'o'i 48 a karshen mako tare da masu halarta fiye da 42,000.
A wani bangare kuma, shugaban kasar Estonia Kersti Kaljulaid ya yi kira ga duniya da ta samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane da yawa suna iya jin tsoron keɓewa, ƙuntatawa na tafiya, illolin magani ko kuma kamuwa da cuta.
BBC ta nakalto Rory O'Connor yana cewa: "Keɓewa ta zamantakewa, kadaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki sune cikakkiyar guguwa da ke haifar da haɗari ga lafiyar mutane da kuma rayuwarsu".
Cutar tana iya kasancewa mai laushi kamar sauran cututtukan na sama na sama kamar sanyi, tare da alamun rashin lafiya kaɗan ko babu alamun cutar.
Yawancin lokaci marasa lafiya masu sauƙi suna murmurewa cikin makonni biyu, yayin da masu tsanani ko masu tsanani suna ɗaukar makonni uku zuwa shida don murmurewa.
Bayanai daga wasu ƙwayoyin cuta iri ɗaya kamar SARS da MERS sun nuna cewa mata masu ciki suna da haɗarin kamuwa da COVID-19. Amma babu bayanai game da cutar COVID-19. A wasu mutane, COVID-19 na iya shafar huhu kuma yana haifar da ciwon huhu.
A cikin mutanen da suka fi fama da cutar, COVID-19 na iya ci gaba cikin sauri zuwa mummunan kamuwa da cututtukan numfashi (ARDS) wanda ke haifar da numfashi, hawan jini, ko kuma lahani na gabobin ciki.
Wasu daga cikin sabbin cututtukan da ke tattare da COVID-19 sun haɗa da hawan jini, ƙwanƙwasawar jini mara kyau, da lalacewar zuciya, koda da hanta.
Rashin daidaiton jini, musamman ƙaruwa a cikin lokacin prothrombin (lokacin daskarewa), an gano a cikin 6% na waɗanda aka kwantar da su a asibiti tare da COVID-19, kuma an gano aikin koda mara kyau a cikin 4% na wannan rukunin.
An kiyasta cewa kashi 20-30% na mutanen da ke da COVID-19 suna da ƙwayoyin halittar hanta (transminases).
Rahoton ya ce matsakaicin lokacin daga bayyanar cututtuka zuwa mutuwa shine kwanaki 10, tare da kwana biyar a asibiti.
Amma, a matsakaita, akwai kwanaki bakwai tsakanin shigar da marasa lafiya asibiti da mutuwa a cikin marasa lafiya da aka sauya zuwa ICU.
A cikin nazarin farkon lokuta, matsakaicin lokacin daga lokacin bayyanar cututtuka na farko zuwa mutuwa shine kwanaki 14 a cikin tsawon kwanaki 6 zuwa 41.
Wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta gudanar ya nuna cewa mace tana mutuwa ne da kashi 2.8% a cikin maza, yayin da mace ke mutuwa da kashi 1.7%.
Gwaje-gwajen cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An gano wasu canje-canje a cikin kwayoyin cutar a cikin ƙwayoyin huhu.
Hoton na numfashi yana kama da cutar rashin lafiyar numfashi (ARDS).
Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito cewa kashi 11.8% na mutuwar da aka ruwaito sun kasance sakamakon lalacewar zuciya tare da yawan matakan troponin ko kuma ciwon zuciya.
A cewar wani rahoto na watan Maris a Amurka, kashi 89% na mutanen da aka kwantar a asibiti suna da cutar. Samun damar samun kayan aikin likita da tattalin arzikin yanki suna shafar yawan mace-mace.
A cewar rahoton, "Kasuwancin da aka yi a cikin wannan yanki ya nuna cewa, a wasu lokuta, mutane da yawa suna mutuwa a sakamakon cutar.
A cikin shekarun da suka gabata, an yi amfani da maganin rigakafi don magance cututtuka masu yawa.
Amma, a cewar rahoton, an rage yawan mutuwar da ake samu a yanzu saboda yawan mutanen da suka kamu da cutar a baya sun mutu.
Masu shan sigari sun fi saurin kamuwa da cututtukan COVID-19 sau 1.4 fiye da masu shan sigari, kuma sun fi saurin fuskantar jinya mai tsanani da mutuwa sau 2.4.
Hukumomin asibiti a Hong Kong sun ce a cikin mutanen da suka warke daga cutar, yawan aiki na huhu ya ragu da kashi 20 zuwa 30 cikin dari, wanda ke nuna cewa binciken huhu ya nuna lalacewar gabobin.
Wannan na iya haifar da alamun cutar da aka riga aka magance a cikin ICU bayan warkewa.
A watan Maris na 2020, ba a san ko cutar ta riga ta sami maganin cutar mai tasiri a cikin mutanen da suka warke daga cutar ba.
Duk da cewa akwai yiwuwar juriya dangane da halayyar sauran coronaviruses, an ba da rahoton cewa a cikin mutanen da suka dawo daga barkewar COVID-19, sun kasance masu ƙarancin kwayar cutar coronavirus.
A cikin waɗannan mutane, ci gaba da kamuwa da cutar zai iya zama mafi muni fiye da sake kamuwa da cutar.
Kwayar cutar na iya zama ta halitta ko ta samo asali ne daga asalin dabbobi.
Ko da yake ba a san ainihin asalin cutar ba, a watan Disamba na 2019, cutar ta kusan zama mai yaduwa daga mutum zuwa mutum.
Nazarin da aka buga a cikin The Lancet a watan Janairun 2020, ya nuna cewa an fara nazarin marasa lafiya 41 na COVID-19 kuma an bayyana ranar farko ta bayyanar cututtuka a ranar 1 ga Disamba, 2019.
A cikin wasiƙun da WHO ta buga a hukumance, an ba da rahoton farkon bayyanar cututtukan a ranar 8 ga Disamba, 2019.
A cikin shekarun da suka gabata, an yi amfani da ma'auni daban-daban don kimanta yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da tsawon lokaci, kuma sun dogara da halaye na yawan jama'a kamar yawan gwaji, ingancin kiwon lafiya, zaɓuɓɓukan magani, lokacin da cutar ta fara yaduwa, da shekaru, jinsi, da kuma lafiyar gaba ɗaya.
Bayan 2019, lokacin da WHO ke tsara lambobin ICD-10 don cututtukan gaggawa, ta bayyana mutuwar da aka tabbatar da cutar SARS-CoV-2 a matsayin U07.1, kuma mutuwar da aka gano a cikin cutar COVID-19 ta hanyar gwajin asibiti na SARS-CoV-2 wanda ba a tabbatar da gwajin asibiti ba ko gwajin cututtukan cututtukan cututtuka a matsayin U07.2.
Bisa ga bayanan Jami'ar Johns Hopkins, a ranar 17 ga Afrilu, 2020, yawan mutuwar duniya ya kai kashi 6.9% (153,822/2,240,191).
Adadin ya bambanta a yankuna. Sauran ma'aunin sun haɗa da yawan kamuwa da cuta (CFR), wanda ke nuna yawan adadin kamuwa da cuta da cutar ta kashe, da kuma yawan kamuwa da cuta (IFR), wanda ke nuna yawan kamuwa da cutar (m da marasa kamuwa da cuta).
Wannan adadi ba ya nuna lokacin da cutar ta fara ba, amma yana nuna yawan mutanen da suka kamu da cutar.
Ko da yake ba duk mutanen da suka kamu da cutar ba ne ke nuna rigakafi, kasancewa da rigakafi na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A wani karamin kauye mai suna Castiglione d'Adda, cibiyar kamuwa da cutar a Italiya, mutane 80 (1.7%) daga cikin mazauna 4,600 sun mutu.
A Gangelt, an yi bikin Carnival don yada cutar, kuma an yi amfani da ita don yaɗa cutar ga matasa, wanda ya haifar da ƙananan mutuwar, kuma ba a sami takamaiman adadin mutuwar COVID-19 ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai da ƙarfi.
A cikin Netherlands, kimanin kashi 3 cikin dari na masu bayar da jini sun sami maganin rigakafi.
A cikin wannan shekarar, mutane 69 ne suka mutu sakamakon cutar COVID-19 (kashi 0.004 cikin dari na yawan jama'a).
Sakamakon annobar da kuma yawan mace-mace da ta haifar ya bambanta tsakanin maza da mata.
A cikin binciken da aka yi a China da Italiya, an gano cewa maza sun fi mutuwa.
Bambanci tsakanin lokacin da maza da mata ke mutuwa ya kai kusan 90%, kuma mafi girman haɗarin ga maza shine maza a cikin shekaru 50.
A kasar Sin, mace-macen maza sun kai kashi 2.8 cikin dari, yayin da mata suka kai kashi 1.7 cikin dari.
Ko da yake ba a san ainihin dalilin da ya sa waɗannan bambance-bambance shida ba, amma ƙwayoyin halitta da halaye na iya zama ɗaya daga cikin abubuwan da ke haifar da hakan.
Bambancin tsarin garkuwar jiki na jinsi, shan taba da yawa da kuma kamuwa da cututtuka kamar hauhawar jini a cikin samari fiye da mata, duk sun haifar da yawan mace-mace a cikin maza.
A Turai, maza ne ke da kashi 57% na masu kamuwa da cutar, kuma kashi 72% na mutanen da ke mutuwa sakamakon COVID-19.
A watan Afrilun 2020, gwamnatin Amurka ba ta bi diddigin bayanan da suka shafi jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan da ke haifar da cutar kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, suna da yawan mata kuma suna da haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020, cewa sunan cutar zai zama COVID-19.
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa yana nufin ranar 31 ga Disamba, 2019 lokacin da aka fara gano cutar a CO a cikin COVID-19, Virus a VI, cuta a D, da kuma 19 a cikin COVID-19.
Don hana zargi, an sanya sunaye bisa ga shawarwarin duniya ba tare da yin la'akari da yanayin ƙasa ba (misali China), nau'in dabbobi, ko al'ummomin mutane. An sanya wa kwayar cutar da ke haifar da COVID-19 sunan coronavirus mai saurin kamuwa da cutar respiratory syndrome 2 (SARS-CoV-2).
WHO ta kara amfani da kalmar a cikin hulɗar jama'a kamar Covid-19 virus da Covid-19 causing virus.
Dukansu cutar da kwayar cutar ana kiransu da coronavirus.
A lokacin barkewar cutar a Wuhan, China, an kira kwayar cutar da cutar da coronavirus da Wuhan coronavirus.
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV a matsayin sunayen rikon kwarya don cutar da cutar, daidai da jagororin 2015 game da amfani da wuraren ɓarkewar cutar da sunayen ƙwayoyin cuta.
An sanar da sunan hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
A sakamakon karancin damar da ke cikin hanyoyin rarraba kayayyaki na yau da kullun, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da na numfashi.
A wani misali, lokacin da asibiti a Italiya ke bukatar bawul din na'urar numfashi, masana'antun ba su iya samar da su a lokacin da ake bukata ba, sai wani karamin kamfani na gida ya sake samar da bawul 100 da ake bukata a cikin dare.
Tun bayan barkewar cutar COVID-19, ra'ayoyin maƙarƙashiya, labaran karya da labarai na karya game da asalin cutar, yaduwarta, rigakafinta, maganin ta da sauran fannoni sun fito kuma sun bazu cikin sauri akan layi.
A cewar wani mai bincike, mutane na iya yada cutar ga wasu dabbobi.
Binciken bai yi nasarar gano wata alama ta cutar a cikin aladu, ducks da kaji ba.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
Cibiyoyin gwamnati, kungiyoyin ilimi da masana masana'antu suna gudanar da bincike na duniya kan alluran rigakafi da magunguna don COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da wani gwaji na musamman don tantance ingancin maganin magungunan guda hudu da ake ganin sun fi tasiri wajen kawar da cututtukan.
A halin yanzu, akwai wasu hukumomi da ke aiki da himma wajen samar da alluran rigakafi, duk da rashin wadatarsu.
Dukansu SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam, suna amfani da ayyukan da aka yi a baya don SARS-CoV.
A halin yanzu, akwai wasu magungunan rigakafi guda uku da ake gwadawa.
A karo na farko, masu bincike suna aiki don samar da allurar rigakafin cutar.
Amfani da cutar da ba ta aiki ko kuma ta mutu yana nufin saurin amsawar rigakafin jikin mutum ga COVID-19 da sabon kamuwa da cuta.
Dabara ta biyu, alluran rigakafi da aka yi da ƙwayoyin cuta na ƙwayoyin cuta, shine ƙirƙirar allurar rigakafi da za ta motsa tsarin garkuwar jiki don samar da wasu ƙwayoyin cuta na kwayar cutar don sake yin yaƙi.
A cikin mutane masu kamuwa da cutar SARS-CoV-2, binciken ya mai da hankali kan furotin mai ƙwanƙwasa S wanda ke taimakawa cutar ta shiga cikin mai karɓar enzyme na ACE2.
Aikin na uku shi ne allurar rigakafin nucleic acid (DNA ko RNA allurar rigakafi, sabon tsari don gano allurar rigakafi).
Za a ci gaba da gwada alluran rigakafin gwaji daga waɗannan dabarun don aminci da inganci. An fara gwajin farko na allurar rigakafi tare da masu sa kai huɗu a Seattle a ranar 16 ga Maris, 2020.
Allurar rigakafi ta ƙunshi lambar kwayar halitta mara lahani da aka kwafe daga kwayar cutar. Ko da yake an ba da shawarar haɓaka dogara da ƙwayoyin cuta don rigakafi a matsayin ƙalubalen da zai iya faruwa a cikin haɓaka allurar rigakafi don SARS-COV-2, wannan yana da rikice-rikice.
A watan Afrilun 2020, an samu rahotanni cewa akwai gwaji sama da 300 a halin yanzu.
Yawancin gwaje-gwaje sun bincika maganin zazzabin cizon sauro da aka amince da su, gami da nazarin huɗu akan hydroxychloroquine da chlorophyll.
Rahoton da aka fitar a ƙarshen Afrilu ya nuna cewa ƙasashe da yawa suna cikin gwaji tara na Mataki na 3 na ramdesivir, wani magani mai cutar rigakafi wanda aka sake amfani da shi a yawancin binciken China.
Ana ci gaba da nazarin ci gaban magunguna don allurar rigakafi da maganin COVID-19 a watan Afrilu 2020. Yawancin magungunan rigakafin cutar da ke cikin gwaji don maganin COVID-19 sun haɗa da ramdesivir, chloroquine, da hydrochloroquine, lupinavar/ritonavar da lupinavar/nitrotova, da kuma haɗin Interferon beta.
A watan Maris na 2020, an yi niyyar samar da hujjoji game da ingancin maganin.
An lura da ci gaban magani a cikin marasa lafiya da ke amfani da maganin ramdesivir wanda ba a tabbatar da shi ba.
Ana gudanar da gwaje-gwaje na Mataki na 3 a Amurka, Italiya da China. An fara nazarin chlorhexidine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, a cikin watan Fabrairun 2020 tare da sakamakon farko a China.
Amma akwai kira ga nazarin juna don bincike.
Hukumomin kiwon lafiya na Koriya da China sun amince da amfani da chlorhexidine.
Koyaya, duk da cewa shawarar yau da kullun ita ce gram ɗaya, masana kimiyyar cutar Wuhan sun lura cewa sau biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin yin amfani da gaggawa na hydrochlorothiazines da chlorothiazines tare da amincewar likitocin da ke kula da mutanen da ke da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar allurai masu yawa na maganin rigakafi don hana SARS-CoV-2 daga cikin bututun gwaji.
Bayan nuna ƙarancin ƙuntatawa na SARS-CoV-2, an ba da shawarar nitasozanine don ƙarin nazarin cikin jiki. Cikakken membrane protease serine 2 (TMPRSS2) yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar mai karɓar ACE2.
Nazarin da aka yi akan chlorophyll da hydrochlorophyll tare da azithromycin ko a'a, yana da manyan iyakoki waɗanda ke hana ƙungiyar likitoci ci gaba da nazarin waɗannan magungunan. Ba a san rawar da oxytamivir ke takawa a cikin maganin COVID-19 ba, ba tare da hana SARS-CoV-2 daga waje ba.
A cikin matakai masu tsanani na COVID-19, ana samun sakamako mai illa wanda ake kira hawan cytokine.
Akwai shaidar cewa hydrochloric acid na iya samun kaddarorin anti-cytokine. Bayan ƙaramin bincike, Hukumar Kiwon Lafiyar Kasa ta China ta ƙara tosalizumab a cikin jagororin magani.
A Italiya, ana gudanar da gwajin matakin 2 na kasa wanda ba a rasa ba bayan an gano masu cutar da cutar a cikin mutane masu fama da cutar.
Ana amfani da shi tare da gwajin jini don cire plasma don gano cutar cytokine (alamu na rashin lafiyar da ke haifar da amsawa) don magance wannan ci gaba, wanda ake tsammanin shine dalilin mutuwa ga wasu mutanen da ke fama da cutar.
A cikin 2017, FDA ta amince da maganin anti-interleukin-6 receptor, bisa ga nazarin nazarin yanayin don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Har zuwa yau, babu wata hujja da aka sarrafa ta hanyar bazuwar da ta nuna cewa tosalizumeb magani ne mai tasiri don CRS.
Ana binciken samar da rigakafi masu tsabta da aka samar ta hanyar tsarin garkuwar jiki na waɗanda suka warke daga COVID-19 don ba da su ga waɗanda suke buƙatar su a matsayin hanyar haɓaka rigakafi ta atomatik ba tare da allurar rigakafi ba.
An gwada wannan dabarar a SARS kuma an sami sakamako mara kyau.
Rage tasirin kwayar cutar yana da wani aiki da ake tsammani saboda ana iya amfani da maganin rigakafin rigakafi na ƙananan hanyoyi don magance SARS-CoV-2.
Duk da haka, wasu hanyoyin, kamar su antibody-dependent cytotoxicity da/ko phagocytosis, suna yiwuwa.
Wasu hanyoyin maganin maganin rigakafi na atomatik, kamar amfani da rigakafin monoclonal na wucin gadi, har yanzu ana ci gaba da gwaji.
Samun samfurin plasma na Nalanta, wanda ke dauke da maganin rigakafi na musamman ga kwayar cutar, wani sashi na jini daga marasa lafiya da ke murmurewa, zai karu don saurin amfani da shi.
Cutar coronavirus, wata cuta mai alaƙa da juna
Likita Li Wenliang daga babban asibitin Wuhan, wanda ya kamu da cutar COVID-19 kuma ya mutu bayan ya kara wayar da kan jama'a game da yaduwar cutar.
